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Human Subjects Research Definitions1 
 
45 CFR Part 46: Code of Federal Regulations covering protection of human subjects. 45 
CFR 46 is divided into four subparts: A, B, C, and D. Subpart A, also known as the 
Common Rule, governs human subject research for most federal agencies; subparts B, C, 
and D address special areas.  
 
Anonymized: Refers to information or data where identifiers (and codes that are linked 
to identifiers) have been removed, as well as other values that would enable individuals 
to be identified by inference. Close correlation with values in additional datasets, or 
unique values, or cells containing few data points, for instance, could support such 
inferences. A dataset, therefore, must at least have been thoroughly de-identified in order 
to be anonymized. For all practical purposes, anonymized data cannot be linked to the 
individual.  
 
Belmont Report: Statement of ethical principles for human subjects research issued by 
the National Commission for the Protection of Human Subjects in 1978. 
 
Beneficence: Ethical principle stated in the Belmont Report, stating an obligation to 
protect people from harm by not doing harm and by maximizing benefits and minimizing 
risks. 
 
Child/Minor: A person who has not attained the legal age for consent to treatments or 
procedures involved in the research  
 
Clinical Trial: Human subjects term indicating a prospective study of human subjects 
designed to answer questions about biomedical or behavioral interventions, e.g., drugs, 
treatments, devices, or new ways of using known treatments to determine whether they 
are safe and effective.  
• Phase I tests a new intervention in 20-80 people for an initial evaluation of its 
safety, e.g., to determine a safe dosage range and identify side effects.  
• Phase II studies an intervention in a larger group of people, usually several 
hundred, to determine efficacy and further evaluate safety.  
• Phase III studies the efficacy of an intervention in large groups of several hundred 
to several thousand subjects by comparing it to other standard or experimental 
interventions, while monitoring adverse events and collecting information that 
will allow safe use.  
• Phase IV is a study done after an intervention has been marketed to monitor its 
effectiveness in the general population, and collect information about adverse 
effects associated with widespread use.  
                                                 
1 The definitions on the following pages are excerpted directly from the federal regulations on human 
subjects research: Department of Health and Human Services regulations 45 CFR 46, Food and Drug 




Common Rule: The central federal policy adopted “in common” by 16 federal 
departments and agencies (and concurred, with some modifications, by the FDA) that 
support and/or conduct research involving human subjects. The adoption of the federal 
policy in 1991 implements a recommendation of the President's Commission for the 
Study of Ethical Problems in Medicine and Biomedical and Behavioral Research that all 
federal departments and agencies "adopt as a common core the regulations governing 
research with human subjects issued by the Department of Health and Human Services 
(codified at 45 CFR 46, Subpart A, Protection of Human Subjects). 
 
Compensation: Payment or other benefits that are provided to participants in research. 
 
Confidentiality: Act of not divulging information disclosed in a relationship of trust 
without permission, including fulfilling the expectation that it will remain private.  
 
Conflict of Interest (COI): Financial, career, or other such interest, including interests 
of family members, that could be advanced by the conduct of a research project. 
 
Continuing Review: Research that has been approved will undergo review until the 
completion or termination of the research, including scheduled continual reviews of 
research that will occur at least annually  
 
Data: Refers to information that is collected for analysis or used to reason or make a 
decision  
 
Deferral: Refers to the status of a protocol that cannot be approved without additional 
information about the research. Several situations can lead to a deferral, including if the 
protocol does not contain enough information to allow the IRB to fully review and 
understand the nature of the research; and, if the IRB feels it does not have enough 
expertise to assess a specific portion of the protocol.  
 
De-Identified: Refers to information or data where direct identifiers such as name and 
address have been removed. Typically this refers to data where it may still be possible to 
identify individuals by inference or through codes held by the investigator or a third 
party. Thus data that is de-identified may not be anonymized because it may still permit 
at least probabilistic re-identification when analyzed in conjunction with other datasets.  
 
Department of Health and Human Services (DHHS): Federal government department 
to which the National Institutes for Health (NIH) belong whose mission is to protect the 
health of Americans and provide essential human services. 
 
Exempt: Human subjects research that is excluded from 45 CFR 46. You do not need 
documentation that your research is exempt; you only need the signatures of the applicant 




Exemption Categories: Human subjects term indicating six research categories exempt 
from human subjects regulations:  
1. Research conducted in educational settings involving normal educational 
practices, such as research on instructional strategies, techniques, curricula, or 
classroom management methods.  
2. Research using cognitive, diagnostic, aptitude, and educational achievement tests, 
or surveys, interviews, or observations of public behavior, unless human subjects 
are identifiable, and disclosure of responses could put them at risk of liability, or 
damage to their reputations or financial standing.  
3. Research using cognitive, diagnostic, aptitude, and educational achievement tests, 
or surveys, interviews, or observations of public behavior, unless subjects are 
public officials or candidates for public office, or federal statutes require that the 
confidentiality of identifiable information will be maintained.  
4. Research involving the collection or study of existing data, documents, records, 
pathological specimens, or diagnostic specimens, if the sources are publicly 
available, or the information is recorded so subjects cannot be identified.  
5. Research and demonstration projects conducted or approved by agency heads to 
study public benefit or service programs, procedures for obtaining benefits or 
services, or other changes to those programs.  
6. Taste and food quality evaluation and consumer acceptance studies in a) 
wholesome foods without additives or b) food containing a food ingredient at or 
below a level and use found to be safe, or an agricultural chemical or 
environmental contaminant at or below a level deemed safe by the following 
agencies: Food and Drug Administration, Environmental Protection Agency, and 
the U.S. Department of Agriculture.  
 
Expedited Review: Review of a research project by a designated voting member or 
members rather than an entire IRB. Expedited review is allowed for some low- risk 
research and minor changes in approved research. 
 
Experimental: Therapy unproved or not yet scientifically validated for safety and 
efficacy. A procedure may be considered "experimental" without necessarily being part 
of formal research. 
 
Federalwide Assurance (FWA): Online form that every institution conducting human 
subjects research must file with the Office for Human Research Protections. The federal 
regulations stipulate that institutions performing research covered by 45 CFR 46 must 
provide written assurance that it will comply with the requirements set forth in 45 CFR 
46. 
 
Food and Drug Administration (FDA): Department of Health and Human Services 
(DHHS) agency that reviews clinical research to regulate the marketing of foods, drugs, 




Full Board Review: Review meeting of a quorum (or majority) of IRB members, 
including at least one nonscientific member. To gain IRB approval, a majority of 
members present at a meeting must agree. 
 
Gender: Human subjects term indicating a classification of research subjects into women 
and men. In some cases, gender cannot be accurately determined, e.g., for pooled blood 
samples. 
 
Human Subject:  A living person with whom an investigator directly interacts or 
intervenes or obtains identifiable, private information private information. Regulations 
apply to human organs, tissues, body fluids, and recorded information from identifiable 
people. 
 
Informed Consent: A person’s voluntary agreement, based upon adequate knowledge 
and understanding, to participate in research or to undergo a medical procedure. In giving 
informed consent, a human subject may not waive legal rights or release or appear to 
release an investigator or sponsor from liability for negligence.  
 
Institution: Any public or private entity or Agency (including federal, state, and other 
agencies). 
 
Institute of Medicine (IOM): A multidisciplinary organization that examines the use, 
costs, quality, accessibility, delivery, organization, financing, and outcomes of health care 
services to increase knowledge and understanding of the structure, processes, and effects 
of health services for individuals and populations.  
 
Institutional Review Board (IRB): Committee set up by a research institution to ensure 
the protection of rights and welfare of human subjects. IRBs make an independent 
determination to approve, modify, or disapprove research protocols based on the 
adequate protection of human subjects, as required by federal regulations and local 
institutional policy. IRBs must register with the Office for Human Research Protections 
(OHRP). 
 
IRB Approval: The determination of the IRB that the research has been reviewed and 
may be conducted at an institution within the constraints set forth by the IRB and by 
other institutional and Federal requirements. 
 
Justice:  Ethical principle stated in the Belmont Report that requires that the benefits and 
burdens of research be distributed fairly. 
 
Minimal Risk: The probability and magnitude of harm or discomfort anticipated in the 
research are not greater in and of themselves than those ordinarily encountered in daily 




Nonaffiliated Member: An IRB member who “is not otherwise affiliated with the 
institution and who is not part of the immediate family of a person who is affiliated with 
the institution” (45 CFR 46.107). 
 
Nonscientist Member: An IRB member “whose primary concerns are in nonscientific 
areas” (45 CFR 46.107). 
 
Nuremberg Code: Code of research ethics developed during the trials of Nazi war 
criminals following World War II and widely adopted as a standard during the 1950s and 
1960s for protecting human subjects. 
 
Office for Human Research Protection (OHRP): DHHS office that oversees human 
subjects protection for DHHS-supported research (formerly the NIH Office of Protection 
from Research Risks).  
 
Peer Review Criteria: Basis for assessing the scientific merit of (typically funded) 
research grant applications:  
• Significance – Is the topic important? Will it advance scientific knowledge?  
• Approach – Are the hypothesis, design, and methods well developed and 
appropriate? Are potential problems addressed?  
• Innovation – Does the proposal involve new ideas or methods?  
• Investigator – Do the investigators have the training and experience to do the 
work?  
• Environment – Will the scientific environment contribute to success? Is there 
institutional support for the project? Does the work take advantage of existing 
opportunities?  
 
Principal Investigator (PI): Qualified person designated by an applicant institution to 
direct a research project or program. The research project or program may or may not be 
supported by a federal agency or other funding body. PIs oversee scientific and technical 
aspects of a grant and the day-to-day management of the research. PIs do not have to be 
employees of a grantee organization; however, these parties must have a written 
agreement specifying their relationship. 
 
Private Information: Information about behavior that occurs in a context in which an 
individual can reasonably expect that no observation or recording is taking place, and 
information which has been provided for specific purposes by an individual and which 
the individual can reasonably expect will not be made public (such as a medical record).  
 
Protocol: Formal design for research involving human subjects that an investigator 
submits to an IRB for review for human subjects research. A protocol generally has an 
objective, rationale, design, eligibility requirements, treatment regimen, and a description 
of research and data analysis methods. 
 
Quorum: A majority of IRB members (required for IRB decisions), including at least 




Research: Systematic investigation, including research development, testing, and 
evaluation, to develop generalizable knowledge.  
 
Respect for Persons: Ethical principle stated in the Belmont Report that involves 
recognition of the personal dignity and autonomy of individuals, and special protection of 
those persons with diminished autonomy. 
 
Risk: Probability of harm or physical, psychological, social, or economic injury resulting 
from participation in a research study.  
 
Scientific Misconduct: Fabrication, falsification, plagiarism, or other practices that 
seriously deviate from those commonly accepted in the scientific community for 
conducting or reporting research. 
 
Scientist Member: A person whose “primary concerns are in scientific areas” (45 CFR 
46.107). 
 
Serious Adverse Event: Adverse event that results in death, life-threatening experience, 
hospitalization or prolongation of hospitalization, significant disability, or a birth defect. 
Investigators must file serious adverse event reports with a sponsor and the IRB, which 
reports them to the appropriate federal oversight body (either OHRP or FDA). 
 
Subject: Historically, a subject was defined as a healthy person or patient who 
participates in a clinical investigation either as a recipient of an investigational drug or as 
a control. This term is also used to describe any human research participant, regardless of 
the nature of the research study. 
 
Subpopulations: Human subjects term indicating a group further defined by geographic 
origins, national origins, or cultural differences. Subpopulation data can be defined and 
reported by self-reporting or other means. Mixed racial or ethnic descent also applies to 
subpopulations, and such combinations may have biomedical or cultural implications for 
the science. 
 
Waiver of Informed Consent: The Common Rule specifies that an IRB can alter or 
waive the requirement to obtain informed consent if it finds and documents that the 
research involves no more than minimal risk to the subjects, the waiver or alteration will 
not adversely affect the rights and welfare of the subjects, the research could not 
practicably be carried out without the waiver or alteration, and whenever appropriate, the 





Issues involving the use of human subjects converge at the intersection of 
research in engineering, science, ethics, medicine, and technology and society. 
Ultimately, questions arise about risks and benefits to research participants and society, 
and the governance of science. By law, research organizations must establish an 
institutional review board (IRB) to decide whether to approve research protocols with 
human participants. Approximately 6600 IRBs exist in the U.S. Previous research on 
IRBs, mostly quantitative, has not studied the relationship between member 
characteristics (such as role and gender) and member perceptions of the IRB process. In 
this research I draw primarily on participatory democratic theory to frame the central 
research questions and the resulting analysis. I examine IRB members’ roles, 
participation, and expertise on the IRB and how these relate to their perception of the IRB 
decision-making processes at seven leading U.S. research universities. 
 Policymakers and researchers alike increasingly are focusing on the adequacy of 
the existing system that oversees research studies involving human participants. As 
tension continues to mount over the applicability of the current guidelines to all research 
involving human participants, federally funded or not, it is timely to examine this 
oversight system to increase our understanding of how these committees actually decide 
whether to approve or disapprove human subjects research in their organizations.  
 In this study, data are collected from personal interviews with scientist, 
nonscientist and nonaffiliated members serving on IRBs at each of the participating 
universities, and from observation of an IRB meeting in session at each site. The findings 
of this research provide a scientific assessment of the relationship between IRB member 
composition and members’ perceptions of the IRB process. This research contributes to 
our understanding of the decision-making process that takes place within IRBs. 
Furthermore it utilizes the IRB as a mechanism for expanding our understanding of larger 
questions about the interfaces of science and policy and science and society. By 
questioning who are the experts and how do different members attribute value to a 
research protocol on an IRB, we can begin to address broader issues of expertise and 





1.1 Background to the research 
Dr. Smith: Okay, we have a quorum now. Let’s get this meeting started. Who’s got #04-
067? Mary, I believe you were primary reviewer on that one. John, you were secondary 
reviewer, right? 
 
Mary: Yes, that was me. Let’s see, Mr. White wants to ask students in the SOC401 class 
about their sexual behavior, beliefs and attitude. He’s hypothesizing that young adults 
from single parent households have more liberal views towards sexual behavior. Looks 
like the lit review is decent but he didn’t cite Doe’s work, which I think is important to 
what he expects to find. There’s a consent form included in the protocol and it seems to 
cover the key elements of informed consent according to our IRB checklist. 
 
John: What department is White from?  
 
Mary: He’s a student in my department but I don’t know him personally. Morgan signed 
off as his advisor. John, do you have anything to add? 
 
John: Yes. Actually, I have two problems with this one. First, I wonder whether it should 
be coming to the board at all. If this is a class project then it could be classified as non-
research and therefore, we don’t need to see it. Second, if it is research for his thesis or 
something like that, I’m concerned about how this will look if the study results hit the 
front page of the local paper, especially if something negative comes out of it and that’s 
entirely possible given the nature of the study. Does the university really want that kind of 
exposure? 
 
Michael: I don’t have the full IRB package. Did he give us any information on the types 
of questions he’s planning to ask? 
 
Kathy: I have a real problem with student research like this. I mean, there are some 
potentially big problems with a student asking his peers sensitive questions on sexuality. 
Is White in this class or is he a TA for the class? Can’t someone else collect the data on 
his behalf? What if someone was sexually abused and some of the questions trigger a 
painful memory for him or her? What if he finds out that one of the students in the class 
sexually assaulted another student on campus? Then what will he do? I am not at all 
comfortable with this research and especially not with the student collecting the data 
from his peers. 
 
Jones: I’m not as concerned about that but I think this research design is awful. How 
could Morgan have signed off on this junk? It makes me wonder if he even read it before 
giving it his approval. What is White comparing his sample group to? How can he get the 
information he’s looking for with this kind of a design? Has the survey instrument been 




Ann: Could we step back for a moment, because I am still not sure whether it is within 
our purview to review the scientific merit of studies? This is a student project and there 
may be no real direct benefit to society. But if this is part of the learning process for the 
student to become a good researcher, doesn’t that ultimately benefit society? 
 
Miss Regs: Ann brings up a good point but let me remind the committee that technically 
speaking we are charged with the responsibility of making sure that the risks are 
minimized in a research protocol. So, if the study design compromises the participants’ 
safety, then we ought to consider the design in our decision. In fact, we’re obliged to 
review the scientific merit and research design according to 45 CFR 46 so it is well 
within the IRB’s purview to do so. 
 
Mary: As we are discussing this, I’m just looking over the survey instrument again and 
the questions look fine to me. They are all validated measures. This is standard in our 
field. 
 
Dr. Smith: Well, do we have enough information on this one to make a motion?  
 
Kathy: I think we need to table this until we get more information about how he will 
handle the issue of data collection and confidentiality. I’m still not comfortable with this 
in its current form. 
 
Dr. Smith: If we push this off another month, it’s going to delay his research. We have to 
think about that and make sure that we’re tabling it for good reasons. Our priority is to 
protect the potential participants, but we don’t want to be an obstacle to the research 
getting done either. 
 
John: I’m satisfied. I don’t think it’s as big of a deal as Kathy does. I move to approve the 
protocol on the condition that we receive written clarification on the PI’s status, 
justification for performing the study, and revisions to the consent form satisfactory to the 
chair. Dr. Smith, is that okay with you? 
 
Ann: I second. 
 
Dr. Smith: That’s fine with me. Miss Regs will include these specific required revisions in 




Mary: I abstain because he’s from my department. 
 
Dr. Smith: Kathy, would it make you feel better to also see the revisions before final 




Reverend Carter: Can I ask a question? What if the parents of these students find out 
about their participation in this study, especially if the results reflect negatively on single 
parents?  
 
Dr. Smith: You raise a good point Reverend Carter. Miss Regs, could you add these 
concerns to the PI letter? Kathy and I will review the revisions prior to final approval. 
Reverend Carter, would you also like to see the revised protocol again? (Carter agrees.) 
Okay, White is approved with aforementioned conditions subject to approval of the 
Chair, Kathy, and Reverend Carter.  
 
 
 There are many issues at play in this hypothetical institutional review board (IRB) 
scenario that invite in-depth examination about the role of the IRB, how members 
determine the potential risks and level of risk in the study, the ways in which IRB 
members make decisions about whether to approve or disapprove a research protocol and 
how (or whether) these decisions are affected by the composition of members and their 
participation in the IRB discussion. The scenario is not intended to represent a specific 
factual case or all IRB meetings; yet, it combines many of the elements and issues 
observed while conducting this research at seven U.S. research universities. Moreover, it 
provides a point of departure for dissecting the human subjects review system and for 
answering more challenging questions about expertise and democratic governance of 
science. 
 The task of protecting human research participants requires balance among risk 
minimization, concern for public values, and a desire to advance scientific knowledge. In 
the U.S., IRBs were conceived as a means to protect human research participants by 
promoting ethical and responsible conduct of research. The pursuit of this balance is built 
into the composition of an IRB via the current federally mandated requirement that all 
IRBs must include at least one scientist member, one nonscientist member and one 
nonaffiliated member on a committee of at least five members1 “with varying 
backgrounds to promote complete and adequate review of research activities” (45 CFR 
46, Protection of Human Subjects, Section 107). In theory, this composition is intended 
                                                 
1 Where necessary and depending on the nature of the research project, members from or representing 
vulnerable populations should also be included in the IRB review process (e.g., prisoners or prisoner 




to ensure that the board is diverse, sufficiently qualified, and sensitive to issues including 
community attitudes. Yet, little is actually known about how IRBs actually function, or 
more specifically about how member characteristics relate to the group decision-making 
process and outcomes of the IRB. Most IRB research (for example, Bell et al., 1998; 
Gray et al., 1978; Goldman and Katz, 1982; Barber et al., 1973) treats the IRB decision-
making process as a “black box”, primarily using quantitative methods to characterize it 
and mostly measuring inputs and outputs. They do little to reveal the decision-making 
process of an IRB itself. 
The policy problem that emerges from the regulation of human subjects research 
is ensuring that human participants in research are granted three basic ethical rights—
justice, beneficence, and respect for persons—while continuing to advance scientific 
knowledge. The conflict over how this should be achieved is indicative of an underlying 
intellectual challenge that lies at the heart of current debates on the issue. Because the 
answers to the policy and intellectual problems are so closely intertwined, this study 
attempts to dissect the system that oversees human subjects research by focusing on the 
arena where novel (and often more risky) research is most prevalent—the research 
university. 
 
1.2 Research problem and research questions 
 It is uncertain whether the regulatory objective of a diverse composition of IRB 
members actually results in the most effective decision-making processes or yields 
quality decision outcomes regarding a research proposal. It is also unclear what “most 
effective” and “quality outcomes” mean in a decision system that blends scientific and 
public values criteria. Is a decision most effective if it allows the investigator to conduct 
the research as long as no risk is inflicted upon the research participants? Is the best 
decision outcome one that provides value-added to the scientific merit or study design of 
the research? Or is it best to disapprove a study outright if it is poorly designed or has 
more than minimal risk? Is a most effective decision one that permits a mediocre student 
project with little or no benefit to anyone but the student researcher? Are these outcomes 
even the outcomes we should be using to measure the effectiveness of the IRB system? 
These are difficult questions that cannot be answered solely by tallying outputs such as 
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counting how many protocols an IRB approves, modifies, defers, or disapproves. Such 
“bricks and mortar” analyses cannot fully explain the IRB decision-making process or 
determine the quality of IRB review provided. These questions cannot be adequately 
addressed without probing deep into the group decision-making process that takes place 
behind the doors of the university IRB meeting. This dissertation represents the first 
phase of what will be a longer-term study of IRB decision-making at the group level. 
To increase our understanding of the IRB decision-making process (and more 
broadly decision-making at the boundary of science and society) in depth systematic 
research is needed at the local level to examine specifically how university IRBs assess 
risk, how members come to the determination that a study should be approved or 
disapproved, and how or whether board composition (i.e., membership characteristics) 
impacts these decision outcomes. In the IRB setting, what matters more is the quality of 
the decision—that is, the extent to which issues such as risks and benefits, and public 
values and concerns are discussed during protocol review—rather than what decision 
(approve, approve with modifications, defer, or disapprove) is taken. A more 
comprehensive treatment of potential risks and benefits, discussion about the contribution 
of the research to knowledge, and so forth contributes to the richness of the group history 
associated with a particular decision that, in the IRB setting, is applicable to future 
decisions. This information is available in the group repertoire and can used again in 
future decision-making about similar human subjects issues that other wise may not 
benefit from such deliberation.  
Thus, the problem addressed in this research is, “what is the relationship 
between IRB member characteristics and members’ experiences and perceptions of 
the IRB process?” To expand our understanding of this problem, I examine the 
relationship between the member perceptions of the IRB decision-making process and 
characteristics of IRB members and their committees. More specifically, I examine the 
relationship of member role in the different IRB settings of public and private universities 
and IRBs that review all types of human subjects research compared with those that 
review primarily biomedical or social and behavioral human subjects research. 
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 Since 2000, federal funding has been suspended at several U.S. research 
universities1 because of violations of regulations governing safety and ethical standards 
in human subjects research. In response, the National Bioethics Advisory Committee and 
some members of Congress have recommended an increase in the proportion of 
nonscientists and nonaffiliated members that serve on IRBs. But empirical evidence is 
lacking as to whether these failures and other IRB issues are directly attributable to 
various board characteristics. To date, no published systematic research has examined the 
influence of board composition on university IRB decision-making processes and 
associated decision outcomes. Thus, this research study seeks to examine that 
relationship between IRB composition—the types of members that serve on an IRB—and 
IRB behavior by asking a series of research questions: How do IRB members make 
decisions about whether to approve a human subjects research protocol—that is, 
about risk-benefit ratio, scientific merit, research design, and adequacy of informed 
consent? What is the relationship between members’ roles on the IRB and their 
level of expertise as these characteristics relate to their experiences and perceptions 
of the IRB process? 
These research questions are driven by a gap in our understanding of how IRBs 
function in practice and by a transdisciplinary call for overhauling the human subjects 
research oversight system. They also arise from the observation that IRBs are being thrust 
directly into the crossfire of researchers’ fight for academic freedom on the one hand and 
a push to expand public governance of science on the other. Furthermore, answering 
these research questions provides entrée into more complex questions about how 
membership characteristics specifically affect the quality of the decision outcome. Thus, 
owing to the nature of my research objective and questions, I will not formally state or 
test hypotheses about the research questions in this dissertation. Rather, based on my 
                                                 
1 Due to the death of gene therapy volunteer Jesse Geslinger all gene therapy programs at the University of 
Pennsylvania were suspended in January 2000. In July 2000, federally funded medical research was 
suspended at the University of Oklahoma because of concerns about the safety of a vaccine to treat 
melanoma. Though there has been no confirmed link to the study, 26 of the participants in the melanoma 
study died over the course of the study. At the University of Washington’s Hutchinson Cancer Research 
Center, 80 of the 82 patients who participated in a failed blood-cancer trial between 1981 and 1993 have 
died. Ellen Roche, a healthy volunteer in a Johns Hopkins asthma study, died in 2001. Also in 2001, Johns 
Hopkins University was accused of purposely misleading volunteers in a lead-based paint study about the 




review of the literature, pilot study results, and my experience working closely with one 
IRB for two years, several preliminary propositions will guide my research about the 
relationship between IRB composition and members’ perceptions of the IRB decision-
making process. More specifically I examine whether: Characteristics of IRB members 
are related to participation in the IRB decision-making process, such that (1) 
nonaffiliated members and nonscientist members participate in the process differently, 
and perhaps less, than scientist members, and (2) female members participate differently 
than male member in the group discussion, regardless of expertise. I will refer to this the 
“member characteristic proposition”. I also expect that the IRB is not immune to group 
behaviors, such as deference, that are evidenced in studies of small group decision-
making. However, I have no a priori expectations about how these behaviors specifically 
manifest themselves among the convened group of IRB members. 
Other explanations for why nonscientist and nonaffiliated IRB members, and 
female members participate in different ways compared with their scientist, and male 
member counterparts could be due to the type of IRB (biomedical, social and behavioral, 
or comprehensive) and whether it is located at a public or private university. For 
example, members who serve on biomedical IRBs may participate differently in the 
decision-making process than their social and behavioral IRB counterparts, specifically 
with regard to the issues they emphasize in protocol reviews. Or, members on IRBs at 
public universities may approach their review of the issue of scientific merit differently 
by virtue of the mission of a public university. Thus, either or both of these “IRB 
characteristics” might instead explain the differences in the relationship of IRB member 
composition and the IRB decision-making process. I will refer to these alternative 
explanations as the “IRB culture proposition”. 
The results of this research will contribute to theory and to policy and practice. It 
is expected that this research will inform the debate over public participation in technical 
decision-making and contribute to our understanding of difficult questions about what it 
means to be an expert in the science policy process. Furthermore, by providing 
universities with knowledge that will relate to the selection of members to serve on an 
IRB, this research will also inform policy and decision-makers for improving human 




1.3 Justification for the research 
 Research on IRBs is varied and what does exist focuses primarily on the 
bureaucratic functions of the research oversight process. Studies have examined the 
workload of IRBs (e.g., Gray et al, 1978; Bell et al, 1998), the perceptions that research 
investigators have of the review process (e.g., Cleary, 1987; Ferraro et al., 1999), and 
various elements of the IRB protocol such as issues of informed consent (e.g., Barber et 
al., 1973). Yet, the actual process by which the members on an IRB arrive at their 
decision to approve, defer, or disapprove a research protocol has been virtually neglected. 
No studies that I have discovered have examined the characteristics of IRB members in 
the context of the federal guidelines that each committee must have three types of 
member: a scientist, a nonscientist, and a nonaffiliated member. None of the earlier 
studies of IRBs have sought to use the IRB as a mechanism to inform our understanding 
of the role of the lay public in technical decision-making or governance of science. And, 
no studies on IRBs have employed the IRB decision-making process as a lens by which 
to examine what it means to be an expert in technical decision-making.  
 During the past 25 years, studies have attempted to characterize IRB operations 
by examining features such as the workload, types of research reviewed, and general 
operating procedures. Those studies were contextually driven by our limited knowledge 
about the development of IRBs in response to the early federal regulations. Little is 
reflected in the published literature about how IRBs formed after the promulgation of the 
1966 U.S. Public Health Services policy requirement for all recipients of federal funding 
to establish an IRB (see McCarthy, 1998). Subsequent studies examined various 
components of IRB legislation such as the requirement for informed consent and consent 
process in general, or they attempted to understand how the oversight process from the 
research investigators perspective (for example, Gray et al., 1978; Goldman and Katz, 
1982; Bell et al., 1993). 
This study differs from prior research in that it attempts to relate IRB members’ 
perceptions of the decision-making process to the composition and participation of these 
members on the IRB and thereby draw conclusions about the impact of composition on 
the resulting decision outcomes and human subjects oversight system. This research is 
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also unique in that the IRB decision-making process is examined via participatory 
democratic theory, which suggests that nonscientists and lay people (“nonexperts”) can 
participate in political decision-making that is obviously dependent on the knowledge of 
experts (Dewey 1927, cited in Fischer 2000). The examination is further informed by 
research on small group decision-making, which suggests that groups exhibit a bias 
toward discussing only shared knowledge. 
Participatory democratic theory implies that maximum input (participation) is 
required by the public, and that output includes not just policies (decisions) but also the 
development of the social and political capacities of each individual involved in the 
process (Pateman, 1970). Participatory democratic theory, therefore, suggests that in the 
ideal IRB setting, the required composition of scientists, nonscientists, and nonaffiliated 
members should contribute to broad discussion about research protocols, and not only 
should this participatory discussion lead to a quality decision (e.g., Phillips, 1995) about 
the research protocol but it should also improve the decision-making capacity of each 
member in subsequent discussions about future research protocols. Yet, evidence from 
research on small group decision-making suggests that groups do not necessarily 
incorporate knowledge that is held by only a few individuals (Stewart, 1998). As it relates 
to nonscientist or lay participation in human subjects decision-making, this evidence 
suggests that unless these members and scientist members share beliefs or knowledge 
about protocol-relevant information or public values, such information is not necessarily 
reflected in the IRB decision process or outcome. 
At the broadest level, I apply participatory democratic theory to IRB decision-
making—that is, to decision-making about scientific research involving human 
participants. Against this framework, I consider the relationship between individual 
member decision processes and the overall group level discussion. By examining the 
relationship between IRB composition and IRB decision-making at a sample of top 
ranking research universities I offer explanations about what it means to be a scientist 
versus a nonscientist (the expert-nonexpert distinction) on the IRB and how these 
characteristics may ultimately influence the quality of the decision outcome of the 
committee. I employ IRBs as a lens through which to examine the expert-nonexpert 
distinction at the interface of science and society. Additionally, by investigating the 
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considerations they take into account during this decision-making process, I aim to 
further clarify our understanding of how IRB committee members arrive at a decision of 
whether to approve research with human participants. It is expected that this research will 
contribute to the identification of a solution to the intellectual dilemma (protect human 
subjects while advancing scientific knowledge) and inform the policy question posed by 
how to best regulate research involving human participants. 
In summary, this research attempts to (1) examine how IRB members determine 
whether to approve a human subjects research protocol, and (2) investigate how member 
composition on the IRB is related to members perceptions about the IRB decision-
making process. While it is beyond the scope of this dissertation to directly examine the 
quality of IRB decisions, I use the results of this research to speculate on the relationship 
between IRB characteristics and the quality of IRB decision outcomes. 
  
1.4 Methodology 
This research employs qualitative analysis and case study methodology to 
characterize the research oversight system in seven top ranking U.S. research universities 
and to articulate a theory of IRB decision-making. A qualitative research approach was 
selected for its ability to investigate IRB attributes and behaviors that are not easily 
quantifiable, but necessary to explain IRB decision-making and improve upon it. 
Interview data are analyzed at the IRB level at each university and then compared via 
cross-case analysis across all participating universities. The methodological approach is 
detailed and justified in Chapter 4. 
 
1.5 Organization of the dissertation 
In Chapter 2, the reader is oriented with the historical context of human subjects 
research and the development of related policies that impact human subjects research in 
the U.S. In Chapter 3, the study of member participation in the decision-making process 
on IRBs is framed in terms suggested primarily by participatory democratic theory but 
also by small group decision-making theory. Given the limited empirical research on IRB 
decision-making I pay particular attention to areas where further research will enhance 
our understanding of governance of science and decision-making at the boundaries 
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between science and society. The theoretical framework plays close attention to the 
participatory culture on university IRBs and their relationship with those they serve in the 
context of a regulatory environment of science. It also illuminates the challenges in 
defining concepts such as participation, risk, public values, and expertise. In Chapter 4, I 
describe and discuss the data sources and methodological inquiry employed in this 
research.  
The empirical chapters of this dissertation are organized in two sections. Chapter 
5 provides a brief overview of the participant demographics. Chapter 6 investigates the 
human subjects review system at the individual case level of each university IRB and sets 
the context for subsequently examining participation and decision-making across the 
cases in Chapter 7. A cross-case analysis is presented in Chapter 7, in which I compare 
and contrast IRB decision-making across the seven universities. In Chapter 8, I offer 
conclusions about both the general research problem and the specific research questions 
that guide this study. Additionally, I consider implications for the theories that frame my 
analysis and human subjects research policy and practice. Finally, Chapter 8 addresses 
limitations of the research and offers more general comments on the problems and 
possibilities of studying IRBs in other contexts (such as hospitals, private research 
centers, developing countries, and so forth). The interview protocols and codebooks for 
obtaining and analyzing the data may be found in the Appendices. 
 
1.6 Definitions 
In order to examine prevailing beliefs of and challenges to oversight of human 
subjects research, it is necessary to clarify terms that will be frequently used throughout 
this dissertation. A complete list (adapted from federal sources1) of common terminology 
in human subjects research and IRB review is provided at the front of this dissertation.  
For purposes of this research the following operational definitions are used. 
Decision-making or the decision-making process is the course of action taken by the 
individual member, or the IRB committee as a whole, as it relates to determining whether 
a protocol is approved or not. Generally IRB members receive protocols for review in 
                                                 
1Definitions were obtained from regulatory guidelines from the Office of Human Research Protections 




advance of the IRB meeting. Members are asked to review the protocols and identify 
potential problems or issues that may prevent IRB approval at the convened meeting. 
Typically IRB members independently review these protocols prior to the actual IRB 
meeting, and then discuss their concerns as a group at the convened IRB meeting. Thus, I 
define the decision-making process as the procedures by which members, both 
independently and as a group, judge the risks and benefits of the proposed research, the 
scientific merit of the study, the appropriateness of the sample selection, and the 
adequacy of the consent process. The decision-making process is also assessed via the 
meeting agenda, available meeting minutes, and correspondence with research 
investigators and other participants in the study via emails, letters or other forms of 
communication.   
Participation means different things to different people. In this study there are 
two contexts in which I consider and discuss participation: participatory democratic 
theory and actual participation on an IRB. Participation in the context of participatory 
democratic theory refers to the normative process of shared decision-making and 
governance between government (decision-makers) and citizens (see Dahl et al., 2003). 
In the context of this study, this concept is situated amidst the decision-making process 
on the IRB that involves scientists and nonscientists, experts and nonexperts, elites and 
lay citizens. I distinguish the normative definition of participation from participation on 
an IRB, which I envision occurs at two different levels: either the member’s active 
involvement (talking about or asking questions about a protocol) in the discussion at IRB 
meetings, or the member’s involvement in the overall IRB process external to the actual 
meeting. Examples of the latter type of involvement may occur at multiple levels that are 
not necessarily equal (in the sense that all members do not necessarily review all 
protocols or in the same manner), including attendance at the meeting, contribution to the 
discussion, active review of protocols, service as a liaison between the IRB and the 
research investigators, or holding or participating in campus-wide IRB workshops. 
Participation level in this study is measured qualitatively in two ways: (1) self reported by 
the IRB member during the in-depth interview, and (2) independently observed at the in-




The federal guidelines for IRB membership—that is, the types of members who 
are required to serve on an IRB—as laid out in the Common Rule (45 CFR 46),1 are not 
overly specific. Specifically 45 CFR 46.107 describes a scientist and a nonscientist 
vaguely as a “member whose primary concerns are in scientific areas” and a “member 
whose primary concerns are in nonscientific areas,” respectively. Per the Common Rule 
(45 CFR 46.107), the nonaffiliated member is characterized not by his or her educational 
background, but rather by his or her affiliation with the research institution. To be 
considered “nonaffiliated,” a member may not have any connection to the university 
which the IRB serves and may not be part of the immediate family of a person who is 
affiliated with the institute. Many IRBs refer to the nonaffiliated member as “the 
community member” since s/he is typically chosen from the surrounding community. 
Often (but not always) these members are ministers, local business owners, retired 
doctors, lawyers, retired teachers, or homemakers. The nonaffiliated member may be 
further classified as a scientist or a nonscientist depending on their educational training 
and experience. And in fact, it is not unusual in some organizations for the nonaffiliated 
member to possess a similar background in education and experience to the scientist 
members on the committee. 
 
1.7 Delimitations of scope and key assumptions 
Several limitations are purposefully imposed upon this research. First, the 
sampling frame was limited to top ranking research universities because the vast majority 
of federally funded and nonfederally funded human subjects research is performed in 
these organizations. While this means that the sample group at the university level is 
somewhat homogenous in certain areas (research expenditure, breadth of undergraduate 
and graduate programs, organizational structure), it can be expected to differ from other 
types of colleges and universities and from non-educational research organizations 
(hospitals, specialized research institutions) where human subjects research is also 
conducted. Second, the sample size is relatively small, though consistent with that 
                                                 
1 The Common Rule (or 45 CFR 46) receives its name by virtue of the fact that its core requirements 
upheld by more than a dozen U.S. federal agencies that conduct or fund human subjects research. 45 CFR 
46 includes three basic requirements: (1) compliance by research institutions, (2) assurance that researchers 
will obtain and document informed consent, and (3) the establishment of certain obligations for IRBs 
including membership, function, operations, review of research, and record keeping. 
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typically seen in qualitative research studies. Seven universities participated in this 
research, which yielded interviews with 37 IRB members. The current composition of 
members on each IRB further dictated which type of member participated in the study by 
virtue of the fact that some universities fulfill the nonscientist and nonaffiliated roles with 
the same person, thereby reducing the number of potential participants from these 
member categories. For example, at one participating university in this study all of the 
affiliated members are scientist members while the nonaffiliated members satisfy the 
nonscientist member requirement simultaneously. 
 
1.8 Summary 
 This chapter laid the foundations for the dissertation. It introduced the research 
problem and the research questions that guided the study and influenced the choice of 
research methods. A justification for this research was provided, definitions and terms 
were presented, the methodology was briefly described, the study was outlined, and the 
limitations of the research were stated. The following chapters will expand upon these 
ideas and in further detail. 
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2.0 A Brief History of Human Subjects Research 
 
In order to formulate a theoretical perspective to inform our understanding of IRB 
decision-making, it is helpful understand why IRBs exist at all. Prior to World War II, the 
ethics of research was seldom mentioned or rarely documented for several reasons: (1) 
clear standards of research ethics were not systematically taught in medical schools or 
research centers at that time; (2) only a very small portion of the federal budget was 
allocated to human subjects research and those studies did not attract much attention from 
Congress or the media; (3) neither the public nor scientists clearly distinguished between 
“research” and “care”; and (4) physicians enjoyed a high level of public trust and thus, 
the ethics of their research was seldom criticized by patient subjects (McCarthy, 1998).  
But history has shown that some human subjects research never should have 
occurred. McNeill (1993) provides a broad account of unethical human experimentation 
dating as far back as Hippocrates and the Ptolemies. However, until the 1940s the 
concept of “research ethics” was not one of widespread concern (Rothman, 1987). It was 
during this time that funding of research significantly increased in the U.S., much of it 
with the intention of benefiting soldiers coping with war-related diseases (McNeill, 
1993). The Nazi medical experiments on prisoners during World War II represent a 
trigger event in research ethics and the need to protect human research participants, and 
ultimately led to the development of the Nuremberg Code (1949)—ten guiding principles 
for conducting permissible medical research on human participants. Twenty-three 
German doctors and scientists were tried for various crimes including placing prisoners in 
low pressure chambers and observing their deaths; exposing prisoners to freezing air and 
water; infecting prisoners with typhus and malaria to test various drugs; sterilization and 
castration by various means; and murdering prisoners (including children) for parts of 
their anatomy (Alexander, 1949).  
But the catalysts that forced ethical standards into the practice of clinical research 
were a series of exposés in the 1960s and early 1970s that made headlines (Rothman, 
1998). In the 1960s, a study at the Willowbrook State School in New York deliberately 
exposed children to hepatitis to observe the course of the disease. In the mid-1960s, a 
study at the Jewish Chronic Disease Hospital in Brooklyn, New York involved injecting 
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elderly and senile patients with live cancer cells to observe how the health system of 
chronically ill patients reacted to foreign cells (Evans, 1982). In 1966, Henry Beecher’s 
(a physician-researcher himself) infamous article in the New England Journal of 
Medicine in 1966 was published, citing 22 examples of ethically deficient and 
questionable health-threatening experiments performed on humans without informed 
consent. In the 1970s, the Tuskegee syphilis study (1932-1972) was made public. The 
Tuskegee study participants were black men with syphilis who were purposefully left 
untreated, even though a treatment for syphilis was available, in order to observe the 
course of the disease if left untreated. Even as recently as the early 1990s, the Johns 
Hopkins University conducted a research study on lead paint exposure, in which 
landlords of lead-contaminated housing were encouraged to rent to families (with 
otherwise healthy young children) who were told the homes had been abated of lead paint 
(Kaiser, 2001). Those families were subsequently recruited to participate in a study in 
which blood testing of the children would be done; however, families were not informed 
that blood lead testing was to be part of the study. 
Not all of the studies that led to the current human subjects policies were 
conducted in the medical sciences, however. In the 1950s, a University of Chicago study 
involved bugging federal juries and led to Congressional hearings and legislation. During 
the same period, Milgram’s famous psychology experiment on obedience led to 
significant controversy among social scientists.  
These and other human subjects research studies conducted during the 20th 
century prompted the federal government in the U.S. and other countries to develop 
human subjects protection policies that have evolved during the past 50 years. The first 
federal document requiring committee review was issued in 1953 but applied only to 
intramural research at the newly opened Clinical Center at the NIH (Levine, 1981). In 
1964, the World Medical Association developed the Declaration of Helsinki as a 
statement of ethical principles to provide guidance to physicians and other participants in 
medical research involving humans (World Medical Association, 2002). In 1966, the U.S. 
National Advisory Health Council issued Policy and Procedure Order 129 (PPO 129), 
which required Public Health Service (PHS) grantee institutions to: 
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…provide prior review of the judgment of the principal investigator or program 
director by a committee of his institutional associates. This review should assure 
an independent determination (1) of the rights and welfare of the individual or 
individuals involved, (2) of the appropriateness of the methods used to secure 
informed consent, and (3) of the risks and potential medical benefits of the 
investigation. 
 
 Thus the institutional review board (IRB) was born. The PHS policy has been 
expanded and revised several times since 1966. But from the beginning the premise 
behind the policy was that the government would demand accountability while 
implementation would be local (McCarthy, 1998). Two key requirements missing from 
earlier versions of PPO 129 were subsequently added in 1981: (1) informed consent in 
cases where the reviewing committee found no risk to subjects, and (2) a justice 
provision that would require equitable distribution of the burdens and benefits of 
biomedical research throughout society (McCarthy, 1998). During this early period of 
regulatory policy, the division of NIH that was responsible for overseeing the new human 
subjects research protection policy was very small and quickly became overwhelmed. 
Early compliance with PPO 129 was dispersed and inconsistent across research 
institutions in part because so little specific guidance was available for institutions 
required to comply with the policy. 
The issuance of PPO 129 was not the final solution to human subjects abuses. As 
noted above, research on the Tuskegee Syphilis Study continued for five years after PPO 
129 was originally issued, and ultimately was the impetus for passing the National 
Research Act of 1974 (Public Law 93-348: National Biomedical Research Fellowship, 
Traineeship, and Training Act). The National Research Act created the National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral 
Research and further strengthened legislative oversight of human subjects research. This 
commission was charged with the task of identifying the basic ethical pillars of 
biomedical and behavioral research involving humans and with developing guidelines 
which institutions could follow to assure that human subjects research was conducted in 
accordance with such ethical principles. Over the course of four years, the 11-member 
committee deliberated on such topics as informed consent, risk/benefit ratios, selection of 
 
18 
research subjects, the use of fetuses and vulnerable populations, and other issues 
(Greenwald, 1982). 
The National Commission responded by preparing the Belmont Report in 1979, 
which set forth three fundamental ethical principles for research involving humans: (1) 
respect for persons, (2) beneficence, and (3) justice. Respect for persons involves 
recognition of the personal dignity and autonomy of individuals, and advocates special 
protection of people with diminished autonomy. The principle of respect for persons is 
achieved via the informed consent process in which potential participants are presented 
with comprehensible information in a manner that allows them to make an informed 
decision about whether or not to participate in a research study. The principle of 
beneficence is embedded in the ethical tradition of medicine via the Hippocratic Oath to 
“help, or at least to do no harm” (Levine, 1981) and involves the obligation to protect 
participants from harm by maximizing anticipated benefits and minimizing possible risks 
of harm. The principle of beneficence is achieved through a careful analysis of the risks 
and benefits ensuring that the expected benefits outweigh the risks, and that the risks are 
minimized. Finally, the principle of justice requires that the benefits and risks of research 
are distributed equally over the population and that participants are not chosen simply 
because they are conveniently accessible. 
In 1981, the U.S. Department of Health and Human Services (DHHS) and the 
Food and Drug Administration (FDA) issued regulations based on the Belmont Report 
(see McCarthy, 1998). Known as the Common Rule (i.e., 45 CFR 46), these regulations 
provide guidance for researchers on the appropriate ways to involve human participants 
in research projects. The Common Rule (so called because its core requirements have 
been adopted by more than a dozen U.S. federal agencies that conduct or fund human 
subjects research) includes three basic requirements: (1) compliance by research 
institutions, (2) assurance that researchers will obtain and document informed consent, 
and (3) the establishment of certain obligations for IRBs including membership, function, 
operations, review of research, and record keeping.  
IRBs are formally designated groups of people that review and monitor research 
involving human participants, with the primary obligation to protect the rights and 
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welfare of human research participants. Today, every organization1 that performs 
federally funded research must submit its research protocols involving humans for IRB 
approval. Federal guidelines require IRBs not only to evaluate the potential risks and 
benefits to research participants, but also to judge the scientific merits of the study 
(because even minimal risk is not permissible if the project is methodologically flawed). 
The IRBs source of authority and its credibility within the research community is 
reflected within the process of appointing IRB members (Ryan, 1982). 
Peer review and ethical review are key components of the human subjects 
research monitoring system (Dunn and Chadwick, 1999). Both the Nuremberg Code and 
the Declaration of Helsinki stipulate that research should be designed in a manner to 
justify the performance of the experiment (Nuremberg 3) and that basic biomedical 
research on human subjects must conform to generally accepted scientific principles and 
a thorough knowledge of the scientific literature (Helsinki, I.1) (Levine, 1981). The 
process of peer review ensures that sound research design and methods are employed 
(Dunn and Chadwick, 1999). Poorly designed research will not yield benefits, thus 
making it difficult if not impossible to uphold the principle of beneficence. Likewise, if 
one agrees to participate in research they are entitled to something of value because of 
their participation. Poorly designed research wastes the time of the participant and 
consequently violates the principle of respect for persons (Levine, 1981).  
Ethical review ensures that risks are minimized or are reasonable with respect to 
benefits; selection of subjects is equitable; informed consent is sought and documented 
appropriately; where appropriate, that data monitoring provisions are adequate; and, that 
additional safeguards are in place if any participants are from vulnerable populations.2 
Federal guidelines (45 CFR 46) grant the IRB autonomy in the interpretation of 
                                                 
1 Many types of organizations conduct research involving humans and thus have IRBs associated with 
them—universities, state and federal agencies, hospitals, and research foundations (National Academy of 
Sciences, 2000). The number of federal wide assurances on file at OHRP totals more than 6,600 (email 
correspondence with OHRP on March 31, 2004). External and private IRBs are also included in this 
number. These independent IRBs provide for-hire services to accommodate those institutions that have 
research activities but either do not have their own IRB (perhaps because they cannot justify the cost of a 
full-time IRB) or desire to supplement existing local IRBs. 
2 Vulnerable populations include groups such as children, prisoners or wards of the state, and the elderly 
(45 CFR 46). 
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regulations. Each IRB is asked to apply its own discretion when deciding how a research 
proposal will be judged to meet the ethical criteria laid out in the federal guidelines.  
The Common Rule delineates three categories under which research with human 
subjects can be classified: exempt, expedited and full board review. But before a protocol 
is classified it must be deemed to be “research”. The term “research” usually refers to a 
class of activities designed to develop or contribute to generalizable knowledge. Per the 
federal guidelines (specifically 45 CFR 46.102) “research” is defined as: 
…a systematic investigation, including research development, testing and 
evaluation, designed to develop or contribute to generalizable knowledge. 
Activities which meet this definition constitute research for purposes of this 
policy, whether or not they are conducted or supported under a program which is 
considered research for other purposes. For example, some demonstration and 
service programs may include research activities. 
 
Research is distinct from the “practice” of medicine or behavior therapy which are 
activities designed solely to enhance a patient’s or client’s well-being (Levine, 1981). 
Generally the determination of whether a study is “research” according to this definition 
is made initially by the IRB administrator and staff, and sometimes with input of the IRB 
chair. Occasionally, a protocol makes it to the fully convened IRB where its classification 
as “research” may be questioned by IRB members during the decision-making 
discussion. 
 The federal guidelines provide additional assistance to aid in the determination of 
whether the research is then “exempt” from or “expedited” through the full IRB review 
process. To be considered “exempt” from the full board review process, a research study 
must fall under one or more of six “exempt” categories (45 CFR 46.101b): 
1. Research conducted in established or commonly accepted educational settings, 
involving normal educational practices, such as (i) research on regular and special 
education instructional strategies, or (ii) research on the effectiveness of or the 
comparison among instructional techniques, curricula, or classroom management 
methods. 
2. Research involving the use of educational tests (cognitive, diagnostic, aptitude, 
achievement), survey procedures, interview procedures or observation of public 
behavior, unless: (i) information obtained is recorded in such a manner that 
human subjects can be identified, directly or through identifiers linked to the 
subjects; and (ii) any disclosure of the human subjects' responses outside the 
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research could reasonably place the subjects at risk of criminal or civil liability or 
be damaging to the subjects' financial standing, employability, or reputation. 
3. Research involving the use of educational tests (cognitive, diagnostic, aptitude, 
achievement), survey procedures, interview procedures, or observation of public 
behavior that is not exempt under paragraph (b)(2) of this section, if: (i) the 
human subjects are elected or appointed public officials or candidates for public 
office; or (ii) Federal statute(s) require(s) without exception that the 
confidentiality of the personally identifiable information will be maintained 
throughout the research and thereafter. 
4. Research involving the collection or study of existing data, documents, records, 
pathological specimens, or diagnostic specimens, if these sources are publicly 
available or if the information is recorded by the investigator in such a manner 
that subjects cannot be identified, directly or through identifiers linked to the 
subjects. 
5. Research and demonstration projects which are conducted by or subject to the 
approval of Department or Agency heads, and which are designed to study, 
evaluate, or otherwise examine: (i) Public benefit or service programs; (ii) 
procedures for obtaining benefits or services under those programs; (iii) possible 
changes in or alternatives to those programs or procedures; or (iv) possible 
changes in methods or levels of payment for benefits or services under those 
programs. 
6. Taste and food quality evaluation and consumer acceptance studies, (i) if 
wholesome foods without additives are consumed or (ii) if a food is consumed 
that contains a food ingredient at or below the level and for a use found to be safe, 
or agricultural chemical or environmental contaminant at or below the level found 
to be safe, by the Food and Drug Administration or approved by the 
Environmental Protection Agency or the Food Safety and Inspection Service of 
the U.S. Department of Agriculture. 
If research cannot be classified as “exempt”, the next category of IRB review is 
“expedited” review. Expedited review does not necessarily mean that the research will 
move quickly through the system. Rather, it suggests that the research can be classified in 
either or both of the following ways (45 CFR 46.110): 
1. some or all of the research appearing on the list and found by the reviewer(s) to 
involve no more than minimal risk, 
2. minor changes in previously approved research during the period (of one year or 
less) for which approval is authorized. 




1. Clinical studies of drugs and medical devices only when condition (a) or (b) is 
met: 
a. Research on drugs for which an investigational new drug application (21 
CFR Part 312) is not required. (Note: Research on marketed drugs that 
significantly increases the risks or decreases the acceptability of the risks 
associated with the use of the product is not eligible for expedited review.)  
b. Research on medical devices for which (i) an investigational device 
exemption application (21 CFR Part 812) is not required; or (ii) the 
medical device is cleared/approved for marketing and the medical device 
is being used in accordance with its cleared/approved labeling.  
 
2. Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture 
(under specific conditions as noted in the regulations). 
 
3. Prospective collection of biological specimens for research purposes by 
noninvasive means. 
 
4. Collection of data through noninvasive procedures (not involving general 
anesthesia or sedation) routinely employed in clinical practice, excluding 
procedures involving x-rays or microwaves. Where medical devices are 
employed, they must be cleared/approved for marketing. (Studies intended to 
evaluate the safety and effectiveness of the medical device are not generally 
eligible for expedited review, including studies of cleared medical devices for 
new indications.)  
 
5. Research involving materials (data, documents, records, or specimens) that have 
been collected, or will be collected solely for nonresearch purposes (such as 
medical treatment or diagnosis).  
 
6. Collection of data from voice, video, digital, or image recordings made for 
research purposes.  
 
7. Research on individual or group characteristics or behavior (including, but not 
limited to, research on perception, cognition, motivation, identity, language, 
communication, cultural beliefs or practices, and social behavior) or research 
employing survey, interview, oral history, focus group, program evaluation, 
human factors evaluation, or quality assurance methodologies.  
 
8. Continuing review of research previously approved by the convened IRB as 
follows: where (i) the research is permanently closed to the enrollment of new 
subjects; (ii) all subjects have completed all research-related interventions; and 
(iii) the research remains active only for long-term follow-up of subjects; or 
where no subjects have been enrolled and no additional risks have been identified; 
or where the remaining research activities are limited to data analysis.  
 
9. Continuing review of research, not conducted under an investigational new drug 
application or investigational device exemption where categories 2-8 do not apply 
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but the IRB has determined and documented at a convened meeting that the 
research involves no greater than minimal risk and no additional risks have been 
identified. 
 
 The Common Rule stipulates that “under an expedited review procedure, the 
review may be carried out by the IRB chairperson or by one or more experienced 
reviewers designated by the chairperson from among members of the IRB…(who) may 
exercise all of the authorities of the IRB except that the reviewers may not disapprove the 
research” (45 CFR 46.110). If the expedited review procedure is used, IRBs must have a 
formal process for keeping all IRB members informed of research proposals which have 
been approved under the procedure. Generally this is achieved by presenting a list of such 
protocols to the full committee at the next IRB meeting for final approval. 
 If a research protocol does not qualify for IRB review under either the exempt or 
expedited review process, it must be reviewed by the full committee at a convened IRB 
meeting at which it will undergo the review process that is a primary focus of this 
dissertation, i.e., the IRB decision-making process at the convened IRB meeting. In 
accordance with federal policies, an IRB has the authority to approve and disapprove 
research protocols based not only on the potential for the study to impart risk to subjects, 
but also on the scientific merit of the study. These IRB actions are deemed essential in 
assuring that the rights and welfare of human research participants are protected at all 
times throughout a research study.  
 The IRB accomplishes its goal of protecting the rights and welfare of human 
research participants through the peer review and ethical review of informed consent 
documents and procedures, determining whether risks are reasonable in light of expected 
benefits, and judging that the risks and benefits of research are equitably distributed 
across the population (Belmont Report, 1979). It is assumed that IRBs use a group 
process to evaluate research protocols and related materials, such as informed consent 
documents, before a study is approved and throughout the duration of an approved 
research study. Thus, the IRB must make decisions at two levels: (1) whether a research 
protocol is approvable and, (2) whether the risk involved is significant or nonsignificant 




• scientific merit  
• research design  
• risk-benefit ratio, and  
• adequacy of informed consent.  
 
The federal guidelines do not provide specific criteria about all of these key areas. Rather, 
each committee is left to autonomously decide how to interpret the baseline regulations 
and in fact, is encouraged to use the flexibility of the regulations where appropriate.  
 The Common Rule provides minimal guidance about the regulatory basis for 
approving a research protocol. Per Section 46.111 of the Common Rule, IRBs are asked 
to ensure that protocols address seven points within the context of the four review areas 
above. First, risks to subjects should be minimized. This is determined by evaluating the 
research design of a study to verify that the research is consistent with sound research 
design and that participants are not being subjected to unnecessary risk. Second, risks to 
participants should be reasonable in comparison to expected benefits. The IRB is told to 
consider only those risks and benefits that may result from the research (as compared 
with those risks or benefits that participants may experience if they were receiving a 
treatment regardless of participation). Third, sample selection should be equitable and not 
limited to a specific group. In such cases where targeted research is being done, such as 
research on the elderly or children or prisoners, it must be justified and special 
considerations for vulnerable populations must be incorporated into such settings. Fourth, 
informed consent should be sought from each participant or his or her legal guardian, 
unless justification for a waiver can be provided. Fifth, the process of informed consent 
must be documented. Sixth, where appropriate, data monitoring procedures must be 
explained and provided. And finally, IRBs should consider whether provisions for 
participant confidentiality are adequate in the context of the research risks.  
 Other than these seven general guidelines for review, the Code of Federal 
Regulations does not state exactly how IRBs ought to arrive at a decision to approve or 
disapprove human subjects research. Rather IRBs and their members are left to 
independently judge the adequacy of submitted research protocol. In July 2002, OHRP 
issued a statement that outlines the required elements set forth in 45 CFR 46. This 
document summarizes requirements of the Common Rule in lay terms by specifically 
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stating what the IRB must do; however, nowhere does it explain how the IRB members 
should arrive at their decision. For example, the July 2002 letter states that: 
Unless a primary reviewer system is used, all members should receive a copy of 
the complete documentation. These materials should be received by members 
sufficiently in advance of the meeting date to allow review of this material. If the 
IRB uses a primary reviewer system, the primary reviewer(s) should do an in-
depth review of all pertinent documentation. All other IRB members should at 
least receive and review a protocol summary (of sufficient detail to make the 
determinations required under HHS regulations at 45 CFR 46.111), the proposed 
informed consent document, and any recruitment materials, including 
advertisements intended to be seen or heard by potential subjects.1 
 
The federal regulations do not provide IRBs or members with specific information about 
what constitutes an “in-depth review”. Upon joining the IRB, members are typically 
introduced to the IRB process via one of the publicly available Internet courses on human 
subjects protection, a training manual, or a workshop designed in-house at their research 
organization. During this introductory training, IRB members learn about the basic 
principles of ethical research, history of human subjects research, elements of informed 
consent and so forth. However, OHRP does not actually require IRBs to formally train 
their members. Instead, 
OHRP strongly recommends that the Institution and the designated IRB(s) 
establish educational training and oversight mechanisms (appropriate to the nature 
and volume of its research) to ensure that research investigators, IRB members 
and staff, and other appropriate personnel maintain continuing knowledge of, and 
comply with, relevant ethical principles, relevant Federal Regulations, OHRP 
guidance, other applicable guidance, state and local laws, and institutional 
policies for the protection of human subjects. Furthermore, OHRP recommends 
that a) IRB members and staff complete relevant educational training before 
reviewing human subject research; and b) research investigators complete 
appropriate institutional educational training before conducting human subject 
research.2 
 
 Greenwald (1982) observes that one of the most perplexing problems facing IRB 
members is the relationship between the ethical components of IRB review and the 
                                                 
1 Office of Human Research Protections (OHRP), “OHRP Guidance on Written Procedures,” July 11, 
2002, Department of Health and Human Services (available at: 
www.hhs.gov/ohrp/humansubjects/guidance/irbgd702.htm; visited on October 12, 2004) 
2 U. S. Department of Health and Human Services, Office for Human Research Protections, Federalwide 
Assurance of Protection for Human Subjects, March 20, 2002 (available at: 
www.hhs.gov/ohrp/humansubjects/assurance/filasurt.htm; visited on October 12, 2004) 
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scientific aspects of the study. In most organizations, a large number of IRB members are 
likely to be nonexperts in the field of the study. Furthermore, the consensus among 
lawyers, clergy, community representatives and others typically serving in the 
nonaffiliated or nonscientist role is that they feel unqualified to judge the scientific merits 
of a protocol (Greenwald, 1982). Yet, the 1979 version of the Federal regulations 
explicitly required IRBs to evaluate research design to determine whether the methods 
are appropriate to the objectives of the study and such that the risks are minimized via 
sound research design. Though the final regulations published in 1981 softened this 
requirement somewhat by focusing primarily on the requirement that “risks to subjects 
are minimized by using the safest procedures with sound research design” (Greenwald, 
1982), IRBs are required nonetheless to review both the research design and scientific 
merit of human subjects research protocols. 
 The flexibility in the federal guidelines is intended to allow IRBs to reflect local 
values (Azar, 2002), and this also holds true for committee composition. Except for 
minimal requirements, IRBs are free to choose which individuals will participate on the 
committee. At a minimum IRBs must be comprised of at least five members, including a 
chair, a scientist, a nonscientist, and a person not affiliated with the university .1 The 
definition of each type of committee member is somewhat vague. The Common Rule 
states only that each IRB must include one member whose “primary concerns are in 
scientific areas” (i.e., the scientist member) and one member whose “primary concerns 
are in nonscientific areas” (i.e., the nonscientist member). Similarly, each IRB must also 
include at least one member who is “not otherwise affiliated with the institution and who 
is not part of the immediate family of a person who is affiliated with the institution” (i.e., 
the nonaffiliated member). Additionally, IRBs are required to make every effort to ensure 
that a committee is not composed entirely of members from one profession or entirely of 
men or entirely of women, as long as “no selection is made to the IRB on the basis of 
gender” (45 CFR 46.107). Where appropriate (depending on the research studies 
reviewed by the organization), IRBs must include representation of vulnerable 
populations such as prisoners, children, and the elderly either in the form of a voting 
                                                 
1 IRBs often refer to the nonaffiliated member as the community member. 
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member who represents one of these groups or, if members do not possess this expertise 
in-house, by obtaining additional expertise from a consultant as needed. 
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3.0 LITERATURE REVIEW 
 
3.1 Introduction 
 Chapter 3 identifies and reviews the conceptual dimension of the literature and 
provides theoretical justification for the research questions that inform this study. In the 
previous chapter, the reader was acquainted with the research subject via a brief history 
of the evolution of IRBs, which provided the historical context of and rationale for why 
IRBs exist at all. In this chapter, the research problem is first situated in the extant 
literatures of participatory democratic theory and decision-making theory (particularly as 
it relates to small group settings). The specific field of the research problem—decision-
making in science and technology—is then discussed within the boundaries of university 
research and more specifically, in the context of university IRBs. This is followed by a 
summary of previous empirical studies on IRBs. Ultimately, two key research questions 
emerge, where methodological weaknesses and knowledge gaps exist in our current 
understanding of human subjects decision-making, and these questions guide and shape 
this dissertation research.  
 
3.2 Theoretical framework 
 The theoretical framework for this research is anchored primarily in the 
participatory democratic theory literature, but is also informed by research on small 
group decision-making. Human subjects review is a political process as much as it is an 
ethical process because it is about balancing the interests of science and scientists against 
the interests of human research participants (McNeill, 1993). A participatory model of 
decision-making is, therefore, useful for examining IRB decision-making because the 
Common Rule requirement for IRB composition implies that better (higher quality) 
decisions will result if the IRB decision-making process includes the perspectives of 
scientists and nonscientists, affiliated and nonaffiliated members (from the community), 
and where necessary, members from or representing vulnerable populations (prisoners, 
children, elderly, patients). Research on small group decision-making theory lends further 
opportunity to understand and begin to explain the actual dynamics of the IRB decision-




3.2.1 Decision theory 
 Decision theory is about how decisions are made. Most decision theories are 
either normative (how decisions should be made) or descriptive (how decisions are 
actually made). In the normative sense, decision theory tells the (rational) decision-maker 
how to achieve a particular objective. But, how decision-makers ought to make decisions 
is not necessarily how decisions actually get made. To answer the latter, several major 
models have evolved to explain decision-making processes in the policy environment at 
the individual, group, and institutional levels. 
Building on earlier efforts of Koopman and Pool (1991), Beach (1997) outlines 
some of the major decision-making models. The classical economics model or the 
rational comprehensive model assumes that the decision-maker is able to identify the 
problem, that his goals, values, and objectives are clear and ordered according to their 
importance, that other ways of addressing the problem are considered, that the advantages 
and disadvantages of each option are investigated, that alternatives and their outcomes 
can be compared with other alternatives, and that the decision-maker will choose the 
option that maximizes the achievement of his or her goals, values, and objectives. 
Simon’s (1955) bounded rational model, sometimes referred to as the information model 
(Beach, 1997), suggests that decision-makers develop a minimum acceptable level for 
each criteria; that is, they satisfice, or settle on a decision that is “good enough”. 
Incremental decision-making or “muddling through” (Lindblom, 1959) suggests that the 
choice of goals and objectives is intertwined with the analysis of the problem. In other 
words the means and ends are not distinct from one another. In this “structural model” of 
decision-making new options may evolve over the course of the decision-making that 
were not clear at the time the original decision was being made (Beach, 1997). A fourth 
model—the garbage can model—portrays organizations as “organized anarchies” (Cohen 
et al., 1972) that have unclear or inconsistent goals. They rely on decisions made by 
members who are inconsistent participants (Beach, 1997). This model of decision-making 
portrays the organization as a garbage can in which collections of problems, solutions, 
participants, and choices are randomly mixed together (Cohen et al., 1972) such that (1) 
solutions can precede problems, (2) solutions and problems may rely on serendipity for 
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decision options, or (3) everything can come together when the decision-making group 
convenes (Beach, 1997).  
The participatory component of the structural and the garbage can models is taken 
further in the participation model of decision-making, which examines the advantages 
and disadvantages of member participation in addition to the conditions under which 
participation is justified (Beach, 1997).  The participatory model of decision-making 
suggests that increased or broader participation by members leads to better decisions and 
greater satisfaction with the decision outcome. Participatory models conceptualize 
stakeholders as active players in the decision-making process on equal footing to one 
another or with equal opportunity to contribute or participate in the process.1 Proponents 
of public participation argue that this process is a means to ensure that ordinary citizens 
have a direct voice in decisions regarding issues that affect them, such as research 
involving humans, either directly or indirectly. Thus, participatory processes provide 
private individuals an opportunity to influence public decisions and are a component of 
most democratic decision-making processes.  
Interestingly, these theoretical arguments for participatory decision-making seem 
directly contradicted by some research on small group decision-making, which indicates 
that group discussion often focuses on what most members already know whereas that 
which is relevant but only known to certain members tends to go unmentioned or is 
ignored when it is brought up (Beach, 1997; see also Stasser and Titus, 1985; Sniezek et 
al., 1990). Gigone and Hastie (1997) and many others2 refer to this as the “common 
knowledge effect” where the impact of information on the group judgment is greater if 
more members know about that particular decision-relevant information before the 
                                                 
1 The literature is replete with examples of applications of participatory theory in such issues as workplace 
democracy, environmental disputes, risk, and public planning (see for example, Mason, 1982; Fiorino, 
1990; Bachrach and Botwinick, 1992; Moote et al., 1997; Allen, 1998; Forester, 2001). 
2 A growing body of literature is emerging on the importance of information exchange in group settings 
(see for example, Brodbeck et al., 2002; Cruz et al., 1997; Cruz et al., 1999; Dennis, 1996; Gigone and 
Hastie, 1993, 1997; Gruenfeld et al., 1996; Hollingshead, 1996a, 1996b; Kameda et al., 1997; Larson et al., 
1996; Larson et al., 1994, 1998a, 1998b; 1998; Lavery et al., 1999; Mennecke, 1997; Postmes et al., 2001; 
Propp, 1997; Savadori et al., 2001; Schittekatte, 1996; Schittekatte and Van Hiel, 1996; Shaw and Penrod, 
1962; Stasser and Stewart, 1992; 
Stasser et al., 1995, 1989, 2000; Stasser and Titus, 1985, 1987; Stewart, 1998; Stewart et al., 1998; Stewart 
and Stasser, 1995, 1998; Van Hiel and Schittekatte, 1998; Winquist and Larson, 1998; Wittenbaum, 1998, 





discussion. In a study of group judgment processes, Gigone and Hastie (1993) find that 
information pooled during discussion has almost no effect on the group judgments, as if 
members exchange opinions but still retain their original opinion. Moreover, shared 
information is usually more likely to be discussed, and discussed earlier in the process of 
decision-making (Winquist and Larson, 1998). The need to reach consensus in 
circumstances where most of the members already share similar preferences may 
decrease the amount of information exchange and result in early consensus (Kerr and 
Tindale, 2004).  
The presence of the “common knowledge” phenomenon in an IRB decision-
making setting has tremendous implications for the rationale behind the federal 
requirement to include certain types of members on an IRB. If the same phenomenon 
occurs in the IRB setting, the contribution of the nonaffiliated member or even the 
nonscientist members arguably could be nonexistent or irrelevant to the ultimate decision 
made by the board, particularly if the rest of the group does not openly share similar 
opinions or information about a research protocol. Thus, if the IRB membership is 
dominated by scientist members who tend only to wear their scientist “hat” or focus 
“primarily on scientific interests”, public values—such as preferences for the outcomes of 
public-funded research—may never become a point of discussion in the IRB decision-
making system. The degree to which members participate and share their opinions or 
concerns about a protocol also influences whether such opinions are ever voiced and, if 
they are brought up at all, to what extent. Members may believe that their individual 
opinion, if shared by most other members, is well informed even if they know they do not 
possess all of the relevant information about a protocol. Then, when new information is 
made available during the discussion they are likely to adjust their opinion insufficiently 
(Gigone and Hastie, 1997). But, relying on shared information at the expense of unshared 
information could lead to faulty decision-making (Henningsen and Henningsen, 2003). 
Because the composition of an IRB is somewhat diverse with respect to expertise that is 
relevant to a protocol, that relevant information which is held by most of the members 
might be assumed to be sufficient to recommend approval of a protocol, or even to 
recommend deferring or disapproving a protocol. The extent to whether this effect occurs 
in the IRB decision-making setting is uncertain and is not directly examined within the 
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scope of this dissertation. But, it does lead one to question whether the IRB decision-
making process could result in decisions that have not considered the full range of 
possible outcomes, potential risks, and so forth, and whether such decisions are free of 
errors related to bias in judgment.  
Most of the effort in organizational decision-making is not directed at reaching a 
specific decision, but at trying to understand a particular “problem” and conceive of 
options for dealing with it (Beach, 1997). Making a decision is not an end in itself; rather 
it is a means to achieving a broader goal (Orasanu and Connolly, 1993). This is certainly 
true of the IRB decision-making process where the broader goal is to protect human 
subjects and to some extent even the researcher and the university itself. The “problems” 
in an IRB setting might on one level be the process of approving a protocol, on another 
level dealing with adverse events of an existing approved protocol, and yet on another 
level handling noncompliance of research investigators. Depending on which problem the 
full board is addressing, several options are available. For the review process, the IRB 
has two sets of options that I will refer to as “bureaucratic options” and “protocol 
tweaks”. The bureaucratic decision options are fairly straightforward. Basically, the IRB 
has four bureaucratic decision options: a protocol may be approved, approved with 
conditions (or required revisions), deferred (due to insufficient information to either 
approve or disapprove), or disapproved.  
On the other hand, “protocol tweaks” are more difficult to assess albeit more 
interesting and possibly more telling about the IRB decision-making process. The option 
to “tweak” protocols is implicit primarily in the IRB decision to approve a protocol 
conditional on certain revisions. The decision to defer a protocol for more information 
also implies a “tweak" because the IRB is essentially telling the researcher that the 
protocol will not be considered until more information is provided. However, of the four 
bureaucratic options above, it is the IRB option to “approve with conditions” that perhaps 
is most affected by issues of expertise and other characteristics of the IRB. Consequently, 
the extent or type of “protocol tweaks” is also subject to features of group decision-
making considered above. 
Underlying the actual IRB decision-making process is the federal mandate, which 
is not simply to approve or disapprove research protocols but rather, to protect human 
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participants in research. Each of the problematic issues associated with the traditional 
models of decision-making is mirrored in the collective IRB decision-making process: 
ethical considerations, governance and democracy, judgment and values, and diversity of 
perspectives. Thus, the diversity among IRBs and their members presents an opportunity 
in which to examine the complex interplay of these issues with IRB decision-making 
processes and to consider the impact of IRB decisions on research with human 
participants. IRB members are presumed to consider decisions carefully because of 
concern about the consequences or outcomes, whose goodness or quality are measured 
against public values. So, if many members share certain information or even beliefs 
relevant to some feature of a protocol, the desire to modify a protocol based on such 
information may translate to a committee requirement in order to grant IRB approval 
(i.e., a protocol tweak). As noted previously, whether such “shared” information enters 
into the IRB decision-making process may depend not only upon the presence of group 
decision-making characteristics such as the “common knowledge effect” but also upon 
the participation of members and their willingness to contribute to the IRB decision-
making process. 
 
3.2.2 Participatory democratic theory 
 
One solution to encourage a decision-making process that includes diversity in 
perspective is the application of participatory democratic principles. Participatory 
democratic theory assumes (1) that people are inherently capable of understanding their 
problems and expressing themselves about these problems and their solutions and, (2) 
that real solutions to problems require the fullest participation of the people in these 
solutions, ultimately without being dependent on authorities and experts (Oppenheimer, 
1971). While participation in a decision-making process is seen as a value in and of itself, 
ordinary citizens generally are not privileged to participate in the science and technology 
policy process. 
 Cook and Morgan (1971) observe that participatory democracy implies two broad 
features in patterns of decision-making: (1) decentralization or dispersion of authoritative 
decision-making whereby authority to make certain decisions is displaced such that 
authority is brought closer to those affected by it, and (2) direct involvement of amateurs 
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in the making of decisions. They clarify that amateurs in this setting are individuals who 
do not carry credentials as formally trained experts; they are laymen and not professional 
participants (Cook and Morgan, 1971). 
 Participatory democratic theory assumes that cross-communication between groups 
increases mutual trust, respect, and understanding. It provides a basis for constructive 
cooperation among participants—such as scientists, nonscientists,1 and lay members on 
an IRB. It is important to note that the requirement to include a nonaffiliated member on 
the IRB is not explicitly intended to ensure that the IRB decision-making process is 
participatory, but rather to expand the diversity in perspectives offered by members 
affiliated with the research organization and also to prevent potential bias in favor of the 
research organization. Though the federal requirement that at least one IRB member is 
non-affiliated with the research organization implies the inclusion of a person from the 
surrounding or potentially impacted community, such members may have credentials 
equal to the scientist members on the committee. From a functional perspective, the 
Common Rule suggests that the inclusion of the nonaffiliated member expands the 
diversity of perspectives on the committee and also helps to alleviate potential dominance 
and institute bias by the affiliated IRB members. Presumably if at least one IRB member 
is not concerned with what the research organization stands to gain or lose, the committee 
is less likely to unanimously approve poorly designed or unjustified research protocols on 
the basis of potential benefits to the university. On the other hand, unless nonaffiliated 
members are scientists in their own right, it is uncertain whether they will argue with 
scientist members about the scientific merits or research design of a human subjects 
                                                 
1The Common Rule membership requirements for an IRB were discussed in Chapter 2. While the FDA 
requirements are consistent with those laid out in 45 CFR 46.107, FDA provides the following elaboration 
on member characteristics. 21 CFR 56.107(c) requires at least one member of the IRB to have primary 
concerns in the scientific area and at least one to have primary concerns in the non-scientific area. Most 
IRBs include physicians and Ph.D. level physical or biological scientists. Such members satisfy the 
requirement for at least one scientist. When an IRB encounters studies involving science beyond the 
expertise of the members, the IRB may use a consultant to assist in the review, as provided by 21 CFR 
56.107(f). FDA believes the intent of the requirement for diversity of disciplines was to include members 
who had little or no scientific or medical training or experience. Therefore, nurses, pharmacists and other 
biomedical health professionals should not be regarded to have “primary concerns in the non-scientific 
area.” In the past, lawyers, clergy and ethicists have been cited as examples of persons whose primary 
concerns would be in non-scientific areas. Some members have training in both scientific and non-scientific 
disciplines, such as a J.D., R.N. While such members are of great value to an IRB, other members who are 




protocol. In reality, since the number of affiliated members typically far outweighs the 
number of nonaffiliated members on most (perhaps all) university IRBs in the U.S, one 
must wonder “how realistic is it to expect one nonaffiliated member to challenge a group 
of affiliated, mostly scientist members on the basis of a conflict between flawed research 
design (which they may not even recognize) and benefit to the organization?” 
Returning to the concepts of public participation and participatory democratic 
theory, it is helpful here to examine their relationship to decision-making. Arnstein 
(1969) models public participation as a ladder with eight steps ranging from 
nonparticipation (manipulation and therapy) to a degree of tokenism (informing, 
consultation, and placation) to degree of citizen power (partnership, delegated power, and 
citizen control).1 She further likens the idea of citizen participation to eating spinach: “no 
one is against it in principle because it is good for you” (Arnstein, 1969). Using 
Arnstein’s model to describe the different degrees of public participation, at the most 
basic level participation may be actively receiving scientific or technical information 
about a specific issue. This form of “participation” was typical in the late 1940s through 
the early 1960s when most government agencies simply focused on getting information 
out to the public, an action deemed legitimate by the agencies as a “goodwill” gesture to 
let the public know about the good things the agency was doing (Creighton, 1999).  
During the last few decades of the 20th century, interest in and debate over the 
role of the public in technological decision-making increased. Beginning in the 1960s, 
practically every piece of environmental legislation held requirements for public 
participation (Creighton, 1999), though most of these were nonspecific or, at best, akin to 
the public comment periods on various proposed rules and permit decisions (e.g., those 
issued by the U.S. EPA). By the 1980s federal agencies such as the EPA began moving 
                                                 
1 More specifically each rung of Arnstein’s ladder of participation are described as follows: Manipulation 
and therapy are non participative. The objective is to cure or educate the participants. The proposed plan is 
best and the job of participation is to achieve public support by public relations. Informing is an important 
first step to legitimate participation. But too frequently the emphasis is on a one way flow of information to 
the public. Consultation takes the form of attitude surveys and community meetings while placation 
allows citizens to advise but retains for power holders the right to judge the legitimacy or feasibility of the 
advice. Partnership entails a relationship in which power is distributed through negotiation between 
citizens and power holders and responsibilities such as planning and decision-making are shared. 
Delegated power gives citizens a clear majority of seats on committees with delegated powers to make 
decisions. At this level the public has the power to assure accountability of the program to them. Finally, at 
the highest level of participation, citizen control, citizens handle the entire job of planning, policy making 
and managing a program. (Arnstein, 1969) 
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beyond traditional rulemaking to more collaborative or consensus-building processes. 
The 1990s ushered in a heightened awareness that citizens could (or perhaps should) play 
a more active role in resolving environmental issues (and also matters of public health 
and transportation). Especially in the resolution of environmental problems, participation 
mechanisms such as citizen advisory boards and consensus conferences became more 
widely accepted forms of engaging the local public. By the end of the 20th century, 
practically every federal agency had at least some stance on public participation. For 
example, the U.S. Department of Energy is among the leaders in this area (Creighton, 
1999) especially with regard to its handling of environmental issues. 
Direct participation “is premised on the notion that democratic governance 
includes the full participation of individuals as individuals” (Laird, 1993). On Arnstein’s 
ladder, this would include partnerships, delegated power, and citizen control. These 
would-be forms of “strong democracy” are introduced into the policy process in which 
citizens participate at least some of the time in decisions that affect them (see Barber, 
1984). In direct participation, participation needs to be active and individual. 
Participatory democratic theory suggests that the only way individuals will learn about 
their own support of technology and about risks and benefits associated with technology 
is by actually participating in decision-making about such issues (Mitcham, 1999). 
Another underlying assumption of participatory democratic theory is that citizens are not 
isolated beings, and that social organizations play an important “educative” role in 
teaching them how to interact and work together and how to act socially as well as 
politically. Citizens are socialized to learn democratic norms by participation in social 
groups, workplaces, and other forums (Pateman, 1970; Mansbridge, 1980; Donovan et 
al., 2004).  
Research suggests that broader participation may contribute to better decision-
making because a more extensive range for values is likely to be considered in the 
decision-making process (Fiorino, 1990). Because citizens are both consumers of 
information and sources of it, participation is communication and, if effective in both 
directions, it is the basis for improving inputs to decisions (Wengert, 1976: Lawrence et 
al., 1997; Burroughs, 1999). Though not explicitly stated as such, the Common Rule 
implies this argument via the requirement that “the IRB shall be sufficiently qualified 
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through the experience and expertise of its members and the diversity of the members, 
including consideration of race, gender, and cultural backgrounds, and sensitivity to such 
issues as community attitudes” (45 CFR 46.107) and suggests a relationship between 
diversity of perspectives and comprehensive discussion of representative values related to 
human subjects research protection. 
Sociologists of science have pointed out this “local knowledge” (i.e., knowledge 
held by the local community, typically about the local community), and contrasted it with 
theoretical knowledge brought to local contexts by scientific experts (see Collins and 
Evans, 2002).  In many cases, local knowledge may be as relevant to appropriate 
decisions as systematic theoretical knowledge (Wynne 1991; Irwin and Wynne 1996). 
Fiorino (1990) argues that lay people have valid judgments that can supplement the 
understanding of experts. When experts and lay experts disagree, a venue for public 
deliberation opens in which scientific experts may be transformed (Wachbroit, 1999). 
Evidence from research studies on AIDS illustrates this very argument (see Epstein, 
1996). Epstein notes that the establishment of randomized clinical trials as the gold 
standard in biomedicine led to the argument that their results were most informative if 
strict research guidelines were followed for selecting participants. Experts further argued 
that valid results could only be achieved if research participants were “clean” in the sense 
that they did not take any other medications while participating in the AIDS drug trials. 
But AIDS activists proceeded to challenge this assumption by demanding answers to 
questions such as why some groups of potential research subjects were excluded from the 
trials. These challenges—presented insistently, articulately, and publicly via the media, 
comments at professional meetings, and letters to journal editors—went on to reshape the 
design and methodology of clinical trials of AIDS drugs (Epstein, 1996). Eventually 
experts conceded and one went so far as to write an article1 about the transformation 
(Wachbroit, 1999; see also Merigan, 1990). Consequently, activists (knowledgeable 
nonexperts or lay experts) have influenced both the biomedical world and the ethical and 
legal premises surrounding that world (Epstein, 1996).  
 
                                                 
1 Merigan, T. (1990) “You can teach an old dog new tricks: how AIDs trials are pioneering new strategies,” 
New England Journal of Medicine. 323(19): 134-1343 (November 8). 
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3.3 Participatory decision-making in research with human subjects 
 Earlier I noted that the fundamental dynamic of the IRB is the process of arriving 
at a decision about a research protocol—that is, whether it minimizes risk and maximizes 
benefit for participants and society, whether the research design is acceptable, and so 
forth—and alluded to the various decision choices available to the IRB. In the IRB 
setting, such decisions are made in two different capacities: individually before the 
convened IRB meeting, and then as a group at the convened IRB meeting (see Figure 1). 
Before the convened IRB meeting, each member is asked to independently conduct a 
review of the research protocols using the guidance put forth in the Common Rule (45 
CFR 46). That is, each member individually must make a judgment about each of the 
four areas of concern previously discussed in Chapter 2: risk-benefit ratio, scientific 













Figure 1. Conceptual model of the IRB decision-making process 
 
 The next phase of the review process takes place at the group level during the 
convened IRB meeting. At this stage, IRB members bring their individual concerns to the 
discussion for deliberation and clarification as a group until a decision is made about 
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whether each research protocol merits approval. In the following decision-making phase, 
members are asked once again to make an individual judgment of the protocol via a vote 
(sometimes formal or informal) to approve the protocol. The focus of this research study 
is on how individual member characteristics, participation, and expertise are related to the 
members’ perceptions of the IRB decision-making process. While the data collected in 
this study do not allow for a comprehensive analysis of the overall group decision-
making process, they do support analysis of member perceptions of that process, which 
subsequently begins to illuminate the group decision-making process and invites future 
research to further explain the complexities of the IRB process. To this end, it is helpful 
to understand the nature of small group decision processes in order to understand the 
process for formal participation (Benello, 1971).  
If we define decision-making as a process in which choices are made or a 
preferred option is selected then a decision involves a point in time and space when 
values are allocated (Parsons, 1995). The decision-maker will make decisions consistent 
with his or her values—things that are important to him or her such as safety, fairness or 
equality. Not surprisingly a group of, say, nine IRB members will hold different sets of 
values individually shaped by their experiences as scientists, administrators, clergy, 
fathers, lawyers, or breast cancer survivors. The extent to which scientists fulfill their 
IRB role of having “primarily scientific interests”, for example, is uncertain and arguably 
impacts the breadth of perspectives that substantively enter into the decision-making 
process. 
The specific composition requirement for IRBs is an attempt to capture a variety 
of perspectives and values related to a research protocol. However, it is questionable 
whether the outcome could be truly representative unless members are selected to the 
IRB because they represent some potentially impacted faction of society or the research 
organization. One scientist from the biological sciences cannot possibly be considered 
representative of all scientists in all disciplines, for example. Moreover, the atmosphere 
of the meeting and the personalities involved can also influence whether and which 
values are promoted.  
Increasingly, the “knowledge elite” expect that public decision-making should be 
left to the experts (Jasanoff, 1999) and, it is not unusual for lay people, and even experts, 
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to defer to presumed authorities or individuals with expertise in “adjacent areas” (for 
example, see Fuller, 1998; Woodfield, 2000; Sarangi and Clark, 2002; Selinger, 2003). 
Moreover, results from a pilot study of IRBs1 suggest that, during IRB review of 
protocols, nonaffiliated and nonscientist members “tend to defer to the scientist members 
and tend to withhold because they don’t want to hold up the process or maybe feel that 
their opinion won’t be respected”.  
3.3.1 Decision-making and expertise 
 
A central concern in achieving group purpose is the role of the expert within the 
group (Benello, 1971) and since the IRB process involves various kinds of social 
decisions, technical knowledge (i.e., expertise in some domain) is usually involved. 
Expertise is conceptualized in various ways. Generally, expertise is based on experience 
of some kind (Nowotny, 2003). Often experts are defined as individuals who possess a 
skill or knowledge in a particular area, such as science, medicine or psychology. The 
term “expert” often reflects more a person’s pedigree rather than his or her possession of 
any particular body of knowledge (Wachbroit, 1999). For example, someone is not a 
scientist only by virtue of what s/he knows but also because s/he possesses certain 
credentials such as a degree in chemistry. Research on expertise has shown that experts 
also tend to possess certain characteristics when compared to novices in their field 
(Shanteau, 1992). Shanteau finds that experts have highly developed perceptual/content 
abilities; know what is irrelevant; are able to simplify complex problems; are able to 
communicate expertise to others; are self confident in their decision-making; possess a 
strong sense of responsibility; and are willing to stand behind their recommendations. In 
most studies of expertise, such characteristics distinguish experts in a field from novices 
or junior members in that domain. 
Experts can also be classified according to different levels of contribution or 
understanding of a particular domain (Collins and Evans, 2002). They may possess 
sufficient knowledge about a domain to converse with other experts in that domain 
(interactional experts). They may possess adequate knowledge to contribute to the field 
itself (contributatory experts). Or, they may have enough knowledge to understand what 
                                                 
1 Details of the pilot study are discussed in Chapter 4. 
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it means to contribute to a particular field (referred experts). Nowotny (2003) observes 
that “expertise has never before been so indispensable, while being simultaneously so 
hotly contested”. Pressure to democratize science and technology decision-making 
further intensifies the debate over whose knowledge (or expertise) ought to be 
incorporated into decisions (Nowotny, 2003; Jasanoff, 2003). The IRB system is not 
immune to this dilemma, and IRB adversaries frequently accuse it of not having or using 
the appropriate expertise to determine whether research protocols merit approval. Yet, 
identifying the experts on an IRB is not as simple as labeling the scientists as experts and 
the nonscientists (or nonaffiliated members) as nonexperts. In fact, at any given time 
during the IRB process, an IRB member may or may not be an expert in the area of a 
particular research protocol. In that case, we are challenged to ask whether the concept of 
expertise on an IRB can or should be classified according to something other than 
disciplinary expertise, perhaps according to methodology or the research objectives of a 
particular area of research or perhaps some other classification, such as IRB processes.  
The question of whether experts are better qualified to make the decisions that 
will benefit society, and whether citizens can even possess the necessary knowledge and 
skills to participate intelligently, is not new to the debate about democratic decision-
making (Fischer, 2000). Moreover, one might argue that scientists are citizens like 
everyone else and therefore are capable of bringing public values into the decision-
making process. In the U.S., decisions regarding science and technology (S&T) policy 
have traditionally been influenced by scientific experts or determined by political leaders 
advised by such experts. The general public often is assumed to be incapable of 
comprehending technical information and therefore, often is excluded from the domain of 
S&T decision-making. Though Fischer (2000, p. 35) tells us “there is good reason to 
believe that significant portions of the citizenry are more intelligent than usually 
credited”, the majority of people are not motivated to question, and they see controversial 
scientific issues as outside their need and competence to judge; more often, they depend 
on a variety of authorities, which leads to an increasing trend of reliance on experts 
(Cross and Price, 1999). In studies where lay people have been shown to raise significant 
social issues about technologies that technical experts are likely to skim over, such 
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concerns have not been raised systematically or with sufficient depth to prevent 
unintended sociotechnological results (Sclove, 1995).  
Proponents of participatory democratic theory would argue that experts (often 
assumed to be society’s scientific and technical elites) play an increasingly influential 
role in decision-making (Fiorino, 1990). Expert perceptions of technical problems (such 
as the potential for risk associated with a human subjects research protocol) are judged to 
be more rational than the “subjective” perceptions of the less technically sophisticated 
public (Fiorino, 1990). While research on expertise in small group decision-making 
suggests that expertise is one of the most important resources available to the group 
(Baumann and Bonner, 2004), it is mitigated by the extent to which the group is able to 
identify who the experts in the group are. Some research suggests that groups can 
sometimes identify their best members (Baumann and Bonner, 2004; see also Littlepage 
et al., 1997; Littlepage and Mueller, 1997; Littlepage et al., 1995; and Trotman et al., 
1983) but because expertise is often difficult to assess or even observe, individuals tend 
to rely on “proxy variables to develop expectations regarding the expertise of others” 
(Baumann and Bonner, 2004). These proxy variables may be age (see Kite and Johnson, 
1988; and Lawrence, 1988), gender (see Cejka and Eagly, 1999; Hollinshead and Fraidin, 
2003; and Wood and Karten, 1986), and ethnicity (see Biernat and Kobrynowicz, 1997; 
and Beirnat and Manis, 1994) among other things. 
Expertise on the IRB also has implications for the credibility of the IRB. 
Credibility of the IRB is an important factor in its success, both within the institution and 
the surrounding community (Levine, 1981). If the IRB is viewed by the scientific 
community as a responsible organization, composed largely of knowledgeable peers 
(experts) and informed laymen, efficiently carrying out its mandate, and successfully 
interfacing with the investigators to assure “smooth sailing” of their proposals, 
cooperation of the investigators will generally be assured. If the IRB is viewed as an 
“enemy,” a “police force”, or an obstructionist group of bureaucrats and paper shufflers, 
such low level of cooperation will impede both scientific pursuits and proper functioning 
(Levine, 1981). To prevent the latter, Levine suggests the following four important 
considerations: (1) the membership of the IRB must be highly respected within the 
institution; (2) the IRB must focus its attention on important things and not allow its 
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efforts to be diluted by trivia; (3) the IRB must avoid a “double standard” wherein 
research funded by the National Institutes of Health (NIH) is accorded one type of review 
procedure and research funded by other sources is handled separately; and (4) the IRB 
must avoid developing an image as a police force, implying that the IRB mistrusts the 
scientific community.  
3.3.2 Lay expertise in technical decision-making 
 
 Benello (1971) argues that because social questions involve value components 
as well as technical components, the values of the various group members must be 
integrated into the decision process. Accordingly, social decisions cannot be made for 
people by experts alone (whose role is to present the costs of various options clearly) 
while leaving the discussion of value consequences to the group (Benello, 1971). The 
desire for a community in which people can control the decisions that affect their lives is 
part of the very nature of society (Benello and Roussopoulos, 1971). In a participatory 
democracy, decision-making is the process whereby people propose, discuss, decide, 
plan, and implement those decisions that affect their lives. Benello and Roussopoulos 
(1971) argue that this requires the decision-making process to be continuous and 
significant, to be direct rather than representative, and to be organized around issues 
rather than personalities. In the participatory setting, there is limited role for self-
appointed elites whose decisions have broad political impact on the society, but who are 
accountable only to themselves or to interlocked groups of their peers (Benello and 
Roussopoulos, 1971).  
History has witnessed multiple debates on the issue of scientific autonomy versus 
public participation in technical decision-making. Most notable are two from the earlier 
part of the 20th century between Michael Polanyi and J.D. Bernal and between Vannevar 
Bush and Senator Harley Kilgore. In the 1930s, Polanyi (arguing from the position that 
outsiders cannot judge science) stressed the need for autonomy and self-governance of 
the scientific community, whereas Bernal believed autonomous science had numerous 
inefficiencies and benefits that could only be realized through a publicly debated plan 
involving government and representative components of society. The debate was again 
revived after World War II. This time, the sides were represented by Bush, arguing for 
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the university as the centerpiece of postwar science policy because of its independence 
and autonomy, and Kilgore,1 who felt that a much closer linkage must exist between 
political institutions and the scientific community regarding the agenda for research.  
Today similar debates continue about who should participate in the IRB decision-
making process. In 2001 the National Bioethics Advisory Committee (NBAC) initially 
recommended an increase (to 50 percent) in the proportion of nonscientists and lay 
members on the IRB. In response, numerous academic professional associations made 
public statements against such recommendations on the grounds that lay members do not 
have the technical knowledge needed to make valid judgments about disciplinary 
research. In a 2001 public statement the Consortium of Social Sciences2 (COSSA) 
opposed the NBAC recommendation that 50 percent of IRB members should be 
nonscientist, nonaffiliated members, stating that  
“such a ratio detracts from the peer review aspect of research. The more important 
issue is the competence of IRB members in the methods and topics of the research 
being reviewed. We support the notion of an increased number of public 
members. Nevertheless, to have 50 percent or more of the membership to come 
without expertise in research would prevent a meaningful judge of the ethical 
practices that are indeed part of the research.”  
 
In response, in NBAC’s final publication in August 2001, the membership 
recommendation was reduced to 25 percent of the committee comprising participant 
perspectives, nonaffiliated members, and nonscientist members.  
In more recent years, the debate on the issue of expertise (or lack thereof) in S&T 
decision-making has increased and publicized attention has been given to the topic. In 
particular, issues surrounding environmental concerns have practically demanded public 
                                                 
1 Kilgore argued that government support for science should be tied to explicit social and economic needs. 
His side of the debate can be viewed in the populist tradition and pushed to develop the state as a 
counterweight to the concentrated power of big business. The only major market failure that Bush 
identified in the governance of technological innovation was the support of university-based research – a 
market failure that private endeavors like those of Herbert Hoover in the 1920s had failed to close. 
(Zachary et al., 1994; available at www.cspo.org/products/conferences/bush/partone/roundtable1.html; 
visited on October 10, 2004) 
2 The Consortium of Social Sciences (COSSA) is an advocacy organization for the social and behavioral 
sciences, supported by more than 105 professional associations, scientific societies, universities, and 
research institutes. In response to NBAC’s recommendations for IRBs, COSSA issued a statement on 
February 16, 2001 entitled: COSSA Responds to NBAC Report on “Ethical and Policy Issues in Research 
Involving Human Participants”. The full statement is available at http://www.cossa.org/NBAC.html 
(visited on October 17, 2004). 
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involvement and in numerous cases, communities have taken it upon themselves to learn 
about highly technical issues and applicable technologies to either clean up their 
neighborhoods or prevent future contamination. The public has become more involved in 
decision-making about information technology and its associated risks.1 The fight against 
AIDS, the war on cancer, and controversy over the appropriate disposal of hazardous 
materials further illustrate heightened public involvement in technical issues (for 
example, see Nelkin, 1975; Jasanoff, 1996; Epstein, 1996; Futrell, 2003). Yet, in general, 
the public does not play a very active role in S&T issues particularly at the decision-
making level. Positivists2 may argue that this is the way it ought to be; that only 
individuals with appropriate scientific training should have a voice in a decision 
surrounding S&T. Others argue (even on ethical grounds) that lay people should take part 
in such decisions if the public is in some way affected by a technology (see for example 
Cole, 1986). As noted previously, these considerations are implicit in the required 
composition of an IRB, where the nonaffiliated member intentionally is positioned to 
counterbalance potential institutional bias.  
 Supporters of the traditional positivistic perspective—that only experts (those 
formally trained in a scientific discipline) or those advised by scientific experts should 
determine technical issues—doubt whether the public is capable of understanding 
significant concepts such as “uncertainty” and nature of science as an incremental process 
(Brooks and Johnson, 1991). Apart from presumed ignorance, other factors—attitudes, 
beliefs, and motivations—may limit the extent to which the public can contribute to 
complex S&T policy decisions (see for example, Ravetz, 1986; McCallum and Santos, 
1997; Rowe and Frewer, 2000). In contrast, other studies suggest that experts also have 
limitations in their technical knowledge (for example, Nelkin, 1986; Kraus et al., 1992; 
Jasanoff, 1997). Collins and Evans (2002) go so far as to argue that scientists have no 
                                                 
1 For example, since 1998, the Internet Corporation for Assigned Names and Numbers (ICANN) has been 
responsible for the technical coordination of the domain name system of the Internet’s. While some may 
argue that ICANN’s efforts to incorporate broad scale public involvement in the corporation’s decision 
process, ICANN has gone to great length to make public participation a cornerstone of its approach. Public 
participation is encouraged by open invitation and encouragement for the public from around the world to 
attend meetings in person or via the Internet (Lane, 2001). 
2 Positivism is the belief that science can be pursued only through what we can observe and measure 
objectively. The implication for technical decision-making is that we should accept what the scientists tell 
us because it is based on factual observation. 
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special contribution to make to technical decision-making in the public domain. Experts 
can, and in fact do, come in all shapes and sizes, not all of them credentialed. Such 
experts may be called “experienced-based experts” (Collins and Evans, 2002) and their 
specialized knowledge can contribute to technical decision-making.  
Expertise in the IRB setting is similarly diverse. Most IRBs are a heterogeneous 
group composed primarily of scientists, other professionals (such as nurses, social 
workers, clergy, pharmacists, and administrators) and lay persons. The term “lay person” 
as applied to an IRB usually refers to a person selected from the community (sometimes, 
though not always, representing the community served by the research institute) who is 
generally not affiliated with the IRB institution in any other way. In some cases, the lay 
representative is typical of the research subjects who might participate in a study (45 CFR 
46.107), and his or her ability to empathize with the potential subject is obviously a great 
strength that they bring to the IRB (Ghio, 1980). On many IRBs the focus of the lay 
person’s review is (or is presumed to be) the consent form. If the consent form is 
unintelligible, confusing, or overwhelming to the lay reviewer, it will likely be similarly 
received by a potential subject. Thus, lay reviewers must be prepared to ask many 
questions when scientific matters or medical terminology require explanation. 
However, the requirement to include at least one nonaffiliated member on the IRB 
does not ensure that this member is in fact a “lay person”. As noted previously, on some 
IRBs, nonaffiliated members possess credentials similar to their affiliated counterparts, 
particularly in cases where the nonaffiliated member is a retired physician or faculty 
member from another university. On other IRBs, homemakers, clergymen, or local 
business leaders serve on IRBs but there is no guarantee there either that these members 
represent ordinary lay people from the surrounding community. While this is not 
necessarily detrimental to the IRB decision-making process, it likely does impact the 
ways in which decisions are made insofar as the extent to which certain values or issues 
are brought up for discussion and deliberated before deciding whether to approve a 




3.4 University research and the social contract 
It is argued that science is most effective when scientists are free to choose their 
own research directions and agenda (McNeill, 1993). The phrase “social contract for 
science” refers to the relationship between science and society—an arrangement by 
which for the last few decades government has funded universities and other research 
institutions to conduct scientific research with minimal restrictions on how this money 
should be spent (see Bush, 1945). Under the “social contract for science”, the federal 
government allocates research funds to universities with the understanding that the 
government will not interfere with scientific decision-making in exchange for science-
driven, unspecified benefits to the public good (Fox and Braxton, 1999). However, with 
the implementation of IRBs the freedom of scientists is limited by the requirement to 
justify human subjects research on ethical grounds (McNeill, 1993). 
Most basic research is done at universities (Guston and Kenniston, 1994) and 
while the choice of which research to support is driven largely by the universities 
themselves, the IRB essentially acts as a research gatekeeper each time it decides whether 
a research protocol should be approved. With the mandated creation of IRBs, universities 
essentially have been told to police themselves in the area of research ethics and scientific 
misconduct. Though many universities initially were slow to regulate the research system 
(Steneck, 1999a, 1999b), most research organizations now rely on a variety of 
mechanisms for promoting scientific integrity.1 For example, with the recent surge in 
faculty research commercialization, many universities have created stand-alone policies 
that address faculty and institutional conflicts of interest. In fact, the Association of 
American Universities (AAU) recommends that any related financial interest in research 
involving humans typically should not be allowed (AAU, 2001).  
Historically, public universities have been founded on three principles: teaching, 
research, and public service. Accountability to the public is embedded in the promise of 
public support via funds from state government to sustain the university. If the university 
is perceived as not fulfilling its public service mandate in ways satisfiable to the state, the 
                                                 
1 The National Academy of Sciences (2002) provides a summary of some of the institutional mechanisms 
used at various universities for promoting scientific integrity. These include a regulatory-based approach, a 
performance-based approach, and an institutional self-assessment and peer review approach. 
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legislature for that state has the power to revoke state funds to the university.1 Arguably 
public universities, whose mission statements often include an emphasis on research for 
the benefit of the public, may be held accountable to the public more so than a privately 
funded university, which is not as financially accountable to its surrounding community 
or state. Under these circumstances, the role of the nonaffiliated member on a public 
university IRB could potentially be more influential than on a private university IRB in 
that this member can go directly to the legislature over issues of how the university 
allocates funds for human subjects research (or any research).  
Studies of university research foundations suggest that the relative importance of 
research and instructional interests in decision-making and the commitment of university 
resources to research are potentially important influences on the shape of a research 
foundation (Daniels et al., 1977). Another characteristic that shapes the research 
organization is whether the university is public or private (Daniels et al., 1977). Since the 
IRB is a well-defined component within the university organizational structure, such 
characteristics when combined with the university mandate could influence the decision-
making process of IRB members. 
Currently, the IRB has jurisdiction over determining whether and how a relevant 
financial interest should be disclosed to research participants.2 Most university IRB 
guidelines stipulate that a researcher who has a financial interest in the results of a 
research protocol cannot serve as principal investigator on that project. Furthermore, IRB 
members with any conflicts of interest generally are required to recuse themselves from 
the voting process, and even from the discussion, for such research protocols. Since the 
primary responsibility for handling complaints of misconduct in science rests with the 
research organization (National Academy of Sciences, 1992), such constraints become 
relevant in understanding and explaining IRB decision-making processes at different 
universities. Moreover, the autonomy of the IRB or the degree to which it is embedded 
within the institution becomes relevant in that each IRB must apply its own discretion 
                                                 
1 For example, the University of Okalahoma’s Research Institute was dissolved by the Oklahoma state 
legislature due to conflicts with the Oklahoma state legislature over management control, specifically the 
issue of controlling the expenditure of what legislature considered as state revenues rather than university 
revenues. (see Cross, G. (1986) The University of Oklahoma Research Institute: 1941-1973. Norman, OK: 
The University of Oklahoma Office of Research Administration.) 
2 The Institute of Medicine (2003) recommends that a separate committee should review financials conflict 
of interest associated with human subjects research protocols. 
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about what constitutes an acceptable research protocol. Federal human subjects research 
policies are written such that an IRB decision to reject a protocol or to require 
modifications cannot be overturned by anyone at the institution, including the president 
of the institute. Effectively the buck stops at the IRB.  
 
3.5 IRBs as the “subject” of research 
Previously in this chapter, I discussed the role of experts and lay expertise in 
technical decision-making. This relationship is central to characterizing the deliberation 
of human subjects research. What should the role of experts be in such deliberations? 
And what should the role of the public be in oversight of human subjects research? The 
research oversight system offers a rich and complex setting in which to examine 
decision-making and participation in highly specialized and technical areas. Examining 
IRB decision-making allows us to tease apart the expert-nonexpert distinction in an area 
where science and society are destined to merge. Creighton (1999) argues that 
participation should be focused such that the public has the opportunity to participate in 
the decisions that are of greatest interest to it, in ways that provide genuine opportunities 
to influence the decision. In some technical areas experts simply cannot escape public 
influence (Dickson, 1988; Jasanoff, 1990; Mitcham, 1999). This includes much, perhaps 
all, human subjects research as most of it is carried out for the purpose of somehow 
benefiting humanity (e.g., cancer research, mental health research, research on 
commercial sports drinks, and research on relationships). 
The behavior of IRBs is a particularly interesting research topic because these 
committees are composed of an uncommon combination of reviewers: not all are from 
the same discipline (or even neighboring disciplines) of the research investigator, and 
IRBs are required to include at least one nonaffiliated member from the community. 
Thus, an IRB is a unique body within the science policy process where the normal social 
forces and authorities of science might be expected to be less likely to apply (Barke, 
2002). The regulatory requirements on board composition described earlier are minimal 
(even vague) and do not stipulate how an institution ought to select members to satisfy 
the regulation. A member at one university may be classified as a scientist, while a 
different university may classify the same person as a nonscientist member. When asked, 
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members might even categorize themselves differently than they are categorized by those 
that select them to the committee (e.g., by the IRB administrator). Additionally it is not 
clear if IRB members (or member types) are representing anyone other than themselves, 
or whether the three member categories should be considered representative at all.  
Normally the “outcome” of a decision-making process refers to its substantive 
decisions, conclusions, or recommendations which can be evaluated using a variety of 
criteria including stakeholder satisfaction with the results, cost effectiveness, or risk 
minimization (Beierle, 1999). And in fact, a pragmatic argument for public participation 
in S&T decision-making is simply that public participation will lead to better outcomes 
(Van Eijndhoven, 1997; Schot and Rip, 1997; Sarewitz, 1996; Mitcham, 1999). 
Participation affects satisfaction with the process and the outcome (March 1994). 
Participation has an integrative effect and aids the acceptance of collective decisions 
(Pateman, 1970). Individuals are more likely to participate in decision-making when their 
own interests are affected than when they are not, more likely to participate when they 
think they can affect the decision outcomes than when they think they cannot, and more 
likely to participate when they think they have no alternative ways of acting appropriately 
or accomplishing what they want than when they think there are other ways (March, 
1994). But Beierle (1999) cautions that narrowly interpreting “outcome” to mean only 
substantive decisions misses some of the key features of a participatory process—those 
which justify inviting the public into the decision process in the first place. Moreover, 
broader interpretation of outcomes includes the degree to which participatory processes 
achieve a set of “social goals” (Beierle, 1999). 
For democracy to really work, we must have maximum participation and the 
development of individual potential to contribute (Oppenheimer, 1971) to the choice of 
“social goals”. In the same way that people with reputations are listened to differently 
than people who are unknown (Oppenheimer, 1971), scientists on the IRB may be 
listened to differently than nonscientists or lay members. In situations where the group 
has not had sufficient time to develop, a dissenting member may be reluctant to speak up 
or voice opposition to the rest of the group. This seems especially likely if that member is 
the lay member on an IRB and finds himself in disagreement with the scientist members. 
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As the following section will illustrate, prior research on IRBs has not adequately 
examined the IRB decision-making process with these characteristics in mind. 
3.5.1 Prior research on IRBs 
 
Much of the prior research about IRBs focuses on functional issues such as 
workload, frequency of meetings, percentage of protocols approved (e.g., see Bell et al., 
1998) and not on the decision-making process itself or related decision outcomes. Those 
key studies that attempt to characterize IRBs are briefly summarized here.  
The earliest known study of IRBs, conducted in 1969, surveyed 300 biomedical 
IRBs about their approval decisions (see Barber et al., 1973). In two separate but related 
studies, Barber et al. set out to examine conformity and deviance in researchers’ 
expressed standards and actual behavior with respect to informed consent and the 
appropriate risk-benefit ratio of their research. The first study entailed a national survey 
of the primary IRB contacts at 293 biomedical research institutions, in which respondents 
were assessed on their expressed standards on ethical issues involving hypothetical 
biomedical human subjects research protocols. The second, more intensive study 
consisted of personal interviews with human subjects researchers from two biomedical 
research institutions (Barber et al., 1973). The results of both studies were used to 
examine patterns of strictness and permissiveness in reviewing human subjects research 
protocols. Barber et al. found that the majority of biomedical human subjects researchers 
are aware of the importance of voluntary informed consent, that a majority are not willing 
to allow undue risk based on the hypothetical research scenarios, and that most 
biomedical researchers do not conduct studies in which the risk-benefit ratio is 
unfavorable for the patient-subjects (Barber et al., 1973). However, Barber et al. also 
found that a “significant minority” exists that is “more permissive” and is either unaware 
of or unconcerned with consent issues, is willing to take undue risk, and is actually 
conducting studies that include unfavorable risk-benefit ratios for participants. Barber et 
al.’s study provides a glimpse into the early structures of the IRB process and gives some 
insight into the types of members who served on those committees. At the time of the 
study (1969), less than 25 percent of the participating universities (all biomedical) 
included any kind of “outsider” on their committees, and in most cases those outsiders 
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had expertise in clinical research at some other university. It is important to note a major 
drawback to Barber et al.’s study: the survey on ethical standards and review processes 
was administered to only one member on each participating IRB. While Barber et al. 
argue that their data are “representative of medical schools, of their affiliated teaching 
hospitals...” it is questionable whether the perspectives offered by the sole respondents 
(in some cases the IRB administrator, in others the IRB chair or an IRB member) are 
truly representative of the group decision-making process of each institution’s IRB as a 
whole or the perceptions of that process as held by other IRB members. 
Gray et al. (1978) conducted one of the more comprehensive national evaluations 
of the IRB system to date in which they assessed IRB performance in an empirical study 
of 61 (again mostly biomedical) committees. The study focused on action taken by IRBs 
on whether to approve a protocol, and on the perceptions of principal investigators 
toward the human subjects review system. Interview surveys were conducted with more 
than 2000 research investigators whose protocols had been reviewed by their IRB, over 
800 IRB members, and almost 1000 human research subjects. The survey data collected 
by Gray et al. illuminate early IRB procedures including the mechanism for voting on 
protocols, meeting attendance, extent to which IRBs modify protocols, and the perception 
that the committee makes judgments that it is not qualified to make.  
Some of Grey et al.’s key findings are summarized here. IRB members who were 
not biomedical or behavioral scientists reported themselves as less active (participatory) 
and influential compared with their scientist counterparts. About two-thirds of the 
participating IRBs had a procedure to screen out protocols that did not need full board 
review; about half used a primary reviewer system; about half took formal votes on all 
protocols and almost all took a formal vote on at least some protocols. Their data also 
suggest that IRBs that review relatively risky research are more careful in their reviews, 
using a more comprehensive set of issues during the review of protocols, and tend to 
require more modifications prior to IRB approval. Gray et al. described the composition 
of the IRBs in their sample (50 percent were biomedical scientists, 21 percent were 
behavioral scientists, and the remainder included administrators, lawyers, nurses, clergy, 
etc.), but they did not specifically relate this composition to the IRB procedures and 
processes described above. Additionally, the study examined the differences in the extent 
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to which each IRB is comprehensive in its discussion of the protocols; yet, specific 
information about how the related scores were constructed or their interpretation are not 
provided by Gray et al. In short, Gray et al. describe the demographics and to some extent 
the perceptions that members, researchers, and participants have about the IRB process 
but they fall short of explaining how these perceptions relate to the actual IRB decision-
making process, how decisions are shaped by that process, and what members’ 
perceptions are of their roles in that process. 
Other studies have examined inconsistency across IRBs (Goldman and Katz, 
1982) and perceptions of the IRB process by research investigators (Cleary, 1987; 
Ferraro et al., 1999). Goldman and Katz (1982) assessed the inconsistency across IRBs 
by submitting identical research protocols—each with unethical components, flawed 
research design, and incomplete consent forms—in oncology and anesthesiology to 32 
IRBs at major universities with medical schools. Among the 22 participating IRBs, the 
results showed consistency in the nonapproval of only three protocols, substantial 
inconsistency in the reasons offered in support of similar decisions about each protocol, 
and substantial inconsistency in the application of standards of ethics, methodology, and 
informed consent (Goldman and Katz, 1982). Based on these results, Goldman and Katz 
conclude that these inconsistencies would result in the approval of flawed research 
studies. In a study of the impact of IRBs specifically on political science research, Cleary 
(1987) also found variation among universities with respect to what constitutes human 
subjects research, what research qualifies as exempt or expedited, and requirements for 
written versus verbal consent. Ferraro et al. (1999) surveyed human subjects researchers 
at the University of North Dakota to determine attitudes toward, perceptions of, and 
experiences with the University of North Dakota’s IRB. Ferraro et al. found that only a 
small percentage (15 percent) of participants surveyed felt that the IRB had impeded their 
research efforts. The majority of respondents believed that the IRB process improved 
their research protocols. However, the majority (75 percent) also felt that the IRB should 
refrain from requiring revisions of research design unless such revisions benefited the 
protection of human participants. 
Three more recent studies have conducted evaluations of the IRB system (see 
GAO, 1996; Bell et al., 1998, and OIG, 1998). A 1996 study by the Government 
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Accounting Office examined policy and oversight roles of the National Institutes of 
Health, the Office for Protection from Research Risks (the predecessor to OHRP), and 
the Food and Drug Administration. The federal role in protecting human subjects was 
evaluated based interviews with NIH, OPRR and FDA officials, in addition to a review of 
regulations, policies and procedures (GAO, 1996). Additional interviews were conducted 
with research institute officials, IRB members, and researchers, as well as experts in 
bioethics, medicine, law and social science. At least two conclusions from the GAO 
evaluation are relevant to this dissertation. First, some IRBs find it difficult to adequately 
review human subjects issues because their members are not familiar with technical 
components of a study. Secondly, IRB autonomy is compromised when members have 
financial ties to studies and when members are reluctant to criticize studies directed by 
leading scientists.  
In a subsequent study, the Office of the Inspector General (1998) conducted 
interviews with federal officials and representatives of about 75 IRBs. Particularly 
relevant to this dissertation is the OIG finding that IRBs review too much, too quickly 
and with too little expertise, particularly at larger institutions. IRBs are also expected to 
support institute interests that provide revenue and prestige to the institute and because 
there is only minimal nonaffiliated member representation, IRBs have only minimal 
ability to counterbalance institutional interests. OIG found that it was not unusual for 
IRBs with 15-20 members to include only one or two nonaffiliated members. The IRB 
system provides minimal training and education for members, which is a disadvantage 
particularly for nonscientist and nonaffiliated members.  
Finally, Bell et al. (1998), under contract with the NIH, examined IRB procedures 
at 491 institutions to identify the number of hours IRB members contribute to the 
process, how long meetings last, general opinions about adequacy of IRB review, 
concerns about review outcomes, and other procedural topics. The study included 435 
IRB members, 632 research investigators, 245 IRB administrators, and 394 IRB chairs. 
Bell et al. found that most (78 percent) of the changes that participating IRBs required for 
approval dealt with issues of informed consent form, while only 6 percent of the 
protocols required modification to the research design before approval was granted. The 
Bell et al. study concluded that, while IRBs are performing consistently with the 
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regulatory requirements for human subjects review, IRB structures and procedures could 
be perfected and training and education of members could be expanded. 
While these studies elucidate IRB procedures to some extent, minimal empirical 
data have been gathered on IRB decision-making—that is, the internal mechanisms and 
characteristics of these committees—particularly with respect to the characteristics of 
board members, and whether or how such characteristics influence IRB decision 
processes, mechanisms of group discussion, quality of decision, or institutional context 
and perception about scientific misconduct. 
 
3.6 Rationale for the research questions 
That the responsibility to protect human subjects is explicitly value-directed adds 
a layer of complexity to the decision-making process. Members have the freedom to 
exercise their collective independent judgment to interpret the regulations and establish 
policies for ethical research standards at their institutions (Beach and Wright, 2000). 
March (1994) notes that participation rules in decision-making processes generally reflect 
three concerns: personal consequences, social benefit, and the creation of community. 
More specifically, democratic theory implies that a proper decision system will provide 
greater access to those who are affected by its decisions. In the human subjects oversight 
system, IRB decisions typically affect four distinct groups, either directly or indirectly: 
(1) human research participants, (2) the general public, (3) research investigators, and (4) 
the university. Secondly, March notes that because some people are seen as making a 
great contribution to society, they are often given greater access to the decision-making 
process based on their competences or expertise in a particular area. Scientists (and 
science in general) are often seen as making a great contribution to humankind and 
perhaps this notion is (intentionally or otherwise) reflected in the disproportionate 
number of scientists that typically serve on IRBs. Finally, March observes that rights and 
obligations to participate are linked to acceptance as colleagues or members of a 
particular community. This characteristic is implied via the nomination or selection 
process of certain IRB members to the committee. Interestingly, however, these three 
democratic concerns appear at odds in the IRB setting, where likely research participants 
are only minimally represented, high profile researchers are not necessarily the scientists 
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serving on the IRB, and the policies for identifying IRB members do not seem to be 
based on any sort of system-wide acceptance criteria. 
In the human subjects protection system, judgments and values are inherently 
interconnected with the issue of risk. But risk research has shown that experts and lay 
citizens approach the characterization of risk in different ways. Experts tend to 
characterize risk in an objective and rational way, while the public is portrayed as seeing 
risk in a manner that seems subjective, emotional, or irrational (Slovic, 2000).1 Risk 
perception can also depend on age, gender, and race. Studies suggest that women and 
younger scientists tend to be more risk averse than their peers (see for example, Barke 
and Jenkins-Smith, 1993; Slovic, 2000; Wester-Herber and Warg, 2002). In 
characterizing risk, two judgments are made: (1) that a particular process or outcome 
merits serious attention and (2) what constitutes an unacceptable level on the outcome 
dimension (Slovic, 2000; Stern and Fineberg, 1996). Since IRBs are composed of a 
unique group of experts and nonexperts (or lay persons) who must make judgments about 
the level of risk in the research protocol in order to decide whether to approve it, these 
observations suggest that further research is needed to understand: 
How do different IRB members make decisions about whether to approve a human 
subjects research protocol—that is, about risk-benefit ratio, scientific merit, research 
design, and adequacy of informed consent? (RQ1) 
 
 Theoretically, the diversity of IRB membership should enable it to assess the 
ethical acceptability of a research proposal with respect to its scientific merit, sensitivity 
to community attitudes, and safeguarding of participant rights and welfare. If IRBs are 
composed as directed in 45 CFR 46.107, scientist members will be drawn from varying 
disciplinary backgrounds, ideally representative of those campus departments that 
conduct human subjects research. While IRBs may or may not select scientist members 
specifically for their methodological expertise, that form of expertise is broadly 
represented by the very nature of the diversity of disciplinary backgrounds often 
represented on the IRB.  
                                                 




 The IRB Guidebook (Penslar and Porter, 1993) specifically comments on the 
role of the nonaffiliated member: 
“The nonaffiliated member of the IRB should be drawn from the local 
community-at-large. Ministers, teachers, attorneys, business persons, or 
homemakers are possible candidates. The person selected should be 
knowledgeable about the local community and be willing to discuss issues and 
research from that perspective. Consideration should be given to the type of 
community from which the institution will draw its research subjects. If the 
community is rural and agricultural, perhaps a farmer would be appropriate, in 
addition to a minister and/or attorney. If the community is predominately African-
American, Hispanic, or other minority, then it would be advisable to have a 
member of that particular minority (or those minorities, if there is more than one 
significant minority population) on the IRB. The nonaffiliated member(s) should 
not be vulnerable to intimidation by the professionals on the IRB, and their 
services should be fully utilized by the IRB.” 
 
 Some studies (such as NBAC) suggest that the mix of IRB member types should 
be more proportionate such that the number of nonscientists and nonaffiliated members is 
increased beyond the current requirement to include at least one of each type of member 
(National Bioethics Advisory Committee, 2001). Yet, it was pointed out earlier that 
professional associations express concern that an already burdened system will become 
slower due to increased questioning of proposed protocols by presumably non-technically 
trained IRB members or non-experts in the field.1 The scientist members are the implied 
“experts”, whereas the nonscientists and particularly the nonaffiliated members usually 
are assumed to be the “nonexperts” in this process. Research has also shown that experts 
tend to promote their own self-interests, often at the expense of the public (Dahl, 1985). 
And indeed, per the Common Rule, a stated role of the nonaffiliated member on an IRB 
is to keep the board from making decisions that are institutionally biased.  
Much of the normative literature on decision-making tells us that if decision-
makers follow a particular preferred process, good outcomes will be achieved (March, 
1994; Beach, 1997). Since people tend to be concerned about how the outcome or 
consequence of a decision is going to make them feel about the decision itself (Larrick, 
1993), individual characteristics and experiences may lead to variation in how IRB 
                                                 
1 See for example the responses to the NBAC (2000) recommendations from the Federation of American 
Societies for Experimental Biology (www.faseb.org/opar/ppp/nbac_resps.html), Consortium of Social 




members approach human subjects research decisions. Because women tend to think 
science is not as useful as men think it is (Fox & Firebaugh, 1992), gender characteristics 
may lead IRB members to judge the benefits associated with a particular research 
protocol in very different ways. Similarly, a member, who experiences frequent criticism 
of the IRB process by departmental colleagues about the impact IRB review has on their 
grants, may be more sensitive to unintended consequences of an IRB decision on the 
research process. Or for example, a member may have had, or know someone who had, a 
personal experience (whether negative or positive) as a research participant. 
Consequently, the composition of IRB members can dictate variation in the range of 
attitudes toward science and the risks and benefits of scientific research. These 
considerations suggest additional research is needed to investigate the effects of 
membership characteristics on the IRB process. Such observations lead to the question: 
What is the relationship between members’ roles on the IRB and their level of 
expertise as these characteristics relate to their experiences and perceptions of 
the IRB process? (RQ2) 
 
The narrow focus of previous studies on IRBs is understandable. After the federal 
requirement to establish university IRBs, little was known about how many existed and 
much less about the workload, numbers of members, or structures of the committees. 
IRBs have now existed for nearly 40 years and there is a clear need for deeper 
understanding of these decision-making entities beyond bureaucratic characterization. 
The purview of the IRB over reviewing scientific design and merit is being questioned by 
both the research community and even some IRBs. Furthermore, many social scientists 
argue that the federal guidelines for IRB review subject social science research to 
unrealistic requirements that were initially developed for biomedical research models. To 
begin to understand these allegations and to find answers to these questions, more 
substantive knowledge is needed about what actually occurs during the IRB decision-
making process. Previous IRB research contributed to the characterization of what goes 
into and comes out of the “black box” of IRB decision-making. By answering the two 
research questions articulated above this research attempts to look beyond IRB inputs and 
outputs and to begin to explain the dynamics inside the “black box” of IRB decision-
making. While a comprehensive explanation of the IRB group decision-making process is 
 
59 
beyond the scope of this dissertation. This study takes the first steps toward such an 
explanation by conducting an initial examination of the IRB process as perceived by 
those who participate directly in it. 
 
3.7 Why will a participatory democratic process work better for human subjects 
research than a non-democratic process? 
 
 The concept of governance can be reduced to one fundamental question: who gets 
to decide? In the context of human subjects decision-making, this simple question has 
tremendous and far reaching implications for research policy and for the governance of 
science. It has been pointed out earlier that through their decision-making process, IRBs 
act as gatekeepers of research conducted at their organizations. It has been further noted 
that IRBs are composed of a unique combination of scientists and nonscientists and lay 
members, and of experts and nonexperts. The mechanism by which these two IRB 
characteristics are related and consequently impact science and society is the dynamic of 
participation. Up to this point, I have discussed the normative arguments for public 
participation in decision-making about technical issues, with the assumption that a 
participatory democratic process is better for human subjects research oversight. Thus, 
the focus of this section, which ultimately justifies the theoretical underpinnings of this 
study, is why democratic participation is better than non-democratic participation. 
 Increased public involvement in science and technology and increased efforts to 
involve the public in decision-making when feasible (Rosener, 1978; Rowe and Frewer, 
2000) could alter the dynamics of decision-making bodies like the IRB if 
recommendations for more nonscientist and lay person participation (like those suggested 
by NBAC and Kennedy’s and DeGette’s proposed pieces of legislation for human 
subjects review policy)1 are adopted.  
                                                 
1 During the 107th Congress, Representatives Diana DeGette and Jim Greenwood and Senator Edward 
Kennedy introduced two separate pieces of legislation in an attempt to overhaul the Federal human subjects 
protection system. Each legislation incorporated recommendations made by the Government Accounting 
Office, DHHS Inspector General, and NBAC. Neither legislation passed; however, discussions emerged 
about (1) the effectiveness of the current IRB system, (2) ways to address conflicts of interest, and (3) the 
appropriate scope of coverage for the Federal requirements. On November 21, 2003, Representative 
DeGette introduced H.R. 3594, the Protection for Participants in Research Act of 2003. The bill, a 
modification of the earlier bill introduced during the 107th Congress, extends protections to all research, 
regardless of funding source; imposes financial conflict of interest requirements for investigators; modifies 
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There are many justifications for including citizen representatives from society in 
the decision-making process about research benefits and risks to human subjects and to 
society, but putting those rationales into practice is neither simple nor certain to produce 
the desired effects that participatory theorists promise. There is no certainty that IRB 
members not affiliated with the institute will (or can) bring a broader humanistic 
perspective to the scientific decision-making encountered in IRB process. The 
participation of lay persons in IRB decision-making may slow this process or make it 
“messier,” but such benefits of “discursive democracy” (Dryzek, 1990) include 
disagreement, critique, and reasons that are not tied strictly to facts. Conversely, it may 
be argued that scientists are capable of bringing public values into the IRB decision-
making process on the grounds that they are also members of society—“specialized 
citizens” as it were (Fischer, 2000)—often with children and families of their own, and 
dealing with health issues and other concerns similar to nonscientists. 
Cook and Morgan (1971) offer a two-part argument in support of direct 
involvement of “amateurs” in authoritative decision-making (such as human subjects 
oversight). Both are applicable to the IRB setting. First, the actual process of direct 
participation in some way makes participants “better” citizens. Participation is a learning 
experience that changes the psychology of the participants. Many theorists argue that the 
experience of direct participation can shape a new person since it socializes people into 
new beliefs, attitudes and values (Cook and Morgan, 1971). Average citizens are often 
reticent to participate in technical decision-making, even when invited to do so, because 
they do not feel capable in communicating about such technical issues. However, the past 
20 years have seen numerous community participation cases where participating citizens 
are empowered by such experiences (e.g., community participation in environmental 
remediation issues, not-in-my-back-yard/NIMBY issues, and so forth) and actually 
develop a localized form of technical knowledge and a deeper understanding for science 
in general. 
                                                                                                                                                 
IRB membership to include more lay members and members unaffiliated with the institution; and expands 
OHRP’s enforcement mechanisms to address violations of the Common Rule. (Detailed information about 
the provisions of this legislation is available at 
http://olpa.od.nih.gov/legislation/108/pendinglegislation/humansub.asp; visited on October 10, 2004). 
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The second argument for involving amateurs is even more applicable to IRBs and 
human subjects research oversight. That is, decisions shaped by direct participation mean 
“better” consequences (Cook and Morgan, 1971). Cook and Morgan admit that one could 
debate the definition of “better” but in general, they define it as more effective problem 
solving. On the IRB, the so-called amateur may really be an “expert” in certain matters 
either because of the learning experience of the participatory process or because of 
knowledge s/he acquired in normal daily activity. This idea hails back to Aristotle who 
stated in The Politics: 
“There is this to be said for the many. Each of them by himself may not be of a 
good quality; but when they all come together it is possible that they may surpass 
collectively and as a body, although not individually, the quality of the few best. 
Feasts to which many contribute may excel those provided at one man’s expense. 
In the same way when all meet together, the people may thus become something 
in the nature of a single person, who as he has many feet, many hands, and many 
senses, may also have many qualities of character and intelligence.” 
 
It was not until 1859 that Mill building on Tocqueville’s observations of 
democratic practice specifically articulated that the process of participating in democratic 
decision-making made participants better citizens (Mansbridge, 1999). Mansbridge notes 
that central to Mill’s claim was the notion that taking responsibility for others in the 
course of collective decision-making enlarges the participants’ conceptions of their 
interests. This awareness is particularly applicable to the IRB decision-making process 
where the primary purpose is to protect human participants in research. Mansbridge also 
reminds us that the father of the term “participatory democracy”—Arnold Kaufman—
argued that “democracy of participation may have many beneficial consequences, but it’s 
main justifying function is and always has been, not the extent to which is protects or 
stabilizes a community, but the contribution it can make to the development of human 
powers of thought, feeling and action”. 
Yet Bozeman (2002) observes that contemporary discourse is often dominated not 
by public values, but by market intervention, technical efficiency, and the private value of 
public things. The IRB decision-making process is not immune to the discussion of such 
issues, particularly when the increasingly more common issue of investigator or 
institutional conflict of interest must be considered as a factor in balancing risks and 
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benefits to potential research participants. Moreover, diversity in membership, expertise, 
experience, personality, values and beliefs of IRB members combine with organizational 
politics, culture, and a variety of multi-level decision outcomes to produce a complex 
arena in which decisions attempt to advance knowledge yet protect research participants.  
Models of decision-making are not substitutes for, nor do they fully capture, such 
complex decision procedures but they do provide a useful starting point for understanding 
and for identifying areas of potential improvement of the systems such as the IRB. They 
also aid in assessing the interaction of actors regarding a judgment procedure and they 
promote the discovery and resolution of problems that might occur during the decision-
making process. In the case of the human subjects protection system, a simplistic model 
can be a particularly insightful way to begin to understand, explain, and improve the IRB 
decision-making process. To this end, in Chapter 3, such a conceptual model was 
presented to illustrate the IRB decision-making process. That model is based on the IRB 
literature and on informal observation of the Georgia Institute of Technology IRB,1 
which I observed and assisted for almost two years while thinking about the research 
conducted in this dissertation.  
While no one theory or model is sufficient to adequately explain all the dynamics 
occurring among actors and institutions during the policy process (Olsen, 2001), the 
process of analyzing the decision task in and of itself in order to identify a model is 
beneficial nonetheless for a more complete understanding of the associated policy 
process. Given the unique composition of members on an IRB, a number of 
characteristics must be considered in order to explain the decision-making process of 
these committees: the ways in which experts (the scientists?) approach problem solving 
and decision making compared with nonexperts (the nonscientists?), differences in how 
experts versus lay people perceive risk, what defines an “expert” (disciplinary 
perspective, methodological expertise, experiential knowledge), decision making in the 
face of uncertainty, gender differences in understanding of and confidence in science, and 
public values decision making among others. 
                                                 
1 The Georgia Institute of Technology IRB did not participate in this study because of the potential to 
increase validity problems brought about by members’ knowledge of the details of the methods and 
questions used in the study. However, anecdotal information was obtained from my informal observation of 
these meetings and helped to shape some of my thinking about this subject. 
 
63 
 A major function of participation in the theory of participatory democracy, noted 
earlier, is an educative one including both the psychological aspect and the gaining of 
practice in democratic skills and procedures (Pateman, 1970). Pateman subsequently 
argues that in participatory theory, participation refers to equal participation in the 
making of decisions and political equality refers to equality of power in determining the 
outcome of decisions. Fiorino (1990) summarizes four participatory theory-based criteria 
for evaluating whether an institutional mechanism is democratic. First, the mechanism 
should allow for direct participation of amateurs (nonexperts) in the decision-making 
process. Perhaps in the IRB process, the nonscientists or nonaffiliated members may 
represent nonexperts or amateurs, both of whom are given an equal voice in the IRB 
decision-making process, at least in theory. Arguably in many cases, the scientists 
themselves could also be classified as nonexperts when the research area of a protocol is 
outside their disciplinary domain. Second, mechanisms can be assessed to the extent that 
they enable the public to share in a collective decision-making process. IRBs are 
designed to provide the nonexperts, and in particular the nonaffiliated members, with the 
opportunity to contribute to the collective decision-making process. Regardless of 
expertise or background, any member on an IRB can voice his or her opposition to 
particular aspects of a scientific study or question the risks or benefits or even the 
scientific merit of the research.  
A third criterion is the extent to which a process provides a structure for face-to-
face discussion over a period of time as a means to discuss, deliberate, search for shared 
values and transform conflict into resolution (Fiorino, 1990). There is no federally 
mandated schedule for when or how often IRBs must meet, other than the stipulation that 
full board review must take place at a convened meeting of a majority of members that 
includes at least one nonscientist. These face-to-face meetings provide an arena for 
extracting public values issues and for ensuring that adequate consideration is given to 
the Belmont principles in human subjects research protocols. Fiorino’s fourth criterion 
for assessing whether a mechanism is participatory is the extent to which citizen 
participants are provided the opportunity to participate on equal footing with technical 
experts. The IRB process allows any member, expert or not, to question other members 
about proposed research, issues of risks and benefits, and scientific merit. Through a 
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discursive process of mutual education about such issues, both experts and nonexperts are 
enabled to participate more effectively and equally in the IRB decision-making process. 
Whether lay members or affiliated nonscientist members choose to exercise equal 
participation in the meeting is, however, questionable. 
While this study is not a formal evaluation of IRBs based on these criteria, such 
measures offer useful insight into how we might examine the IRB decision-making 
system in the context of a democratic decision-making process via the principles of 
participatory democratic theory. Thus, the data collected in this research will be analyzed 
with these principles in mind and will employ participatory democratic theory principles 
as a means to probe the bigger picture questions about expertise and decision-making at 
the boundary of science and society.  
 
3.8 Summary 
This chapter identified and reviewed conceptual dimensions of the some of the 
decision theory literature (particularly as it relates to small group decision-making) and 
participatory democratic theory literature. The case for studying IRBs was argued 
specifically via the literature from decision-making in science and technology and in 
particular, in the case of university research. A summary of previous empirical studies on 
IRBs was provided. Limitations and gaps in the theoretical literature and the empirical 






Chapter 3 provided the theoretical framework for conducting this research and 
identified several research questions. In this chapter, I describe and justify the 
methodology used to provide data to investigate the research questions and to study the 
decision-making process at seven university IRBs. A brief introduction to the 
methodology was provided in Section 1.4 of Chapter 1; this chapter aims to build on that 
introduction. Chapter 4 is organized around four major topics: the sample domain, the 
sampling procedures, qualitative research techniques, and data processing.  
 
4.2 Justification for design and methodology 
A case study design was selected to develop an explanation for IRB decision-
making. Several explanatory case study approaches were considered; however, due to the 
low level of understanding about the IRB decision-making process, a clinical case study 
approach (de Vaus, 2001) was ultimately chosen. Unlike theory-testing case studies or 
theory-building case studies, clinical case studies are case centered and use theory to 
understand a case (de Vaus, 2001). Qualitative information about individual experiences, 
perceptions and values was gathered individually from 37 research university IRB 
members.  A case study approach is appropriate for the investigation of cases when it is 
necessary to understand parts of the case within the context of the whole (de Vaus, 2001).  
A qualitative research design is particularly useful here because there are aspects 
of the functioning of an IRB that cannot easily be quantified, e.g., the experience of board 
members and the quality of the IRB decision yet are essential to our understanding of 
how IRB decision-making works. A semi-structured interview protocol was designed to 
elicit information about how members define their role on the IRB (what does IRB 
review entail), how they perceive the role of other members (what is the purpose of each 
type of member required to serve on the IRB), and how they perceive their impact on the 
decision-making process and outcomes of the committee (what is the purpose of the 
IRB). Other areas of inquiry included the efficacy of current IRB procedures and the 
estimated impact of potential changes to IRB regulations. General topics were explored 
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with the respondents to help uncover their perspectives while preserving the way in 
which each respondent framed and structured their responses (Marshall and Rossman, 
1995). Such semi-structured protocols do not constrain the interviewees to answer a list 
of specific questions. Instead, these procedures attempt to guide respondents with several 
general topics and probes, such that the elicited ideas evolve from their perspective and 
are not unduly responsive to a priori expectations. 
The conceptual model presented in Chapter 3 informed the theoretical basis of the 
interviews. It portrays the IRB decision-making process (that takes place within the 
convened IRB meeting) as I have come to understand it based on the empirical literature 
on IRBs and on my tenure working with the Georgia Institute of Technology IRB, and 
suggests that IRB members bring to the process their own set of values, perceptions, and 
judgments, which are further shaped by the research focus of the IRB (e.g., biomedical 
versus social and behavioral science research). Because my focus is on member 
perceptions of the group decision-making process that occurs at the convened IRB 
meeting, the model does not illustrate final decisions about protocols that are made prior 
to the convened full board meeting, such as whether a protocol qualifies for expedited 
review. Generally, the IRB administrator or staff (sometimes in conjunction with the IRB 
chair) decides whether a research protocol may be “exempt” from or “expedited” through 
full board IRB review. In either case, such protocols are not typically reviewed by the 
fully convened IRB membership and the related decision-making process about them is 
not the focus of this study.  
Thus, it was my expectation that the individual judgments and related experiences 
or expertise  of members are initially used to decide whether a protocol satisfactorily 
addresses federally-mandated review areas such as scientific merit, research design, risks 
and benefits to research participants, and informed consent. In other words, members 
receive a protocol (or some portion thereof) to review prior to the full board meeting. 
They conduct that review independently and, in the context of the four review areas laid 
out in the Common Rule, form a judgment about whether the research protocol merits 
approval. The members then convene as a group to discuss all human research protocols 
submitted for review, with each person contributing his or her own comments and 
concerns based on their independent review. 
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Subsequently, through the process of group discussion, I posit that individual 
judgments are sometimes reshaped and the protocol components sometimes rejudged 
until the group is satisfied that the regulatory criteria are met. At that point a decision to 
approve, approve conditional on revisions, defer (or table for more information), or 
disapprove is made. At this second, group level of decision-making IRB members from 
diverse backgrounds make the case for what risks they perceive as acceptable, whether 
the methodological design will minimize risk, whether human participants (or even the 
researcher and the university) are adequately protected, and so forth. It is at this level that 
expertise, participation, and small group dynamics are particularly relevant and likely to 
impact the decision outcome. 
 
4.3 Sampling and sample size 
The participants in this research study are experiential experts in the IRB process 
and for that reason, the sampling methodology employed is mostly purposeful. The 
decision to focus on universities rather than hospitals, government agencies, or other 
types of research organizations primarily was based on time and budget constraints, 
which did not permit sampling across IRB types for this study. It was also based on 
difficulty I experienced with gaining access to hospital IRBs during an earlier pilot study. 
However, I believe that universities are an appropriate subpopulation for this research 
given the breadth of research issues and disciplines, and potential for variability in their 
IRB structure and member selection procedures.  
The sampling strategy employed both comparable case selection (i.e., only 
research universities) and reputational case selection (i.e., where possible, universities 
that received a compliance determination letter1). The starting point for identifying 
                                                 
1 OHRP reviews institutional compliance with the federal regulations governing the protection of human 
subjects in HHS-sponsored research 45 CFR 46. The agency evaluates all written substantive allegations or 
indications of noncompliance with the HHS regulations, which are either made known to OHRP by a 
variety of source, including the institution itself (because institutions are required by law to report any 
serious or continuing noncompliance issues to OHRP). If complaints or concerns arise regarding an 
institution’s human subject protection practices, OHRP opens a formal evaluation and, if necessary, 
requires corrective action by the institution. During this evaluation, findings of noncompliance are issued in 
the form of determination letters, which before being made public are edited to remove those portions that 
relate to issues still under discussion with the institution. Compliance determination letters are intended to 
correct noncompliance issues and to prevent them from reoccurring. OHRP reports that most corrective 
actions are resolved at the OHRP level and do not have to be handled at a higher level. In serious cases, 
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comparable cases was the annual list of research universities that rank in the top tiers of 
U.S. News and World Report. Selection of participant sites was not purely random 
because an effort was made to include universities (i.e., reputational cases) that received 
at least one compliance determination letter in response to purported human subjects 
violations. It was expected that because of a compliance issue members at such 
universities could more broadly discuss issues that might inform our understanding of the 
relationship between IRB decision-making process and outcomes. Thus, a purposeful set 
of 25 universities from the U.S. News and World Report 2003 list of “top tier” 
universities was sent an email invitation to participate in the study. The text of the 
invitation email can be found in Appendix B. The sample boundaries, other than the 
university characteristics described above, included the requirement that participating 
universities allow me to interview the administrator, the IRB chair, a scientist member, a 
nonscientist member, and a nonaffiliated member on at least one IRB at the university. 
The choice of which members who would participate was determined by the IRB 
administrator. In most cases the administrator simply forwarded the invitation to 
participate on to the IRB members, allowing them to decide whether or not they wanted 
to be interviewed. In at least one case the administrator appears to have selected specific 
members.  
The resulting sample contained seven universities and 37 participating IRB 
members, including 21 scientist members, 13 nonscientist members, and six nonaffiliated 
members. Note that the total number of each type of member interviewed is different than 
the total number of IRB members (37) interviewed because it includes chairs and 
administrators in their membership role (i.e., scientist or nonscientist) as well as their 
administrative role. For example, the 13 nonscientist members also include the six 
nonaffiliated members because they too are nonscientists. Seven administrators (three of 
whom are not voting members on their IRBs) and seven IRB chairs were also 
interviewed. With one exception all of the chairs consider themselves, and are considered 
                                                                                                                                                 
OHRP may revoke its approval of an institutions Federalwide assurance or even suspend research activities 
at the institution. In most cases, OHRP requests verification that the institution has implemented the 
changes necessary to overcome the noncompliance problems. Often this will be revising policies, 
improving researcher training, and so forth. (available from: www.hhs.gov/ohrp/compliance; visited on 




by their IRB members and administrators, to be scientists. At University D, the IRB 
administrator actually classified the chair as a nonscientist because of the chairs 
disciplinary background (business); however all other IRB members at University D 
(including the chair) classified this chair as a scientist member.  
In general, choices of informants were driven by the conceptual questions, and not 
by a concern for “representativeness” (Miles and Huberman, 1994). The primary concern 
in this study is with identifying and explaining the conditions and processes by which 
IRB decision-making takes place at university IRBs, not necessarily with the 
generalization of the findings to other research settings such as hospitals and private 
research centers.  
 
4.4 Data collection and procedures 
Building on the theoretical framework presented in Chapter 3 and on preliminary 
results from a pilot study conducted in 2002 (described below in section 4.4.4) I designed 
data collection instruments to capture the elements of the decision-making process as 
perceived by IRB members and to determine how those members participate in the 
process. The interview protocol was further refined by posing the questions to three IRB 
members who serve on the IRB at my university.1 The following methodological 
discussion applies particularly to university IRBs.  
4.4.1 Instrumentation 
 
Data were collected via personal interviews with IRB members at the seven 
research universities. Interviews were designed to obtain rich contextual information on 
specific IRB functions and processes from the perspective of the members who perform 
them. A semi-structured interview technique was selected to facilitate a deeper 
understanding of IRB functioning, from institutional and individual board member 
perspectives. The interview questions (see Appendix C) were designed to draw out the 
participants and to get them to reflect on their experience as an IRB member and their 
                                                 
1 This round of pre-testing the protocol was conducted not to gather data, as in the pilot test, but rather to 
assess how the potential participants would interpret each questions and whether questions were clear and 
made sense as asked. During this phase, I conducted a mock interview with each of the three Georgia Tech 
IRB members while simultaneously discussing their perceptions and interpretations of the questions. 
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perception of their role and the role of other types of members on the IRB. The 
interviews, ranging from 45 minutes to two hours, were carried out on site at each 
university. All interviews were tape recorded to ensure accuracy of the participant 
responses. A set of supplementary interview questions (see Appendix D), also tape 
recorded, was posed to the administrators at each university to obtain factual information 
to assist the characterization of each university IRB. To improve the accuracy of results, 
both sets of interviews were fully transcribed prior to data analysis. Ethical 
considerations for these procedures are discussed in more detail in Section. 4.8.  
4.4.2 Observational data 
 
The interview questions were designed to examine how individual IRB members 
participate in the decision-making process. However, because there is no guarantee that 
members truly participate how they say they do, observing them in an actual IRB meeting 
provides an extra degree of reliability to their responses. Each university permitted me to 
attend and observe an IRB meeting in session at the university. Observational notes were 
recorded at the meetings, but tape recording was not permitted. I also recorded my 
personal notes and impressions during and immediately after each site visit. By attending 
an IRB meeting at each university, it was possible to see how members actually 
participate and to observe the decision-making environment in general, both of which 
provide additional information about the IRB decision-making culture. The observation 
notes for each university—coded and analyzed in a similar manner to the interview 
transcripts—are particularly useful for beginning to characterize the decision-making 
process at the group level and for improving the reliability of the results.  
4.4.3 Archival data 
 
Two additional data sources—university policies and compliance determination 
letters—were used to further characterize the culture of the IRB decision-making process 
at each university. All of the universities in this study make available, via the Internet, 
their university policies on research with human subjects. Additional resources such as 
review checklists were obtained from the administrator during the on site interviews.  
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The second source of archival data came from compliance determination letters 
between July 2000 and February 20041, which are made public via the Office of Human 
Research Protections website.2 Prior to conducting the personal interviews, I collected 
data on whether compliance determination letters were issued against the universities in 
my sample at any time up through the interviews. Where relevant, the nature of such 
complaints and the board’s role in the events that led to such complaints were 
incorporated into the interview protocols to identify any relationships between these 
outcomes, member participation, decision processes, or general IRB structure.  
4.4.4 Preliminary studies 
 
Personal interviews were conducted during a pilot study in April 2002 with IRB 
members from two research organizations in Georgia to explore anticipated differences in 
member perceptions and to develop a useful interview protocol. The resulting transcripts 
suggested that member behavior is influenced by position or role on the committee. 
Furthermore, those respondents indicated that IRB members may perceive their role, and 
the role of other members, in different ways. For example, members not affiliated with 
the organization may feel that their purpose on the board mainly is to ensure that the 
consent document is adequate, whereas scientist members may tend to emphasize issues 
regarding the research design. Furthermore, nonscientists on one IRB may be considered 
to be scientists on the IRB of another organization.  
Another perception that emerged in the preliminary interviews with nonaffiliated 
members was the belief that they were less active or participatory than scientist members, 
an observation also supported in the extant literature on IRBs (Gray et al., 1978). The 
following quotes from IRB members interviewed during the pilot study reaffirm the need 
for in-depth examination of roles of different types of IRB members and how these roles 
impact IRB decision-making processes and outcomes: 
“The consent form is a priority for community members. Community members 
are not primarily responsible for judging [research] design.”  (Nonaffiliated 
member, social and behavioral science IRB, April 2002) 
                                                 
1 If compliance letters were issued after the last site interview/observation, they were not included in this 
analysis. 
2 The OHRP website provides compliance determination letters at 




“Scientists always talk more because they can break down quantitative aspects, 
etc. especially the statistician. But, [participation] depends on the issues and 
protocols.” (Nonscientist member, social and behavioral science IRB, April 2002) 
 
“Nonaffiliated and nonscientist members participate less. They do not have as 
many comments and they don’t review [as primary reviewer] as many protocols. 
They tend to defer to scientist members and tend to withhold because they don’t 
want to hold up the process or maybe feel that their opinion won’t be respected.” 
(Scientist member, biomedical IRB, April 2002) 
 
“Everyone looks at the consent form. Scientist members typically focus on the 
rationale for a proposed study and on its design. Nonscientist and nonaffiliated 
members tend to look at whether there is consistency between the lay synopsis 
and informed consent.” (Scientist member, biomedical IRB, April 2002) 
 
The preliminary interviews suggest disparate views among members and types of 
IRBs (i.e., social and behavioral IRBs versus biomedical IRBs) that call for systematic 
study to examine the relationship between composition and behavior. 
 
4.5 Case study analysis 
 Case study analysis revolves around assessing the “fit” between an individual 
case and the theory or theories being tested (de Vaus, 2001). De Vaus emphasizes that 
because case studies are fundamentally theoretical, their analysis is also fundamentally 
theoretical and must be built around the theoretical propositions being developed. Thus, 
in order to really understand the IRB process and its related outcomes, it is helpful to 
understand the characteristics of the individuals who participate in that process—the 
member characteristic proposition—and the corresponding culture—the IRB culture 
proposition. Case study analysis is ideally suited to achieve this understanding and 
developing preliminary hypotheses about the relationship between member 
characteristics and IRB decision-making. 
 The theoretical propositions that shape and guide this research center on the 
characteristics and roles (and perceived roles) of the different types of members who 
participate in the IRB process. In earlier chapters, I proposed that the IRB process—
ultimately the decision-making process and the decision outcome—might be affected by 
such individual member characteristics as gender, expertise, and level of participation in 
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the process. Furthermore, characteristics of the IRB and its affiliated university may 
affect the IRB process. That is, features such as whether the IRB is affiliated with a 
public funded or privately endowed university; or, whether it reviews social and behavior 
or biomedical or all types of research for the university. It is, therefore, a primarily goal 
of analysis to “test” these theoretical propositions. 
 Yin (1989) suggests that cross-case analysis can only be done after each 
individual case is understood as a whole. I achieve this objective by first examining each 
university case individually, organizing each one around the theoretical concepts and 
research questions that guide the research. By analyzing each case around a common 
framework it becomes possible to compare the cases to arrive at higher-level 
generalizations (de Vaus, 2001).  
 
4.6 Data analysis software 
N6 software1 was used to manage and conduct qualitative content analysis of the 
interview and observation data in this study. N6 permits reliable tracking of pieces of 
data and reflection on the emerging concepts, which enhances the interpretive accuracy 
of analysis. N6 allows the researcher to store and organize text databases, code words and 
phrases within the text, search and retrieve the text for occurrences of a particular theme, 
and generate theory by displaying the categories or themes and their interconnections 
(Richards, 2002).  
N6 operates using a node structure, which employs an index tree that can be 
altered as data analysis evolves. In N6 terminology, a category (i.e., a theme) that stands 
by itself is called a “free node”. While reading through transcripts, “nodeworthy” ideas 
can be placed into the free node section of N6’s index tree structure, which functions as 
an electronic container for holding ideas. During early coding, this allows the researcher 
to simply create holding areas for both theoretical codes and codes that emerge during the 
initial pass through the transcripts without worrying about exactly where each idea 
belongs. As coding and analysis progress the researcher is able to move these free nodes 
into more organized groupings. N6 refers to this as a node hierarchy, in which the first 
                                                 
1 N6 is the sixth version of the NUD*IST (Non-numerical Unstructured Data Indexing Searching and 
Theorizing) software package developed by QSR International specifically for analyzing qualitative data 
(see www.qsrinternational.com; visited on October 20, 2004). 
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level node is called the parent node and those under it are called child nodes. For 
example, in this study “gender” is a parent node, whereas male and female are considered 
the child nodes of the parent. Similarly, scientist, nonscientist, and nonaffiliated member 
are all child nodes of the parent node “IRB member type”. A hierarchical node name 
includes all the parent nodes. In the case of the above examples, the hierarchical code 
name is “base data” because it represents the basic demographic data of all the 
participants in this study (see Figure 2). The numbers in parentheses in Figure 2 represent 
the “address” of each node, which is used by the software to locate each code during 
analyses. 
 
Figure 2. Example of node index tree and hierarchical structure. 
 Once nodes and the tree structure are created, they can be explored in their 
original occurrences in the interview and observation transcripts. N6 permits the 
researcher to “spread the text” in order to view a larger portion of the transcript around a 
particular code and situate the context appropriately. In other words, the text stored at any 
node can be retrieved and reviewed at any time to verify its context. Moreover, using N6 
it is also possible to generate reports about all of the text that is coded at a particular 
node. This means that instead of manually going through each transcript in search of text 
and corresponding codes, N6 will group together all of the text associated with the code 
“deference”, for example. Now just the portions of each transcript that contain the code 
“deference” can be more easily compared, which subsequently allows the researcher to 
Tree Nodes 
(1) Base data 
(1 1) Member self 
(1 2) Member regs 
      (1 2 1) Scientist 
      (1 2 2) Nonscientist 
      (1 2 3) Nonmember  
       (nonvoting) 
… 
… 
(1 10) Gender 
        (1 10 1) Female 
        (1 10 2) Male 
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interrogate the data in ways that would ordinarily be very tedious. The next section 
discusses the coding approach more specifically. 
 
4.7 Coding scheme 
 Coding proceeded in multiple phases consistent with the qualitative research 
approach. A “provisional start list” of codes (Miles and Huberman, 1994) was developed 
from the research questions, conceptual framework, and observations made during a two-
year research assistantship with the IRB at my home institution (see Table 1). In true 
qualitative fashion, interview data were coded throughout the data collection process 
using a multi-tiered approach.  
4.7.1 Phase I: open and flexible coding 
 
First, the raw data were sorted into manageable conceptual categories (e.g., 
member characteristics, expertise, participation, IRB purpose) using an open coding 
approach (Strauss, 1987). Open coding is so named because the categories or concepts 
are flexible and open to modification as analysis progresses. I began coding data from 
interview transcripts and field notes using the predetermined list of coding categories 
suggested by my conceptual framework, research questions, and the literature (see Table 
1). As anticipated additional categories (for example, “not research design” and “not 
scientific merit”) emerged as the analysis progressed. The final coding thesauruses are 
provided in Appendices E and F.  
Using an open and flexible coding approach as I reviewed the interview material, 
I assigned descriptive codes to pieces of text that represent either important concepts 
(e.g., expertise, risk-benefit ratio, “not our job”), emerging common patterns between 
respondents (e.g., willingness to defer to scientists, reluctance to speak out on certain 
issues), or distinct responses by different subgroups (e.g., scientists versus nonscientists). 
Text associated with each code was isolated and then re-grouped into broader conceptual 
categories to allow for meaningful comparison and interpretation in the subsequent 
phases of coding described below. For example, during my initial phase of coding I 
liberally noted references to different dimensions of participation, regardless of whether 
the action took place prior to or during the convened IRB meeting. At this stage in 
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coding, I allowed every code equal status with every other code before placing codes into 
a meaningful hierarchy for interpretation. 
Table 1. Preliminary codes derived from conceptual framework and IRB literature 
Code Description 
Member characteristics Scientist, nonscientist, or nonaffiliated (lay) member; 
chair; administrator; gender; IRB experience 
Expertise Disciplinary expertise; methodological expertise; lay 
expertise; lack of expertise; development of expertise 
over time 
Participation Presence (or lack thereof) of mechanisms that encourage 
members to participate; email; group training and 
workshop opportunities; assignment of reviews to 
members; direct participation; influence over decision 
outcome; number of nonaffiliated or lay members; 
resources for participation (compensation) 
Decision-making culture Formality of meetings; discussion process; consensus; 
deference to authority or experts 
IRB purpose Purview of IRB; whether or not to review scientific merit 
or research design; protect human subjects; minimize 
risks 
 
As noted earlier N6 is used to create a node system to serve as an uncoordinated 
collection of “free” categories that serve as a “parking space” or as an electronic 
container for ideas (Richards, 2002) about the interview transcripts and emergent codes 
until logical relationships can be identified between categories (such as member type, 
public or private university, and gender).  Thus, I used N6 to search the text of each 
transcript for words from the preliminary list of codes such as “expertise”, “experience”, 
“participation” and variations on these words to be sure I did not overlook occurrences 
such as “expert” or “participate” with similar meanings.  
For each of these text searches N6 permits the creation of a new document that 
includes only the occurrences of the specified text, which can then be expanded to show 
the context of a key phrase or word in its original transcript. Using this newly created 
document, only the relevant portions of text can be re-read in order to determine whether 
a word or phrase actually referenced the concept on which the text search was performed. 
For example, using N6 I searched all the texts for the word “expertise”. By expanding the 
paragraphs where expertise was mentioned, it is possible to determine whether the 
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respondent was talking about lacking expertise to judge research design, deferring to 
disciplinary experts to decide the merit of a protocol, possessing expertise to determine 
the level of risk, and so forth. Clearly there exist important differences in the meaning of 
expertise in each of these contexts that cannot be fully appreciated without referring to 
the original context of the interview response.  
4.7.2 Phase 2: pattern coding 
 
During open coding, certain “patterns” or repeated relationships between 
properties and dimensions of categories begin to appear (Strauss and Corbin, 1990). Thus 
in the second phase of coding, I re-read across all the interview transcripts to specifically 
identify such similarities and differences using a pattern coding approach (Miles and 
Huberman, 1994). At this level, I focused on the actual interview responses in the context 
of the interview questions asked and assigned code labels for thematic categories one 
category at a time (Strauss, 1987). This pattern coding stage is useful for identifying 
patterns or ways in which key concepts cluster together or relate to one another (Neuman, 
2000). Data are put back together in new ways by making connections between 
categories (Strauss and Corbin, 1990).  
An example is useful. Using the earlier example of “participation”, after initially 
coding all the transcripts and placing each potential dimension of participation into “free 
nodes” in N6, I recombined each code into two broader categories of participation: group 
participation and individual participation. Group participation thus encompasses any 
participatory actions taken by members during the convened IRB meeting and the 
associated group decision-making process. On the other hand, individual participation 
refers to member involvement in the review process that occurs outside of the convened 
IRB meeting (e.g., clarifying questions with investigators during pre-meeting review of 
the protocol, conducting expedited reviews, review of assigned protocols). 
This level of coding is particularly useful for making comparisons between 
different types of IRB members and their decision-making processes or attitudes towards 
concepts such as “expertise” or” purview of IRB”. This stage also permits the 
identification of overlapping codes that could be combined or single codes that may need 
to be further refined. Using the N6 software, this is achieved by placing free nodes into a 
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“tree structure” where, for example, a node for “member role” (a parent node) has 
subcategories for scientist, nonscientist, and nonaffiliated member (child nodes of the 
parent node).  
4.7.3 Phase 3: thematic coding 
During the final review of the data, identified themes were used to aid in the 
analysis and interpretation of the IRB member interview responses and to identify 
structural relationships between the thematic categories. In the third pass through the 
data, I compared and contrasted themes across the cases using the N6 software 
capabilities to “interrogate” the date. I used the tree node and free node indexing system 
to “ask questions” about the themes and concepts identified during the first two coding 
passes and in the context of my research questions. Using Boolean style search 
techniques, I was able to examine where, for example, certain codes intersect with or 
occur near other codes. Using such collation operators allowed me to examine text coded 
at categories within specified relationships, such as how different types of members view 
the purview of the IRB, or whether there are differences between members’ views 
depending on whether they serve on a public university IRB or a private university IRB.  
Similarly, it is possible to ask questions such as whether IRB members talk about 
deference to other members or staying silent when they also talk about the concept of 
expertise. Or, how IRB members talk about making a decision to approve a research 
protocol and where close by they also talk about lack of expertise to do so. I also 
examined participation of members such as how nonscientist members participate when 
research design of a protocol is the subject of discussion. These contextual searches were 
performed using N6, by asking questions about how interview text is coded by one node 
in the context of coding by another node and they provide potential answers to the 
research questions that guide this study.  
Throughout this process, I attempted to link emerging themes and patterns 
particularly with the literatures on participatory democratic theory and small group 
decision-making to my preliminary propositions about the influences of IRB member 
characteristics on the decision-making processes and outcomes. For example, I looked for 
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evidence that members of the group might be influenced by the group process (as 
suggested by decision research on conformity). 
 
4.8 Limitations of selected methodology: reliability and validity 
Validity in qualitative research is defined as the extent to which the data is 
plausible, credible and trustworthy. Maxwell (1992) identifies three types of validity that 
are relevant to qualitative research in general. Descriptive validity is the accuracy of what 
is reported by the researcher (for example, events, objects, behaviors, and environment). 
Interpretive validity is the accuracy in interpreting what is going in the minds of the 
participant and the degree to which the participant’s views, thoughts, feelings, intentions 
and experiences are accurately understood by the researcher. Theoretical validity is the 
extent to which the theoretical explanation developed fits the data and therefore is 
credible and defensible.  
Case study designs are devised to yield sensible, plausible accounts of events and 
in this way internal validity is achieved (de Vaus, 2001). De Vaus further claims that case 
study designs achieve explanations by constructing “a full picture of the sequence of 
events, the context in which they occur, and the meaning of actions and events as 
interpreted by participants and their meaning as given by a context.” The external validity 
of case studies is enhanced by the strategic selection of cases rather than by the statistical 
selection of cases (Yin, 1989). To allow for more meaningful comparison, this study was 
intentionally restricted to university IRBs and particularly to those that are classified in 
the “top tiers” of all research universities. Furthermore, the validity of data interpretation 
is improved throughout the dissertation by continually linking observations and 
interpretations back to the literature, which frames this study. In this manner, it can be 
seen that such interpretations are, in fact, the product of conscious analysis. 
Interpretations and findings are further substantiated with the actual words of the research 
participants where possible. 
A major assumption about reliability when conducting qualitative research is the 
acceptance that different researchers or researchers using alternative measures will get 
distinctive results because each researcher sees data collection as an interactive process 
(Neuman, 2000). Triangulation—or the use of multiple methods, data sources, and 
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theories—to substantiate data sources increases the reliability of qualitative research. 
Increased agreement between sources of data permits the more reliable the interpretation 
of the data. In this study, three data sources are used—personal interviews with IRB 
participants, archival data sources, and nonparticipant observation of IRB meetings—and 
examined via qualitative data analysis and case study methods. Moreover, results are 
interpreted vis-à-vis two theoretical perspectives: small group decision-making and 
participatory democratic theory. Additional conventions were followed to enhance 
reliability. For example, throughout the study, extensive use was made of fields notes 
recorded during and immediately after each site visit.  
4.8.1 Intercoder reliability 
Miles and Huberman (1994) assert that definitions become sharper when two 
researchers code the same date set and discuss their difficulties in coding. Disagreements 
indicate that a definition ought to be expanded or clarified (Miles and Huberman, 1994). 
To check reliability of coding beyond that which is offered by using the N6 software 
program, I asked two independent coders to code three (approximately 10 percent) 
randomly selected transcripts. Coders were instructed to do line-by-line coding of the 
text, using the coding thesauruses in Appendices E and F, to search for specific key ideas 
or phrases listed in the column entitled “synonyms/related themes”. Each time a key idea 
or phrase was identified, the coder was instructed to label that text according to the code 
listed in the first column. The fact that two coders independently assign the same code is 
assumed to be a sufficient indication that the researcher himself or herself, coding the 
same response in accordance with his or her instructions, would similarly have chosen 
that same code (Hak and Bernts, 1996). Reliability calculations were performed for three 
scenarios: between the two independent coders, between Coder 1 and the researcher, and 
between Coder 2 and the researcher. The results are summarized in Table 2. Reliability 
was calculated according to Miles and Huberman’s (1994) formula: 
 
Reliability = Number of Agreements/(Total Number of Agreements + Disagreements) 
 
Agreement between coders should be in the 90 percent range, depending on the size and 
range of the coding scheme (Miles and Huberman, 1994). 
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Coder #1 and 
researcher 
Reliability between 
Coder #2 and 
researcher 
24 89% 87% 90% 
27 95% 95% 93% 
34 84% 88% 86% 
 
4.9 Ethical considerations 
This research study was found by the Georgia Institute of Technology IRB to be 
of minimal risk to the research participants in this study, and as a consequence underwent 
expedited IRB review. Prior to submitting the research to the Georgia Tech IRB, 
considerable thought was given to the possible ways in which participants might perceive 
risk associated with their involvement in the study. While university IRBs conduct their 
proceedings behind closed doors, many openly list the names of IRB members on the 
Internet. Yet, usually the review process is conducted akin to the peer review process in 
which the research investigator does not know who reviews his or her proposal. Given 
the tension that is currently present within the research oversight system, it is 
understandable why many universities choose to maintain such a “blind review” system.  
I deliberated several approaches for how to identify IRB members that 
participated in this study. The most comprehensive way to represent IRB members and 
their institutions was to name both the participant and their university affiliation. Given 
the possibility that some universities might not want particularly negative aspects of their 
process identified publicly, I anticipated that this option would lower my initial response 
rate. A second method of identification considered was to identify participants only by 
their university affiliation. But, at some universities, it might be easier to further identify 
IRB members because the university may only have one nonaffiliated member or one 
scientist member with a particular disciplinary background that is evident from the 
person’s responses especially when combined with a member list on the Internet. 
Furthermore, this second method of identification would also make it very easy to 
identify the chair and administrator at each university. The third method of identification 
considered was to provide complete confidentiality to participants, identifying them by 
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member type only and in the context of the type of IRB on which they served and the 
type of university (public or private) in which the IRB operates.  
In the end, and in order to maximize the response rate and to provide an 
environment in which potential participants would be comfortable providing maximum 
disclosure of their IRB experience, I opted to provide full confidentiality. This decision 
was reaffirmed by repeated expression from the participating IRB members that I not 
identify them or their university. During my initial contacts, several university IRB 
administrators asked me to verify confidentiality. One IRB went so far as to require me to 
sign a statement of confidentiality for attending the IRB meeting and to submit the 
resulting observation transcript for final approval. IRB approval and consent forms are 
located in Appendix A. 
 
4.10 Summary 
This chapter described the research methodology and sampling procedures used to 
examine the IRB decision-making process at seven research universities. In exploring the 
dynamics of these boards, my primary research objectives were two-fold. First, I set out 
to characterize these IRBs, including their member composition, the type(s) of research 
they review, the ways in which members participate in decision-making, and the 
processes by which members determine whether the proposed research merits IRB 
approval. The second research objective was to investigate whether a relationship exists 
between these characteristics and IRB decision making processes at the group level and 
whether it can be explained, at least in part, by the variables such as selection criteria and 
composition of IRB members, roles of members, and group dynamics. To determine 
these attributes, data were collected using in depth personal interviews with IRB 
members, and using archived documents from the universities (IRB policies and 
guidelines) and from the Office of Human Research Protections (compliance 
determination letters). To improve reliability of the data, observations were recorded of 
an in-session IRB meeting at each participating university. Reliability and validity issues 
were also discussed.  
In the remaining chapters, I present patterns of results and analyze them for their 
relevance to the research questions. In Chapter 5, I briefly introduce the IRB members 
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who participated in this study. In Chapter 6, each university IRB is profiled on an 
individual case level based on the data obtained from the personal interviews, available 
archived documents at each university, and available compliance letters. Chapter 7 
presents a cross-case analysis, comparing the decision-making process across all seven 
IRBs. In Chapter 8, I will discuss my findings from Chapters 5, 6 and 7 within the 
context of the literature presented in Chapter 3 and draw conclusions and implications for 
policy and practice. 
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5.0 IRB MEMBER CHARACTERISTICS 
 
5.1 Introduction 
 This chapter presents a brief introduction to the individuals who participated in 
this study. Demographic information is provided about the group as a whole and also 
according to the regulatory-defined subgroups (scientists, nonscientists, and nonaffiliated 
members).  
 
5.2 Research participant demographics 
The subject group in this research consisted of 37 IRB members from seven U.S. 
research universities. The overall demographics are summarized in Tables 3 and 4. The 
classification of participants as presented in this section is based on information provided 
by the administrators at each university. This is important to point out because the IRB 
administrator’s definition of a scientist or nonscientist may be different than the 
individual IRB members’ definitions of themselves, as was noted previously. This 
variation in definition or classification of member types is important for explaining the 
relationship between member types and their perceived role on the IRB and their 
perceptions of the IRB process because it must be taken into consideration when 
interpreting related interview responses.  
For example, at University D three members (specifically, researchers in 
education, business, and economics), including the IRB chair, classified themselves as 
“scientist members”. One of those respondents (a researcher in economics) was not sure 
whether he was correctly classifying himself but he was also relatively new to the process 
(having served only one semester on the IRB). However, during my interview with the 
IRB administrator at University D, she specifically referred to the members from these 
disciplines as “nonscientists”. In contrast, one member (a nurse) at University C 
classified herself as a nonscientist while the IRB administrator at that university clearly 
identified this member as a “scientist”. The only other conflict in member classification 
occurred at University A, where one member who is pursuing a social science PhD 
classified herself as “probably a scientist”. However, the IRB administrator classified this 
member as a “nonscientist until she completes her degree”. Since the administrator’s 
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definition is the one that is used to satisfy the regulatory requirements for committee 
composition, I use this classification throughout the data analysis to provide an initial 
profile of the sample group in this study. However, where relevant to those members’ 
responses I will point out this difference in classification and how it might affect the 
interpretation of responses.  
Table 3. Demographics of members according to Administrator classification 
 Total Scientist Nonscientist Nonaffiliated Male Female
Chairs 7 6 1 0 3 4 
Administrators 7 1 6 0 0 7 
Scientists 21 - - 0 11 10 
Nonscientists 13 (16)1 - - 6 5 8 (11)1 
Nonaffiliated 6 0 6 - 4 2 
 
Table 4. Demographics of members according to Self classification 
 Total Scientist Nonscientist Nonaffiliated Male Female
Chairs 7 7 0 0 3 4 
Administrators 7 1 6 0 0 7 
Scientists 24 - 12 0 12 12 
Nonscientists 10 (13) 1 - - 6 5 5 (8) 1 
Nonaffiliated 6 0 6 - 4 2 
 
Of the 37 participants, 21 are classified as scientist members, 10 as nonscientist 
members, and six as nonaffiliated members.3 All of the nonaffiliated members are also 
classified as nonscientists. Seven IRB chairs and seven IRB administrators were also 
interviewed. While all of the chairs classified themselves as scientist members, only six 
were classified as such by their IRB administrators (as noted above). One IRB 
administrator is classified as a scientist member, while three are classified as nonscientist 
                                                 
1 Three of the IRB administrators are nonscientists; however, they are not voting members on their IRBs. 
The numbers in parentheses represent the number of participants if these three individuals are included in 
the total counts. 
2 One member (with an engineering background) classifies herself as both a scientist and nonscientist. The 
IRB administrator classifies this member as a scientist. 
3 Recall that three of the original 37 participants are not voting members on their IRBs. These three 
participants are IRB administrators, and also nonscientists. However, their responses to interview questions 
are not included in analyses of perceptions shared by the nonscientists who are voting members. 
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members. The remaining three IRB administrators are non-voting members on their 
IRBs.  
The members interviewed represent notable breadth in disciplinary expertise and 
years of service on their IRBs (see Table 5). The cells in Table 5 are sorted according to 
university ID, affiliation, and role on the IRB as designated by the IRB administrator, 
respectively. Twenty-one participants are female; 16 are male. All of the IRB 
administrators are female. Four females are chairs of their IRB. Four of the nonaffiliated 
members are male. Of the 21 scientist members,1 about half (10) are female. Nine of the 
scientist members received their highest degree in a medical field. The remaining 
scientists (12) have doctoral degrees in social science disciplines. The educational 
backgrounds of the 13 nonscientist members include health administration, public health, 
social work, law, art history, engineering, theology, and research administration. The 
backgrounds of the nonaffiliated members are also diverse: two are employed in social 
work areas (primarily with the elderly community), one works for a local art museum and 
has a background in art history, one is a retired engineer, one is a clergyman, and one is a 
homemaker with a law degree. 
                                                 
1 As they are classified by the IRB administrator on each IRB. If the self classification is used, the total 
number of scientist members is 24. 
 
 
Table 5. Demographic information for study participants. 
Univ 
ID 












A no nonscientist nonscientist engineering member private social 
behavioral 
4 M 25 
A yes nonvoting 
member 
nonscientist research  
admin. 
admin private social 
behavioral 
4 F 22 
A yes scientist scientist sociology 
professor 
chair private social 
behavioral 
5 F 23 
A yes scientist scientist psychology 
professor 
member private social 
behavioral 
4 M 24 
B no nonscientist nonscientist humanities  member private biomedical 16 F 16 
B yes nonscientist nonscientist policy admin private biomedical 8 F 11 
B yes scientist scientist physician chair private biomedical 8 M 10 
B yes scientist scientist health research member private biomedical 3.5 F 12 
B yes scientist scientist physician member private biomedical 2.5 M 13 
C no nonscientist nonscientist lawyer member private biomedical 6 F 21 
C yes nonvoting 
member 
nonscientist research  
admin. 
admin private biomedical 5 F 17 
C yes scientist nonscientist nurse member private biomedical 2 F 18 
C yes scientist scientist physician member private biomedical 7 M 19 
C yes scientist scientist physician chair private biomedical 6 M 20 
D yes nonscientist scientist education 
professor 
member public comprehensive 2 F 32 
D yes nonscientist scientist economics member public comprehensive 0.5 M 35 
D yes nonscientist scientist research  
admin. 
admin public comprehensive 5 F 36 
D yes nonscientist scientist business 
professor 
chair public comprehensive 8 F 37 
D yes scientist both engineering  member public comprehensive 2.5 F 33 
D yes scientist scientist social science 
professor 























E yes nonscientist scientist social work member public social 
behavioral 
2 F 2 
E yes scientist scientist nursing professor member public social 
behavioral 
1 F 1 
E yes scientist scientist clinical 
psychology 
member public social 
behavioral 
2 M 3 
E yes scientist scientist psychology admin public social 
behavioral 
2.5 F 4 
E yes scientist scientist physician member private biomedical 2.5 M 14 
E yes scientist scientist psychology 
professor 
chair public social 
behavioral 
5 F 15 
F no nonscientist nonscientist clergy member public comprehensive 2.5 M 27 
F yes nonscientist nonscientist research  admin. admin public comprehensive 3 F 29 
F yes nonscientist nonscientist research  admin. member public comprehensive 6 F 31 
F yes scientist scientist physician member public comprehensive 1.5 M 26 
F yes scientist scientist physician chair public comprehensive 8 M 28 
F yes scientist scientist physician member public comprehensive 1 F 30 
G no nonscientist nonscientist business member private social 
behavioral 
1 M 6 
G no nonscientist nonscientist business member private social 
behavioral 
2 M 7 
G yes nonvoting 
member 
nonscientist university admin. admin private social 
behavioral 
1 F 5 
G yes scientist scientist sociology 
professor 
chair private social 
behavioral 
4 F 8 
G yes scientist scientist sociology 
professor 
member private social 
behavioral 




5.2.1 Scientist members 
 Twenty-one scientist members participated in this study. With one exception (a 
nurse), all possess either PhDs or MDs in science or medicine. Nine received their 
highest degree in a medical field. Eleven hold PhDs in a social or behavioral science 
discipline and one is a nurse. Almost half (10) of the scientist members are female. Of the 
female scientist members, one is a physician, one is a nurse and the rest have social 
science backgrounds. Of the 11 scientist members who are male, seven are physicians 
and four have social or behavioral science backgrounds. In this study, the average 
number of years of IRB service for scientist members is 4.3. The range of IRB service is 
one to nine years (mode = 2.5 years). All of the chairs consider themselves to be scientist 
members, and with one exception their committee members agree. The exception is 
University D, where the chair has a business education background and is classified as a 
nonscientist according to the IRB administration. While there is no stipulation that the 
IRB chair must be a scientist, the IRB administrator classification is what is reported to 
the Office for Human Research Protection (OHRP) as part of the university IRB 
registration. The average range in years of IRB tenure for chairs is four to eight (average 
= 6.3 years). 
5.2.2 Nonscientist members 
 Nonscientist members in this study include both affiliated IRB members and 
members not affiliated with the universities. The affiliated nonscientist members have 
backgrounds in university administration, business, the humanities, and theology. IRB 
tenure for nonscientist members ranges from one-half to 16 years (average = 4.6 years). 
The average is 3.5 years when calculated without the member who holds 16 years of 
experience.  
5.2.3 Nonaffiliated members 
 As mentioned above, all of the nonaffiliated members are also nonscientist 
members. They have an average of 5.3 years of IRB experience, with one member having 
served 16 years on her IRB. When this member’s experience is excluded from the 
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average, nonaffiliated members have served an average of 3.1 years on the IRB. Four of 
the nonaffiliated members are male. 
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6.0 INDIVIDUAL CASE ANALYSIS – UNIVERSITY IRB PROFILES 
 
6.1 Introduction 
In 2003, more than half (55 percent) of basic research conducted in the U.S. was 
performed at universities (Shackelford, 2004) with the U.S. research university serving as 
the benchmark for the rest of the world (Commission of the European Communities, 
2004). These characteristics make the research university an ideal laboratory in which to 
examine aspects of the IRB decision-making process. Though human subjects review is 
required at any institution or organization that receives federal funding for human 
subjects research, the university represents a unique opportunity to get inside the “black 
box” of the IRB decision-making process and examine its complexity from the inside out 
for several reasons explained below.  
Generally it is more difficult to gain access to the IRB meetings or to related 
documents at private organizations such as hospitals or medical research centers. Such 
institutions typically do not make their human subjects research policies or their IRB 
membership publicly available. In contrast most universities publicly post their human 
subjects research policies and in many cases make their committee membership lists 
available on the Internet. While the IRB meetings at universities are private to the extent 
that they are not “open door” meetings, guests and visitors are generally permitted to 
attend a meeting if arranged in advance with the IRB staff or chair. Thus, the research 
university is an ideal venue for this research not only because it allows for a study of 
decision-making at the cutting edge of research, but also because—perhaps by the very 
nature of its purpose—it provides entrée into a system that elsewhere tends to be closed 
to outsiders. For these reasons, universities with the Carnegie Classification of 
Doctoral/Research Universities were invited to participate in this study, using the 
sampling methodology discussed in Chapter 4.  
Universities that agreed to participate are profiled here in a manner that provides 
the context in which their IRBs are situated, but without revealing the actual identity of 
the university. Because the universities and IRB members in this study explicitly 
requested confidentiality associated with their participation, I do not disclose the identity 
of any of the IRB members or their university affiliation. Thus, I have chosen to profile 
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each university according to several academic characteristics and IRB traits in a 
descriptive but nonidentifying manner. While this choice may take away from the 
credibility of the results, it was a critical decision to maximize participation and depth of 
interview responses, particularly given the current regulatory climate for human subjects 
research. For more information about ethical considerations refer to section 4.9. 
The Carnegie Classification of Doctoral/Research University describes such 
universities as those that “offer a wide range of baccalaureate programs and…are 
committed to graduate education throughout the doctorate.” About seven percent (i.e., 
248, or 162 public and 86 private) of U.S. universities are classified as Doctoral/Research 
Universities.1 These same universities tend to be classified among the “top tiers” by U.S. 
News and World Report in its yearly rankings of U.S. colleges and universities. The 
universities in this study are further profiled according to publicly available statistics 
including approximate number of graduate students enrolled, breadth of disciplinary 
programs offered and range of total expenditures for research and development. Within 
the sample group, four universities are privately endowed and three are publicly funded. 
All participating universities have an affiliated medical school or center; however, this 
was not a stipulation for participation. The universities are located across the U.S. and are 
not concentrated in any particular geographic area. A summary of overall university 
profiles is provided in Table 6. 
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An important distinction in oversight committees is the extent to which they apply 
or carry out their human subjects protection jurisdiction. The method, intensity, and 
frequency of research oversight activities depend upon university resources (e.g., staff 
and budget) allocated to the IRB. Information about these demographics of the IRBs was 
obtained directly from the IRB administrator at each of the participating university. 
Figure 3 illustrates a breakdown of the number of IRB members in the study according to 
university type and the research focus of the IRB. The bar patterns in Figure 3 represent 
the percentage of study participants serving according to the type of IRB on which they 
serve and the type of university in which the IRB is located. The legend provides the 
numerical distribution of members broken down similarly. For example, 17 participants 
serve on IRBs at public universities. Of that group, five participants serve on an IRB that 
reviews social and behavioral research. The remaining 12 public university IRB members 
serve on IRBs that review all types of human subjects research at their respective 
                                                 
1 With the exception of the Carnegie Classifications, the data for this table were obtained from available 
reports from the participating universities. To protect the identity of the universities, ranges are provided to 




universities. Neither biomedical IRBs at public universities nor comprehensive IRBs at 
private universities are represented in this study. This was an unintended result related to 




























Figure 3. Breakdown of participating IRB members by type of university and IRB 
 
Additional detail with respect to university-level demographics is provided in 
Table 7, which indicates the approximate total number of protocols each university 
reviews per year, the total number and type of members on the committee that 
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6.2 University A  
 University A is a Doctoral/Research University-Extensive,3 privately endowed 
university with a separate but affiliated medical school. The approximate number of 
graduate students attending University A ranges between 5000 and 10000. The university 
offers degrees in a wide range of disciplines including engineering, business, law, 
medicine, arts, humanities, theology, and social and physical sciences. The university 
employs between 1500-2000 faculty (roughly 80 percent male and 20 percent female). 
Research & Development (R&D) expenditures for FY 2001 totaled between $350-400 
million.  
University A operates separate IRBs for the review of social and behavioral 
research and biomedical research. The IRB that participated in this research was the 
social and behavioral committee. The official university IRB was originally established in 
                                                 
1 Information that was not provided or obtainable at the time of interviews is represented by a question 
mark (?). 
2 Shortly before University D agreed to participate in the study, the nonaffiliated member resigned from 
this committee. At the time of the interviews, the IRB at this university was still searching for a 
replacement from the community. 
3 Doctoral/Research University-Extensive means that, during the Carnegie Foundation study period, a 
university awarded 50 or more doctoral degrees per year across at least 15 disciplines. 
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the early 1980s, although an earlier committee was established in response to the PHS 
regulations issued in the mid 1960s. University A has always maintained two separate 
and distinct IRBs for the review of biomedical and social/behavioral research. The 
operation funds for the social/behavioral IRB are allocated from the Provost, via the 
university office that handles the pre-award funding process. The committee reports to 
the university Vice Provost for Research.  University A’s social and behavioral IRB 
meets twice per month and meetings typically last about 90 minutes. Meetings are held 
during lunch and food and beverages are provided. Approximately 100 protocols are 
reviewed per year, with about 15 percent undergoing review by the full board. About 35 
percent of the protocols are reviewed via the expedited review process; the remaining 50 
percent fall under the exempt category (per 45 CFR 46) and are not reviewed by the 
convened IRB.  
University A does not have a written policy on how members are selected to the 
IRB. Usually members are identified via word of mouth. Networking off campus is used 
to identify nonaffiliated members. With the exception of the nonaffiliated member, all 
members must be approved by a university-wide committee and are subsequently 
officially appointed by the Provost. The IRB chair is selected by the Provost but is also 
determined simply by whichever member is willing to take on the responsibilities of the 
IRB chair. Members are not compensated for their service; however, the chair receives 
release time from two classes for service on the IRB.  
While the social and behavioral IRB has not received any compliance directives 
from OHRP, the biomedical IRBs at University A have received two compliance 
determination letters, citing issues about the use of appropriate consent procedures in 




 Nine members serve on the social/behavioral IRB.1 Five are female and four are 
male. All of University A’s members are Caucasian. Two scientist members participated 
                                                 
1 The biomedical IRBs at University A did not participate in this research. However, publicly available 
information was obtained about these IRBs. The biomedical IRBs at University A are comprised of five 
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in this study; Both hold doctorates in social science fields (sociology and psychology). 
Two nonscientists serve on the committee, one of whom is the nonaffiliated member who 
participated in this study. The other nonscientist is a lawyer who works for the university. 
University A also has three alternate members who are former IRB members that no 
longer serve actively on the board. 
 
Observation of IRB meeting 
 University A’s IRB employs a primary reviewer system whereby members are 
individually assigned to fully review specific protocols and lead the related discussion at 
the convened meeting. All members, regardless of position or member role on the IRB, 
can serve as primary reviewers. The meeting I attended began at lunchtime and lasted one 
and a half hours, during which time three full board research protocols were presented 
and considered for IRB approval. The meeting atmosphere was informal and casual; the 
group discussion was tape recorded. Two nonaffiliated members were present at this 
meeting, including one who was introduced as a new member who will serve as an 
alternate nonaffiliated member. The group was given information about the background 
of the new non-affiliated member; however, backgrounds of the other members were not 
disclosed to the new member. Both nonaffiliated members are retired professionals 
(formerly, one an engineer and the other a “natural” scientist). The official start of the 
meeting began with group approval of the previous meeting minutes. 
 With the first protocol, the issue of conflict of interest between IRB members and 
research protocol arose. The member with the conflict expressed concern about leaving 
the room but was told to stay and “put your head down during the vote” because the room 
was cramped1 and it would prove difficult to get in and out quickly. All the members, 
except one, have social science backgrounds; however, from the discussion of each 
protocol it was not obvious which member came from which disciplinary background.
 The role of member expertise manifested itself in the discussion such that 
members with relevant expertise appeared to speak on behalf of research investigators in 
                                                                                                                                                 
committees: four meet monthly and one meets as needed. Each committee has a separate chair (all are male 
scientist members). Committees are comprised of 16-25 members (on each committee one member is 
nonaffiliated, 4-6 are nonscientists, and the remainder are scientists). 
 
1 At this particular meeting, the group had to meet in a room that was not their typical meeting space. 
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order to facilitate approval of a protocol. For example, in one case an IRB member 
attempted to make the case for why a protocol should receive a “waiver of consent”. In 
spite of the member’s justification, however, the chair remained firm that a waiver should 
not be granted in this case and would be required for approval of the protocol. 
 The role of the IRB chair at University A was one of a facilitator. Her personality 
was strong and her opinions about the IRB approval process were evident. By 
comparison with other members, her knowledge of both investigators and research being 
conducted at the university was vast and comprehensive. In spite of the strong presence 
of the chair, the group tended to defer more to the administrator (who is not a voting 
member) particularly when it was not clear what the impact of the IRB decision will be 
on a research study. The administrator, who appeared very confident in her knowledge of 
the human subjects regulations, was quick to step into group discussion to assist members 
in understanding the impact of their decisions within the regulatory context and prior IRB 
history. The administrator also served the function of keeping the group abreast of current 
regulatory issues that could potentially impact the scope of the review process. For 
example, the issue of whether oral histories are subject to IRB review was brought up at 
this meeting and the administrator provided extensive discussion about the current OHRP 
opinion. 
As an observer, I was unable to determine which members fulfilled which 
regulatory role (i.e., scientist, nonscientist, nonaffiliated member) based on the nature of 
the discussion. With few exceptions every member contributed opinions to each protocol 
that was reviewed at this meeting. The member who spoke the least is a lawyer, which I 
came to know during the meeting discussion. 
 Two themes emerge from this meeting and seem to characterize the personality of 
the IRB as a whole. First, the IRB is concerned about its role as a “facilitator of 
research”. Rather than critiquing the research design of protocols, members of the group 
note that “friendly suggestions” might be made in the investigator’s IRB letter. Research 
investigators are told that these “friendly suggestions” are not a requirement for IRB 
approval, but recommendations that are based on the research experience of the IRB 
members and possibly worth the investigator’s consideration for improving the research 
design of the study. The second feature that characterizes this group is the level of 
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equality in member role. Any member, including the nonaffiliated member, may serve as 
a primary reviewer. But perhaps more interestingly, the reviewers also serve in a liaison 
role between the IRB and the research investigators at the university. In other words, 
members are encouraged to communicate openly (i.e., not anonymously) with the 
researchers prior to and after the IRB meeting. For this particular meeting, the 
nonaffiliated member had in fact contacted the research investigator for more information 
via email during the reviewer’s pre-meeting review of the protocol. There seemed to be 
genuine concern among all members at University A that the research investigators are 
adequately engaged in the IRB process. Frequently, the chair or other members suggested 
calling the investigators directly to obtain additional information that may facilitate the 
approval process. 
 
6.3 University B  
University B is a Doctoral/Research University-Extensive, privately endowed 
university with an affiliated medical school. The university offers degrees in disciplines 
from the social and physical sciences, medicine, law, theology, arts, humanities, and 
business. University B enrolls less than 5000 graduate students. The university employs 
between 2500-3000 faculty (roughly 50 percent male and 50 percent female). R&D 
expenditures for FY 2001 totaled between $200-300 million.  
University B operates five separate but equal IRB committees, four of which are 
dedicated to the review of biomedical research. The original IRB, which served the entire 
campus, was established around 1975. The biomedical review committees report to the 
Dean through the School of Medicine. IRB operating resources come from the university 
through the School of Medicine. Each committee meets once per month, such that during 
any given week one of the biomedical committees convenes. The typical workload 
includes about 10-15 applications for renewal of currently approved protocols and 7-10 
applications for new research protocols. In contrast, the social and behavioral IRB meets 
once per month and reviews 2-3 full protocols per month on average. Between January 
and October 2003, about 1000 protocols underwent IRB review: 50 percent by the full 




The current IRB chair at University B is the chair for each of the biomedical 
committees, which allows for some consistency in decision-making across the four 
committees. He has a medical background and had IRB experience at another university 
prior to joining University B. The chair receives a portion of his salary from the IRB 
budget to compensate him for his service on the IRB. Each biomedical committee also 
has a vice chair, who receives a salary supplement of $5000 per year. Nonaffiliated 
members receive $150 per meeting, whereas affiliated members are not compensated 
monetarily. Meetings are held in the afternoon and typically last about two hours with 
food and beverages are served at each meeting. 
During the mid 1990s, University A underwent an audit by the Food and Drug 
Administration (FDA), which resulted in findings that led to a reorganization of the 
overall university IRB structure. A recent FDA audit resulted in no findings. University B 
has received one compliance determination letter, which addressed concerns that one of 
the university IRBs approved a consent form that did not provide adequate description of 
research procedures. To OHRPs satisfaction, the university responded to this charge by 
developing training and education programs that provide members with information 
about the elements of informed consent. 
 
Member characteristics 
Each biomedical IRB has 15-17 members, while the committee that reviews 
social and behavioral research protocols is comprised of nine members. Across all the 
committees, 37 members are female and 36 members are male. The demographic 
characteristics for the biomedical committee which I interviewed and whose meeting I 
attended were somewhat more diverse compared with the other universities in the 
sample. This committee consists of 17 members, 12 men and 5 women. Of these 
individuals, eight hold MD degrees, eight hold a Masters degree, six hold PhD degrees. 
The committee includes two nonaffiliated members drawn from the surrounding 
community. Two of the affiliated members also represent the university-affiliated 
Veteran’s Affairs medical center. 
Two members are Latino (one scientist and one nonaffiliated member), three are 
Asian (all scientists), one is African-American (a nonaffiliated nonscientist member), and 
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the rest are Caucasian (representing a mix of member types). There is no written policy 
on how members are selected, though in general the staff work directly through the 
various departments on campus to identify willing representatives from each discipline. 
Six IRB members were interviewed at University B; four of them are classified as 
scientists. Of those four, three are physicians and one is a social scientist. One of the two 
participating nonscientist members also fulfills the role of nonaffiliated member and has 
remained in that role for 16 years, the longest IRB tenure of any member interviewed in 
this study. 
 
Observation of IRB meeting 
 University B’s IRB initially exhibited an informal atmosphere, in which members 
interacted very casually and joke around while waiting for the meeting to start. Dinner is 
provided as an incentive to encourage members to attend the meetings. Because there 
were several new members joining this IRB at the time of my observation, the chair 
asked all members to introduce themselves and say something about their research. 
Through this process, both I and the IRB members became at least somewhat aware of 
the domains of expertise of fellow members. 
 This IRB also tapes the meeting discussion. A primary reviewer system is used, 
which includes secondary reviewers to back up the primary reviewer. Ideally the 
secondary reviewers submit their review to the primary reviewer who then pools all the 
information and presents it to the entire committee. Otherwise reviews appeared to 
progress in a random fashion, with the chair asking “who wants to present next”. 
Discussion continued until group consensus was achieved and all members were satisfied 
that their concerns had been stated and addressed. No formal votes were taken; however, 
for protocols approved with conditions, the chair summarized the conditions and asked 
for any objections before moving on to the next protocol. 
 My knowledge of the members’ expertise or disciplinary background is based on 
what was said during the discussion. For example, several times during different reviews 
the chair specifically requested different members to contribute because they had more 
experience in a particular area of the protocol research. It appeared that most of the 
members are physicians; however, from pre-meeting discussion at least one member is a 
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social scientist who has served on the board for 18 years. Most of the members, 
regardless of disciplinary background, focus on issues of risk and the consent form. 
 The chair assumed the role of facilitator and frequently reminded members about 
their IRB duty and what various IRB definitions mean (e.g., expedited, high risk, key 
concerns to look for in renewal applications). He was consistent about making sure that 
all members contribute if they have something to say. In one case, a scientist member 
was interrupted by other members and the chair made a point to come back to this 
member so his concerns could be stated. The chair also regularly contributed the 
discussion to clarify items that other members did not seem to know. This chair seemed 
to have broad knowledge about the protocols and an extensive awareness of human 
subjects research being conducted on the campus. He fully reviews every protocol that 
comes through the IRB. The chair also exhibited willingness to admit ignorance about 
some topics and routinely throughout the meeting, he solicited expertise from other 
members when clarification about research methods or standard procedures were needed 
to facilitate discussion. When members struggled with whether a issue they brought up is 
significant or not, the chair often stepped in to clarify and occasionally reverted to his 
own formal review of that particular protocol. Though he was not dominating, members 
did appear to defer to him particularly when he interjected to clarify certain issues about 
which the group otherwise was uncertain. 
 Unfortunately, the nonaffiliated member that I interviewed from University B did 
not attend the IRB meeting I observed at University B. While the membership list 
indicated another nonaffiliated member was in attendance, it was not apparent to me who 
this person was based on participation or protocol concerns demonstrated by members. 
 Interestingly the structure of this meeting seems to go back and forth between 
informal and formal. Most of the members addressed the chair as “Dr”, while the chair 
addressed members mostly by their first name. At other times during the discussion, 
however, the chair referred to some of those same members as “Dr”. In one instance, 
when the chair referred to a member as “Dr”, she quickly corrected him to use “Ms” 




6.4 University C  
University C is a Doctoral/Research University-Extensive, privately endowed 
university with an affiliated medical school. The university offers undergraduate and 
graduate degree programs including disciplines spanning the arts, humanities, medicine, 
physical and social sciences, law, theology, education, business, and policy. Less than 
10,000 graduate students attend University C. The university employs between 2000-
2500 faculty (male/female ratio is not published). Total R&D expenditures for FY 2001 
ranged between $100-200 million.  
The official university IRB was established in the late 1980s, although an earlier 
committee was established in response to the PHS regulations issued in the mid 1960s. 
Currently University C operates five IRBs, three of which serves the biomedical research 
community at the university—two that review new submissions and amendments to 
existing protocol and one that only reviews renewal applications for currently approved 
protocols. The other two IRBs at University C review social and behavioral research 
protocols. The biomedical committees report to the Dean of the School of Medicine. The 
IRB staff operates within the university office that manages funding-related activities at 
the university. The operating budget comes from the Dean of the medical school.  
Each committee meets once per month and meetings typically last 4-5 hours, with 
lunch and beverages provided. On average committees reviewing new submissions and 
amendments review about 30 new protocols each meeting, whereas the committee 
responsible for renewal applications typically reviews about 60 protocols per meting. 
Review of expedited protocols is usually done by the chair or vice chair of each 
committee. 
University C has received two compliance determination letters from OHRP. The 
issues identified in these letters addressed concerns about inadequate committee review 
of research design, inadequate disclosure of risks in consent forms, consent forms written 
at too high a reading level, inadequate written IRB policies, lack of written meeting 
minutes, and insufficient data and safety monitoring procedures. The university 
responded satisfactorily to these charges by modifying its policies to address each area of 
concern, by providing retraining of its IRB members, and by developing a reviewer 





The committee that I interviewed is comprised of 13 members (four female and 
nine male). Three of the female members are nonscientists, one of whom is the 
nonaffiliated member, and one is a scientist. All of the male members are scientists. 
University C does not have a written policy on how members are selected to the IRB. In 
general the Dean of the medical school appoints members such that all the departments 
are represented on the committee. Department chairs may also recommend members. 
Nonaffiliated members are recruited through referrals from local community 
organizations. The chair serves as chair for all three of the biomedical committees and is 
appointed by the Dean. Members are not compensated; however each year they are 
presented with a small token of appreciation from the university. 
 
Observation of IRB meeting 
 As with most of the other university IRBs, this IRB offers food as an incentive to 
encourage members to attend the meeting. The initial atmosphere was very informal and 
casual but as soon as a quorum was met, the chair assuaged all conversation and called 
the meeting to order immediately. The structure thus became very formal. For the most 
part, members referred to one another on a first name basis though some members 
referred to each other as “Dr”. Overall the tone of the meeting was light yet serious and 
extremely focused; however, when some members spoke directly to the nonaffiliated 
member the tone was noticeably informal and casual. 
 With regard to meeting structure, University C’s IRB offers an added incentive to 
members to get them to the meeting on time. Members present their reviews in order of 
their arrival; that is, whoever arrives at the meeting first presents all of their reviews first. 
The exception to this “rule” is for members who have another obligation and need to 
leave the meeting early. 
 Awareness of expertise was immediately apparent at this meeting. In addition to 
what I would call symbolic evidence of expertise—several members wore white 
physician coats—members explicitly solicited certain expertise from other members 
during the protocol reviews. For example, during the first review the primary reviewer (a 
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physician) immediately looked around the room for the statistician to confirm whether 
the power of a particular protocol was sufficient. 
 Early discussion during the meeting occurred mainly between the primary 
reviewer and the IRB chair. Throughout the meeting the chair was quick to point out 
limitations of his knowledge but it was obvious that he has extensive and substantive 
knowledge in many areas of research germane to this particular university. The chair 
consistently served in a facilitator capacity, moving discussion along. Frequently he 
contributed to the substantive issues of the discussion adding information to help clarify 
issues that reviewers brought up as concerns. In this manner, his role almost seemed that 
of a liaison between the research community at the university and the IRB. 
The IRB meeting at University C was somewhat different that the other meetings 
in that the discussion style seemed very intense. It was immediately apparent that no time 
is wasted during the discussion; however, this style seems mostly due the chair’s 
personality because later in the meeting when the chair recused himself due to a conflict 
of interest with a protocol, the discussion became much more relaxed and slower-paced. 
As soon as the chair re-entered the discussion the discussion speeded up again. 
This was a very large group (16-20) of IRB members and, other than the white 
coat symbolism discussed above, it was not always apparent to me who was from what 
discipline. Deference to a particular member or type of member was not apparent at this 
meeting. In one case the group deferred to the opinion of the nonaffiliated member and 
granted approval of a protocol subject to her final review of the modifications. In another 
instance, disagreement between the chair and the primary reviewer (another physician 
member) over the issue of compensation in a protocol resulted in the chair deferring to 
the reviewer. 
 
6.5 University D  
University D is a public university with a separate but affiliated medical campus. 
University D is classified as a Doctoral/Research University-Intensive1 and is the only 
university with that classification participating in this research study. The university 
                                                 
1 This classification indicates that, during the most recent Carnegie Foundation study period, this university 
awarded at least ten doctoral degrees per year across three or more disciplines, or at least 20 doctoral 
degrees per year overall. 
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grants degrees in a variety of disciplines including architecture, liberal arts, business, 
humanities, engineering, education, public affairs, public health, social and physical 
sciences and medicine. Less than 5000 graduate students are enrolled at University D. 
The university employs less than 1000 faculty. Roughly 60 percent of University D’s 
faculty members are male and 40 percent are female. R&D expenditures for FY totaled 
less than $100 million.  
 No data were available to determine when University D established its original 
IRB; however, the university currently operates multiple IRBs. The IRB that participated 
in this study is responsible for reviewing all research for the main campus, which is 
primarily social and behavioral but also includes public health protocols and any 
biomedical protocols that have a social science component. For this reason University 
D’s IRB is classified as a “comprehensive” IRB. Two biomedical IRBs also separately 
serve the affiliated medical campus. The “comprehensive” IRB reports to the Dean’s 
office. Resources for operating the IRB come from general university funds and indirect 
costs.  The “comprehensive” IRB meets monthly for two to four hours. The IRB office 
reviews approximately 10 protocols per month, with three to five of these undergoing full 
board review. The IRB administrator and the Chair generally perform expedited reviews. 
 University D does not have a formal written policy for how members are selected 
to the IRB. Generally the IRB accepts whoever is willing to serve or is nominated by the 
Dean; however, an attempt is made to ensure representation from the major schools on 
campus. Nonaffiliated members are identified by word of mouth or personal contacts. 
The chair is provided release time, but no extra salary compensation. Community 




 Eight members (five females and three males) currently serve on the 
“comprehensive” IRB at University D. Just prior to when these interviews were 
conducted, the nonaffiliated member on this IRB resigned from the committee for 
reasons that were not disclosed to me. The committee is presently struggling with 
identifying a nonaffiliated member from the surrounding community. The exclusion of 
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this member category will be discussed further in the remaining chapters. Of the existing 
affiliated members, all but one member are Caucasian. The classification of member roles 
on this committee is interesting because three of the members who classified themselves 
as scientist members are actually classified as nonscientist members for regulatory 
purposes, per the IRB administrator. This difference in perception of roles is relevant 
when attempting to explain differences in how scientists versus nonscientists approach 
the IRB decision-making process and will be discussed further in Chapter 7. 
 
Observation of IRB meeting 
Compared to the other IRBs in this study, the IRB at University D had a very 
different atmosphere that was apparently immediately. The group was very small (with 
only six of the eight IRB members present) and there was no nonaffiliated member. 
Several months prior to my site visit, the nonaffiliated member resigned from the IRB for 
reasons that were not disclosed to me. The meeting structure was very informal and 
casual; no incentives are offered to members for their participation. This meeting had the 
feel of a coffee shop gathering where a few faculty members may have gathered together 
to discuss several controversial issues at the university.  
All of the current members come from social science backgrounds and seem to 
share equal roles on the committee. Interestingly, this was the only IRB in the study 
where at least half the members interviewed categorized themselves differently than the 
IRB administrator classified them. Throughout this meeting, the female members spoke 
twice as much (sometimes more often that that) as compared with the two male members 
on the committee. It does not appear that the participation level of these two quieter (less 
participatory) members is obviously related to their experience on the IRB. However, 
they represent the extremes at either end of the length of IRB service on this particular 
committee. One has less than a year on the IRB, while the other member has served on 
the committee for almost ten years (longer than anyone else on this particular committee). 
Every member on this IRB is expected to fully review every protocol. There is no 
primary reviewer system and no particular order to presenting. Members literally launch 
right into listing their concerns about the first protocol listed on the meeting agenda. 
Interestingly, formal votes are taken only for some protocols and with no apparent 
 
108 
pattern. In at least one case, and unlike other IRBs in this study, the motion to vote was 
made and taken by the administrator not the chair. The administrator and the chair share a 
strong role on the committee. As with other IRBs in this study, the chair possesses a vast 
knowledge of the research conducted on campus. She also serves as a facilitator and 
seems keenly aware when all of the members are not participating equally in the 
discussion. To compensate for their lack of participation, the chair occasionally called on 
these members by name and asked them if they had stated everything they wanted to say 
about a protocol. 
Like University A, members on this IRB seem to serve in a liaison role with the 
research investigators. However, it appeared that members do so with reluctance that may 
in part be due to a negative perception of the IRB or the IRB process by the university 
community. Nonetheless, the chair explicitly asked one member to speak with a student 
researcher’s faculty advisor about IRB concerns about a particular protocol. 
Disagreement over issues of concern was discussed at length in order to capture 
all members’ viewpoints. However, full group consensus did not necessarily seem to be 
the goal of this IRB in all cases. In at least one case, one member continued to voice 
concern about the methods of a protocol. To satisfy the member’s concerns the chair 
asked “would it help if…” and suggested that the member, the IRB chair and the 
researchers meet to discuss the member’s concerns. This approach seems connected to 
the liaison role discussed above and very possibly may be why IRB members at this 
university seem to embrace the liaison role less than those at University A. I observed no 
evidence of deference by or to any particular member at this meeting.   
 
6.6 University E  
University E is a Doctoral/Research University-Extensive, public research 
university with an affiliated medical school. The university grants degrees in disciplines 
such as the arts, humanities, social and physical sciences, architecture, business, 
medicine, education, engineering, law, nursing, public affairs, and social work. More than 
10,000 graduate students are enrolled at University E. The university employs more than 
3,000 faculty (roughly 50 percent male and 50 percent female). R&D expenditures for 
FY 2001 totaled greater than $400 million. 
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The original IRB at University E was established during the early 1970s. The 
university now operates five separate committees, all of which report to the Provost. 
Resources for operating the IRB come through the grants and contracts division of the 
university. The IRB that participated in this study meets every two weeks for two to three 
hours, with food and beverages provided. Approximately six new protocols undergo full 
board review per meeting. Another six to eight renewal protocols undergo re-review at 
each meeting. A separate subcommittee to all IRBs at University E generally performs 
expedited reviews. 
 University E does not have a formal written policy for identifying or selecting 
members to serve on the IRB. The committee has “certain requirements and looks for 
certain attributes in order to make sure that we have people who will…be able to fulfill 
certain roles. Because we do social science research, everyone is pretty much oriented 
towards social science. We do however have someone from the nursing department who 
we hope can provide us some kind of maybe basic medical information just to warn us if 
we hit biomedical stuff and don’t recognize it.” To identify nonaffiliated members, the 
IRB administrator at University E directly contacts local social service organizations and 
issues public announcements for potential volunteers. In lieu of compensation members 
are provided with complimentary parking for the meeting and expenses paid for IRB 
training workshops. University E has received no compliance directives from OHRP. 
 
Member characteristics 
 Nine members (six females and three males) currently serve on this IRB. Six 
members are classified as scientists; three are nonscientists including one nonaffiliated 
member. One of the IRB members was also a doctoral student at the time of these 
interviews and is categorized as a nonscientist until the PhD is awarded. As was the case 
with University D above, this classification was determined by the IRB administrator and 
differs from the IRB member’s self classification of “scientist”. One administrator-
classified nonaffiliated member on this IRB (who did not participate in the study) is 
technically not “nonaffiliated” because she received her master’s degree from the 
university. However, she worked closely with the surrounding community at the time of 
the interviews and consequently brought the community perspective into the IRB 
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discussion. The other nonaffiliated member apparently is a prisoner’s advocate but did 
not participate in the meeting I observed. 
 
Observation of IRB meeting 
 University E’s IRB appeared to follow the same general pattern of most other 
IRBs in this study—informal, casual atmosphere with food offered as an incentive. 
Everyone was first introduced to me, which also served the purposed (albeit 
unintentionally) of informing or perhaps reminding other members of the types of 
expertise on the committee.  
This IRB employs a primary reviewer system in which both affiliated and 
nonaffiliated members may serve as primary reviewers. While other members contribute 
to the discussion based on their review of some of the protocol package, only the primary 
reviewer receives the full IRB application that includes both the protocol and the research 
proposal and other supporting research materials. The primary reviewer presents a 
summary of the entire protocol, which suggests that all portions are examined fully 
during the initial review. Throughout the presentation by the primary reviewer, other 
members interjected with their own questions. Different members interjected with 
questions to each other, asking what would make dissenting members feel more 
comfortable so the protocols could be approved. This type of group deliberation seemed 
to be the standard mechanism of achieving consensus on this IRB. Formal votes were 
taken after each review was presented and fully discussed. 
The general view of members on this IRB is that it is not within their purview to 
review the research design. In such instances where research design issues are brought 
up, members explicitly stated that it was outside the IRB purview but still presented their 
concerns about the design. The belief that research design issues “outside our purview” 
was mentioned several times throughout the meeting. 
Extensive deference to certain members was not apparent on this IRB. In one case 
where members did differ in opinion about a protocol issue, the chair suggested deferral 
to the primary reviewer. In at least one case, the primary reviewer (coincidentally a 
graduate student) appeared to look to the administrator for verification on which position 
to take. Though the administrator had only a few years of experience in her IRB 
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administrator role, she also holds a PhD, which could explain why the IRB member 
appeared to seek the administrator’s approval on this particular protocol. Interestingly 
with this particular protocol, the administrator’s recommendation was to defer it; 
however, the primary reviewer seemed clearly bothered by this and asked whether there 
was some “middle ground option” because she was concerned about the impact that the 
deferral would have on the research study. As with other IRBs, this IRB used the option 
of inviting PIs to the subsequent IRB meeting to clarify questions that were not 
adequately addressed in the protocol but were required for final approval. 
Based on issues of concern or participation style, it was not evident who 
possessed what background or expertise. The chair seemed to play the role of a 
discussion facilitator to keep the meeting discussion moving along. Yet, his personality 
was not strong or domineering. However, it should be pointed out that his official role on 
the committee is actually Vice Chair but at this meeting, he was filling in for the IRB 
chair who was not in attendance. 
 
6.7 University F  
University F is a Doctoral/Research University-Extensive, public university with 
an affiliated medical center and enrolls between 5000-10,000 graduate students. The 
university offers degrees in a variety of academic disciplines including medicine, 
engineering, liberal arts, social and physical sciences, business, policy, social welfare, 
nursing and fine arts. The university employs between 1500-2000 faculty (roughly 60 
percent male and 40 percent female). R&D expenditures for FY 2001 totaled between 
$100-200 million. 
The IRB at University F was established in the late 1970s. In 2001, a single 
committee was divided into two separate committees that review all research—both 
social/behavioral and biomedical—for the university campus. The assignment of research 
protocols to each committee primarily depends on when the protocols are submitted 
during a given month, and to some extent whether the protocol is a new protocol or one 
that is undergoing the renewal process. Both IRBs report directly to the Provost for 
Research and together operate autonomously within the university structure. Operating 
resources come through the office of the Vice Provost for Research.  
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Each committee meets once per month; meetings usually last about three to four 
hours. Meetings are held at the end of the day and dinner is served to the members. On 
average, both IRBs review about 800 protocols per year. Approximately half of these 
undergo full board review. Twenty-five percent of the full-board protocols are new 
submittals and 25 percent are renewal applications. IRB members also review expedited 
protocols. University F identifies potential IRB members via recommendations from 
current members. The administrator interviews and selects potential members. 
Nonaffiliated members are also identified via current IRB members and also undergo a 
similar interview process prior to appointment to the IRB. The Institutional Official 
selects the Chair, but to some extent this depends on who is willing to serve in this 
capacity. None of the members receive compensation for their service on the IRB. 
University F has received two compliance determination letters from OHRP. 
Issues identified by OHRP included deficiencies in informed consent (appropriate 
procedures and accurate representation of risks and benefits), review of protocols without 
sufficient information, lack of appropriate expertise on the IRB to adequately review 
some research, written IRB policies, safeguards for a vulnerable population, and 
continuing review policies. OHRP reports that University F responded satisfactorily to 
these charges by developing improved written IRB policies, providing more detail to 
research investigators about what is required for IRB approval, and assuring that the 
appropriate expertise is available in order to adequately review certain protocols. 
 
Member characteristics 
 Each IRB at University F is comprised of 14 members. On the committee I 
interviewed, five members are female (one is an African-American, scientist member). 
One of the male members is Asian and a scientist member. The nonaffiliated member is a 
male, nonscientist member. The majority of members serving on this IRB are physicians 
serving in the scientist role. The nonscientist members come from research administration 
and social work-related backgrounds. These members voluntarily reported that they do 
not participate as actively in the group discussion. The IRB experience on this committee 




Observation of IRB meetings 
 University F’s IRB meeting was informal and casual. Dinner was served to 
members as an incentive to participate. Meeting minutes are approved once a quorum is 
achieved. The IRB employs a primary reviewer system in which the primary reviewer 
presents their synopsis of the research study and their concerns with the protocol. 
However, it appeared that all members receive all information associated with a protocol 
and independently conduct their own full review, which is submitted to the administrator 
at the end of each protocol review. Members who were not primary reviewers interjected 
throughout the presentation with questions of their own. The expertise of primary 
reviewers appeared to be matched with the protocol research area where possible (e.g., 
pediatrician reviews protocol that involves children). However, in comparison with the 
other university IRBs, it appeared that many of the physicians on University F’s IRB 
possessed knowledge about the recent literature beyond that of their immediate medical 
specialization based on the substance of the group discussion. 
 The chair fulfills a facilitator role on this IRB, permitting discussion to continue 
sometimes even off track, but then bringing everyone back to the issue at hand for a vote. 
He occasionally sought out members who were not contributing verbally to the 
discussion and asked for their opinions. Although the chair did not have a dominant 
personality, it was evident that he is knowledgeable about the breadth of research 
conducted at the university. 
 Based on what members said and how they addressed each other (first name 
basis), it was not apparent to me who was serving the IRB in what role. Because my 
interviews were held prior to the meeting I knew who the nonaffiliated member was and 
who at least one of the nonscientist members was. Both of these members hardly 
contributed to the discussion unless they were specifically asked about their opinion by 
the chair or another member. In most of these cases, they replied that they had nothing to 
contribute. On one protocol, however, the nonaffiliated member initiated discussion 
about concerns that he had about the welfare of children participating in the study. His 
concerns seemed to parallel his experience working with families in his profession 




 The IRB administrator and staff appear to play a major role in educating the group 
about regulatory issues. Throughout the discussion, these members were asked to clarify 
regulatory items that impact the protocols. 
 Deference to certain members did not seem pervasive. However, in at least one 
case where the primary reviewer was a physician and the secondary reviewer was a 
nonscientist, the nonscientist deferred to the primary reviewer (a scientist/physician) and 
offered no substantive input on the review. Domains of expertise were not obvious. 
While there are several social scientists serving on this IRB, I could not tell who they 
were based on the discussion. Disagreement over protocol issues seemed to be handled in 
a two phase process. The chair allowed discussion to continue among members and then 
asked them to “get back to where we were”. After the group considered all suggested 
possibilities for how to facilitate the research while satisfying the regulations, if 
consensus was not achieved through the discussion, a formal vote was taken. 
 
6.8 University G 
University G is a Doctoral/Research University-Extensive, privately endowed 
university with a separate but affiliated medical school. Less than 5000 graduate students 
attend this university. The university offers degrees in disciplines such as engineering, 
life sciences, physical sciences, arts and humanities, law, management, medicine, and 
architecture. The university employs between 2500-3000 faculty (roughly 70 percent 
male and 30 percent female). R&D expenditures for FY 2001 totaled greater than $400 
million.  
The IRB at University G was established in the mid-to-late 1960s. A separate IRB 
serves the medical campus. The social and behavioral IRB serves the main campus and 
reports to the Vice Provost for Research. Operating resources for the IRB are allocated by 
the Vice Provost for Research. The social and behavioral IRB meets monthly for one to 
two hours over lunch. Expedited reviews are conducted by the chair or if the chair has a 
conflict of interest there tend to be three long standing members who are called upon to 
do the expedited reviews. The IRB reviews about six full board protocols per month. 
The chair consults with the Vice Provost to select affiliated members to the 
committee. Members are not compensated for their time; however the chair receives a 
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faculty stipend that can be used for research related activities. No OHRP compliance 
directives have been issued to University G. 
 
Member characteristics 
 Currently this IRB is comprised of 15 members. All of the affiliated members are 
considered to be scientist members, whereas two nonaffiliated members satisfy the 
minimum requirement for the nonscientist position. Ten members are male; five are 
female. Both nonaffiliated members are male and come from business backgrounds. All 
members are Caucasian. 
 
Observations of IRB meeting 
 As with the previous IRBs, the atmosphere at University G was very informal. 
Lunch was provided to members as an incentive to participate. The meeting begins with 
informal group discussion about general campus matters that relate to human subjects 
issues. Votes were taken by show of hands. 
University G’s IRB employs a primary reviewer system. Although two reviewers 
are assigned to each protocol, they share equal roles in that one is not primary and the 
other secondary. Rather they are “co-reviewers”. They are invited by the chair to decide 
between them who would like to present first. Nonaffiliated members serve in the 
primary reviewer role in the same manner as affiliated members. 
The IRB chair clearly serves a facilitator role at University G. Members also seem 
to defer to her and look to her for confirmation of their concerns about protocols. She has 
a strong personality; however, she is not domineering and did not attempt to control the 
discussion at the meeting I observed. The chair has obvious extensive breadth of 
knowledge about human subjects research on the campus. Her role as a campus liaison 
with the IRB was also apparent in that she frequently conducts educational seminars 
about the IRB with researchers and students.  
As with some of the other universities in this study, University G’s IRB seems 
conflicted with its purview over research design and scientific merit. On the one hand, 
reviewers state “although we are not really supposed to review scientific merit” yet then 
continue on to discuss and judge scientific merit.  
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Interestingly, the IRB chair frequently exhibited concern about the potential 
impacts of the IRB decisions on research at the university. Other members also express 
these concerns at different points in the discussion. Overall, the committee seemed intent 
on finding ways in which they can make the process more informative for investigators 
so that the IRB review process goes smoothly. It is also telling that during the discussion 
there were many references to a “university X culture” or the “university X research 
investigator stereotype” as if the members were acknowledging that the researchers at 
this university did not like to be told what to do. In spite of this perception, there was no 
implication that this perception changed how members review protocols or what issues 
they focus on. Rather, it seemed to more greatly impact the way members sought to 
overcome such issues, so as not to hinder the research process. 
 
6.9 Summary 
In this chapter, I presented justification for studying IRB decision-making in the 
university setting. Each of the universities that participated in this research was profiled 
according to their Carnegie Classification, R & D expenditures, and IRB demographics. 
In Chapter 7, I will compare and contrast members’ perceptions of the decision-making 





7.0 CROSS-CASE ANALYSIS – COMPARING AND CONTRASTING UNIVERSITY IRBS 
 
7.1 Introduction 
A primary objective of this chapter is to identify and explain member-related 
differences in perceptions of decision-making among university IRBs. To this end, the 
interview and observation data were analyzed using qualitative content analysis to 
identify trends in the data. Moreover, the use of a case study approach permits the 
development of an “inside view” (Young and Mills, 1980) of IRB member behavior. 
Cross-case analysis enhances generalizability and deepens understanding and explanation 
(Miles and Huberman, 1994) about the human subject review system within these public 
and private research universities, and the use of multiple case studies or cross-case study 
designs also increases external validity (Yin, 1984). In these ways, qualitative analysis is 
used to assess data at the IRB member level and at the overall university level, 
specifically according to whether the research focus is primarily biomedical, 
social/behavioral, or “comprehensive”1 in nature. A summary of the detailed coding 
strategy described in Chapter 4 is provided here.  
 
7.2 Patterns of data for each research question 
 In Chapter 4, I described my analytical approach for coding the interview texts. 
The results of those analyses are presented here in the context of the research questions 
and propositions that motivated this study. To be able to explain differences among IRB 
decision-making processes we need a better, more complete understanding of the actual 
process that takes place within an IRB meeting. The decision-making literature suggests 
that group members assess and use expertise in different ways that subsequently impact 
the group choice and potentially the quality of the decision outcome. The literature on 
participatory democratic theory further suggests that the notion of expertise is related to 
participation in decision-making. Both of these concepts—participation and expertise—
were investigated in this study and can be used here to begin to dissect the process by 
which an IRB arrives at a decision to approve a human subjects research study. However, 
it is important to restate that this analysis is limited by the fact that these data represent 
                                                 
1 In this study, I use the term “comprehensive IRB” to denote IRBs that review all research for their 
university, as compared with IRBs that review only biomedical or social and behavioral research. 
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individual members’ retrospective perceptions of the group decision-making process at 
their university. 
7.2.1 Research Question 1: How do IRB members decide whether to approve a 
human subjects research protocol—that is, about risk-benefit ratio, scientific merit, 
research design, and adequacy of informed consent?  
 
Implicit in the IRB decision-making process is the assignment of scientific and 
ethical values articulated by a diverse set of individuals, some with scientific training and 
interests, and some with expertise in areas completely nonscientific. Regardless of their 
individual expertise or experience, IRB members as a group decide whether to approve a 
human subjects research protocol by assessing the four criteria required by 45 CFR 46: 
scientific merit, research design, risk-benefit ratio, and adequacy of informed consent. 
Specifically how they go about “assessing” is one of the objectives of this research. 
While the IRB Guidebook1 offers some suggestions on how members can proceed with 
this assessment, in reality, members do not appear to follow a specific process. Each 
required criterion is discussed below with evidence via the eyes of individual IRB 
members to inform our understanding of how they perceive the decision-making process 
to unfold during the IRB meeting. Across these criteria, I looked for differences that 
emerged between IRBs at public and private universities, between male and female IRB 
members, among social and behavioral, biomedical, and comprehensive IRBs, and 
among the different types of IRB members (scientist, nonscientist, and nonaffiliated).  
 
Risk-Benefit 
Assessing the risk-benefit ratio is one of the primary goals of the IRB. The IRB 
Guidebook suggests that this process includes a series of steps: (1) identify the risks 
associated with the research, as distinguished from the risks of therapies the subjects 
would receive even if not participating in research; (2) determine that the risks will be 
minimized to the extent possible (3) identify the probable benefits to be derived from the 
research; (4) determine that any risks are reasonable in relation to the benefits to subjects, 
and the importance of the knowledge to be gained; (5) assure that potential subjects will 
                                                 
1 The IRB Guidebook was prepared by OHRP to assist IRBs in fulfilling their mandate. It can be found at 
the OHRP website (http://www.hhs.gov/ohrp/irb/irb_guidebook.htm; visited on September 25, 2004) 
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be provided with an accurate and fair description of the risks or discomforts and the 
anticipated benefits; and (6) determine intervals of periodic review, and, where 
appropriate, determine that adequate provisions are in place for monitoring the data 
collected.  
Most likely the approach that, say, a sociologist, medical doctor, or clergy 
member will take towards performing these steps is influenced not only by educational 
training but also by personal and professional experiences. The risk literature is replete 
with evidence that experts perceive risk differently compared with how lay citizens 
perceive the same risk (for example, U.S. Environmental Protection Agency, 1987; 
Slovic, 1997; Sjöberg, 1999). If so, how then do these differences in perception factor 
into the risk-benefit assessment of a human research protocol?  
Fischer (2004) suggests that public perception of risk can be understood through a 
form of rationality that is shaped by the circumstances under which the risk is identified 
and publicized, the standing or place of the individual in his or her community, and the 
social values of the community as a whole. Ordinary citizens, without advanced technical 
knowledge, tend to rely on past experiences to understand risk (Fischer, 2004; see also 
Hill, 1992). When IRB members in this study were specifically asked how they assess the 
risk of a proposed research study, none stated that they use a formal method of risk-
benefit analysis. Instead IRB members assess the risk-benefit based mostly qualitatively 
and on personal experience (“probably subjective on our part”). In the words of one 
committee chair: 
Common sense and medical expertise. I also consider the regulations (such as 
Helsinki and Nuremberg) and the history of human subjects research in this 
country. (Scientist member, comprehensive IRB, public university) 
 
Additionally, IRB members also try to imagine how they would feel if their parent or 
child or friend were participating in the research, or if they themselves were participants 
as described by this social scientist IRB member: 
Each of us may have different points or thresholds at which we become 
uncomfortable. As a result we tend to talk about things that start out as just simply 
“would that make me feel bad. Is that like embarrassment? Would that make me 
reconsider?” So the “what if” kinds of things that may not have been addressed. 
Those are very subtle nuanced ways of responding that poses a certain level of 
risk that, as long as you sensitize the subject to potential embarrassment or 
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feelings of discomfort, that is sufficient to address it. (Scientist member, 
comprehensive IRB, public university) 
 
Nonaffiliated members also rely on common sense or what “feels right”; however, the 
issue of deference to the scientist members also factors into their informal risk 
assessment. Because citizens tend to trust physicians more than other types of experts 
(Bostrom, 1997), deference to the physicians on an IRB could impact whether the 
potential risks of a study are given full consideration or even brought up in the first place: 
I ask the physicians what they think and to clear it up for me. I have a few 
resources where I can go for help sometimes. (Nonaffiliated member, 
comprehensive IRB, public university) 
 
The chair at a comprehensive IRB, also at a public university, provides a detailed 
example to illustrate the challenges that members experience during their evaluation of 
potential research risks: 
A lot of them [risks] you hope are already stated by the investigator. The 
reviewer, one of whom should be semi familiar with the kinds of stuff that would 
go on on that project, would hopefully be aware of some of those risks and maybe 
add a few more. The nonscientist reviewers will often be the one who talks about 
nonphysical risks more, so breaches of confidentiality for instance, losing your 
insurance because somebody finds out you’ve got disease X. Or that somebody 
finds out you’re participating in an HIV study your reputation is damaged. Those 
are sometimes risks that aren’t thought about by the investigators actually. It a 
balance of what the PI tells you and what you glean from the protocol and what 
you and the other committee members bring to that whole process maybe not as 
an expert in that particular thing but your own experience as a scientist and 
frequently as a physician, as well as somebody who after a while has had some 
experience reviewing research protocols. You get a feel after a while that this kind 
of study often has risk X as a primary problem. Probably one of the hardest things 
is the issue of not just identifying the risk but quantifying it and then balancing 
that in some way if you can against the benefits. For that, if we don’t know on the 
committee we will sometimes talk to the PIs to get their opinions or some other 
expert in that field. So for instance if there was a drug study that sounded like it 
may be a bit risky or if we didn’t know how risky, we might ask the PI for more 
detail or we might ask somebody else in that same field and try to come up with a 
nonbiased view on the whole thing. I think quantifying these things is the hardest 
part. (Scientist member, comprehensive IRB, public university) 
  
It was pointed out earlier that the characterization of risk involves two judgments: 
(1) that a particular process or outcome merits serious attention and (2) what constitutes 
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an unacceptable level on the outcome dimension (Slovic, 2000; Stern and Fineberg, 
1996). Consider, for example, a common IRB scenario in which members must assess 
whether using a classroom setting for some types1 of research that subject students to 
potential coercion by virtue of the fact that the students are a captive audience. The 
decision whether to include research venue as an issue of concern or potential risk 
reflects a value judgment about the primary purpose of the classroom. Some IRB 
members may not be concerned that a researcher intends to request participation from his 
students during normal class time. Yet, other IRB members may feel strongly that 
students are paying tuition to use classroom time for learning and not for participating in 
their professor’s research study. One study participant expressed this specific concern, 
which also emerged during interviews with other members on his committee: 
The venue also matters, like in the classroom setting. It’s a lot different if you 
advertise for volunteers and advertise that this is the nature of the questions and 
they could be upsetting. I’m pretty okay with that even if you want to ask a few 
sensitive questions. It’s just that when you’re going to walk into a classroom and 
say “this is what I want you to do but if you really don’t want to do it, that’s okay. 
You can just sit quietly in your seat but you can’t leave.” That’s pretty coercive 
for me and I can just imagine someone coming to class to get a lecture in 
psychology and then having to take this questionnaire that’s upsetting or 
offensive. (Scientist member, comprehensive IRB, public university)  
 
To further complicate this, IRB members are asked to make judgments about 
potential risks to potential participants who probably have different values and 
consequently may make a different judgment about the same issue when invited to 
participate in the research. What constitutes an acceptable risk for one member may be, 
and often is, completely different for another member or the potential participants. The 
same IRB member from the prior example tells how he attempts to bring public values 
into the IRB decision-making process:  
For example, just the classroom setting issues. We think about what are the values 
that our students share; we need to be sensitive to those values. (Scientist member, 
comprehensive IRB, public university) 
 
In contrast, one nonaffiliated IRB member shares a perspective on the challenges for 
scientist IRB members to fully comprehend local community values: 
                                                 
1 Certain types of research in the classroom may subject students to some level of risk, e.g., surveys on 
sensitive topics such as sexual abuse. 
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…most of them [scientists] are homeowners. They’re families. They’re parents, 
have children in school and so forth. They certainly do bring a lot of that but I 
also see that their children go to the same schools as all of the other professors. 
All of their social activity deals in the academic environment. And a lot of them 
have never been out in [local areas] where people live in trailers; a lot of seasonal 
employment, a lot of people are on food stamps and so forth. They’ve never been 
there. They don’t understand it. They will make their contribution to this fund and 
that fund but they’ve never been hungry in their life. They’ve never had to want 
for a car that will get them to work on time. And so they lack that perspective. But 
they do bring that perspective of having children and putting up with teenagers 
and all that stuff. So it depends on where they’re coming from, where they’ve 
been and where they are now. (Nonaffiliated member, social/behavioral IRB, 
private university) 
 
As is often the case with other technical issues, the decision outcome thus reflects 
the value judgments and priorities of those making a decision that can be neither 
objective nor purely scientific (U.S. Department of Agriculture, 2003). As evidenced by 
these and other direct quotes, IRB members do not appear to follow any prescribed or 
standardized methods of assessing the risks or benefits of research protocols aside from 
occasionally using “in house” developed check-lists, which simply list topics to look out 
for (e.g., are vulnerable subjects involved, are risks listed in the protocol). 
 
Scientific merit and research design  
 IRB purview to review the topics of scientific merit and research design continues 
to generate much debate within the broader research community. Yet, the value of 
research depends upon the integrity of study results (Penslar and Porter, 1993). Because 
these topics are inherently intertwined, I will discuss them together for purposes of 
analysis and interpretation. While the federal regulations clearly stipulate that the IRB is 
responsible for reviewing scientific merit and research design, this is perhaps the one area 
where IRB adversaries accuse committees of not using the full flexibility provided in the 
regulations. In reality the review of scientific merit and research design provides a 
challenge for most IRBs. As discussed in previous chapters, the IRB is composed of a 
diverse set of individuals with backgrounds in medicine, social science, nursing, law, 
theology, and administration juxtaposed with diverse personal life experiences. 
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Methodological choices for research design are often discipline specific. What 
constitutes the “norm” in one field may be frowned upon in another. These differences 
are brought into the decision-making process of the IRB and can present stumbling 
blocks for approving a protocol. To determine whether (and which) IRB members assess 
scientific merit and research design, I asked members to tell me in their own words “what 
elements of a research protocol the IRB is responsible for reviewing” (Question 21), and 
then more specifically “what elements does the member tend to focus on” (Question 27).  
Using N6 software to organize participant responses, I find several interesting 
differences (see Figures 4 and 5) that I will discuss in the context of each preliminary 
proposition: member characteristics and IRB culture. With regard to the first 
proposition—member characteristics—this research suggests that more scientists than 
nonscientists consider “research design” and “scientific merit” as standard elements of 
IRB review. In response to the first question (Q21), 71 percent (15) of the scientists 
compared with 31 percent (4) of the nonscientists (including nonaffiliated members) 
stated that the IRB is responsible for reviewing the “research design” of a protocol. In 
other words, 15 interview transcripts from scientists were coded for “research design” 
compared with only 4 interview transcripts from nonscientists. Yet, in the case of 
“scientific merit”, both types of members list it as a required review element almost 
equally: 57 percent (12) of the scientists compared with 54 percent (7) of the 
nonscientists. These numbers reflect only whether or not a member explicitly listed the 
terms “research design” or “scientific merit” in their response to these two questions. 
Using N6, I was able to further limit the responses to just this question and 
examine the context of member responses in more detail to determine if there was any 
difference in the amount of discussion about these review elements. In fact, re-reading 
the full context of the text units coded for these two review elements indicates that 
scientists do talk about “research design” more often than nonscientists. Similarly, 
although scientists and nonscientists equally mention “scientific merit” as a required IRB 
review element, scientist members also talked about this review element more often than 
nonscientists did during the interviews. 
 The second dimension of member characteristics involves analyzing the data 
according to the gender of the member. Using similar techniques describe above, I used 
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N6 to group together elements of review (Q21) according to whether the respondent was 
male or female. Differences are apparent in three of the four key categories of risk-
benefit ratio, research design, scientific merit and informed consent form. Both male and 
female members list “informed consent” and “risk-benefit assessment” as the most 
important IRB review criteria. However, more female members than male members also 
consider “research design” and “scientific merit” when deciding whether to approve a 
human subjects research protocol. Interestingly, although more female than male 
members list “research design” as an important review element, more female members 
also state that IRBs should not review research design. Closer examination of the 
transcripts coded at each of these key nodes (i.e., words/phrases or categories) suggests 
additional gender differences in IRB review. Although both male and female members 
list “informed consent” and “risk-benefit assessment” as key review areas, the male 
members that list it actually talk about it more often in their interviews.  
 
Saliency of review areas










































Figure 4. Total number of transcripts coded for each IRB review criterion, organized 
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Figure 5. Total number of times a specific IRB review criterion was listed during all 
interviews, according to “member characteristics”. 
 
To better understand these differences, I also examined participant responses 
according to the “IRB culture” proposition—that is, according to type of university and 
type of IRB (see Figures 6 and 7). In response to Question 21, roughly the same number 
of members at both private (10) and public (9) universities lists both “research design” 
and “scientific merit” as within the IRB purview. Closer examination of what these IRB 
members actually say about “research design” and “scientific merit” in the full context of 
their responses shows that public university IRB members mentioned these terms more 
often as part of their IRB decision-making process. Given that public universities are, to a 
great extent, driven by a public service mandate perhaps IRB members at public 
universities are more concerned with ensuring that research funds and resources are spent 
on well-designed and meaningful research studies. Moreover, as long as the federal 
human subjects guidelines are satisfied, private universities are not usually held 
accountable to the public for how the universities spend their research dollars. 
I also coded the transcripts for instances where IRB members specifically 
mentioned that their job was not to review scientific merit or research design. The same 
number of members (5) at both private and public universities specifically used the terms 
“not research design” and “not scientific merit”. However, members at public universities 
talked more about not reviewing research design; that is, the phrase was brought up more 
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often during the course of the interview. For example, in the case of “not research 
design”, four IRB members at public universities specifically listed this compared with 
only two IRB members at the private universities in this study. 
 
































Figure 6. Total number of transcripts coded for each IRB review item, organized according 
to “IRB culture characteristics”. 
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Figure 7. Total number of times a particular IRB review item was listed during all 





Next, the data were analyzed according to the type of IRB—biomedical, social 
and behavioral, or comprehensive. A few differences are notable and possibly reflect the 
types of research primarily reviewed by each IRB. Compared with biomedical and 
comprehensive IRBs, social and behavioral IRBs more often list “consent process” and 
“debriefing” as key IRB review elements. Social and behavioral science IRBs also list 
“not scientific merit” and “not research design” more frequently than their biomedical 
and comprehensive IRB counterparts. Often the risks in social and behavioral research—
because they are not usually physical risks—are more difficult to identify. Typically, 
social and behavioral research studies encompass subtler forms of risk such as economic 
or social risk that initially seems less “risky” compared with physical risk. For example, 
family member of research participants can be stigmatized by a participant’s involvement 
in a particular study (NRC, 2003). Additionally, because there is no solid base of 
evidence regarding nonphysical risks, it may be difficult to estimate such risk (NRC, 
2003). 
Members of the social and behavioral science IRBs in this study noted that they 
review many psychology studies, which often involve deception and these studies usually 
must also include participant debriefing. Differences between these committees’ review 
of the overall “consent process” as distinct from the actual “informed consent form” 
suggest that the potential risks in social and behavioral research are often subtle and 
ought to be covered adequately via the consent process and not simply listed on the 
informed consent form. An interesting difference emerges with respect to members not 
reviewing scientific merit or research design. Although more social and behavioral IRB 
members specifically say they do not review scientific merit or research design, they 
spoke about IRBs not reviewing research design more often than not reviewing scientific 
merit. The chair of a social and behavioral IRB offers an illustrative explanation: 
According to the medical IRBs if you do poor science, anytime you request a 
subject [to participate] is disrespectful of their human rights. You should not ask 
their time unless this is going to be excellent science. One minute of poor science 
is excessive respondent burden is essentially what they say. My understanding is 
you’ll get a bunch of people arguing whether it’s poor science or not. From a 
psychologist’s point of view, it’s good science. From a pathologist's point of 
view, who never talks to a human being and only looks at slides it may look 
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stupid as hell. I think that’s ridiculous. I think if your disciplinary peers think its 
worthwhile science then we have to take their word for it. I don’t think I can 
judge. A lot of the anthropology stuff looks interesting to me but it doesn’t look 
like science and it’s not my job to judge. So they will say over there [on the 
medical IRB] that the only risk is that the science is poor and we’re not going to 
let you do it. We don’t do that. In addition, a lot of our protocols are from 
graduate and even undergraduate students. Every undergraduate protocol I’ve 
ever seen is technically bad science. They can have a beautiful instrument, 
whatever. They do not have the dollars to go out and interview a representative 
sample of anything. For their honors thesis they’re going to interview 30 people 
about this but it’s not representative. We believe that it is not a waste of 
participants’ time if it contributes indirectly to generalizable knowledge by 
helping to train [the student]. I don’t see it as so much different than a pilot study 
that big wigs do in order to be able to put it in their grant application that ‘we tried 
it on 30 people and this is what it looked like.’ I think it is cutting hairs. We could 
never get away with imposing that because we would bring I’d say 70 percent of 
graduate research and 100 percent of undergrad research to a screaming halt and 
that’s not what universities are about. (Scientist member, social and behavioral 
IRB, private university) 
 
To further answer my first research question—how do IRB members decide 
whether to approve a human subjects research protocol—I asked members a series of 
questions to examine determine their perceptions of the roles of different types of 
members on the IRB, and specifically how each type of member reviews research 
methodology: What aspects of protocols do (scientist members, nonscientist members, 
nonaffiliated members) typically focus on?” (Q53, Q55, Q58, respectively) And, more 
specifically “how do nonscientist (and nonaffiliated) members generally participate when 
research methodology is being discussed?” (Q57, Q60, respectively)  
The responses to these questions suggest that scientist members, regardless of 
their disciplinary background, tend to dominate the discussion about research design, 
whereas nonscientists (whether affiliated or not) tend to defer to the scientists during such 
discussions or to phrase their concerns as a question to the group (as opposed to a 
declarative statement about a protocol deficiency). A scientist member describes how 





Well…either they’ll stay silent or if they bring something up or if there’s a 
question it might be asking for more information or bringing up something that a 
scientist member needs to say and explanation of why you wouldn’t do it 
scientifically some other way. (Scientist member, social and behavioral IRB, 
public university) 
 
Similarly, other scientist members note that: 
…two of them [community members] participate almost not all. One participates 
here and there when she’s asked and clearly can serve quite well. And the fourth 
one who I’m thinking of specifically if she doesn’t understand something 
methodologically she’ll ask “Why? Why do they want to do that?” or “What’s the 
reason for that intervention?” or “Why would someone want to put themselves 
through such a thing?” (Scientist member, biomedical IRB, private university) 
 
They tend to leave this to the other members unless they are asking for 
clarification on something. Our previous members [a retired professor] did 
participate though and often posed questions such as “what do you think about 
this approach?” (Scientist member, comprehensive IRB, public university) 
 
Nonaffiliated members seem to agree: 
We sit there and listen and ask questions if we have any. (Nonaffiliated member, 
biomedical IRB, private university) 
 
Ask questions like “is this really important” or “is this worthwhile?” 
(Nonaffiliated member, social and behavioral IRB, private university) 
 
There are often discussions of course on research potential, benefits, the consent 
process. And of course they [scientist members] gravitate towards their expertise 
and in these cases, uh, I’m trying to think of how I can provide an example. Um, 
in a behavioral study involving children, we often will have someone that has 
experience in child psychology jump in and say “well I don’t understand why this 
is happening this way” and it’s, you know, accommodates discussion so it’s a, 
you know, it’s an intriguing process which I again observe, as much as I 
participate. (Nonaffiliated member, social and behavioral IRB, private university) 
 
Very little. I don’t know the working of the drug. If they’re talking about the 
mechanism of drug delivery, I don’t know it. Now if they’re talking about, say, a 
stint, the chair will turn and say “for our nonscientist members, a stent is 
whatever…” It’s very helpful. Or he’ll explain a device. He often will say “for our 
nonscientist members, this is a drug that does such and such” and that’s helpful 
but we don’t get into those discussions. As soon as they start talking specifics, I 
start flipping through other things…it’s not a perfect system. (Nonaffiliated 




Other responses to these same questions about nonscientist member participation 
in the discussion about research methodology offer additional insight into the differences 
between how scientists and nonscientists approach the federal requirement to assess the 
research methodology criterion.  
We usually just sit back and let the physicians discuss that. (Nonscientist, 
comprehensive IRB, public university) 
 
I guess in my case I know a little bit about research but not really the kind of 
research they do. I guess it’s more a question of is this really important or 
worthwhile. I don’t know that...we’ve said we only deal with research [design] if 
it’s not good and because of that it’s a waste of somebody’s time. I don’t think 
that we’ve actually rejected any on that basis. Maybe we have. I think we would if 
it was necessary. (Nonaffiliated member, social and behavioral IRB, private 
university) 
 
They generally don’t say much when methodology is being discussed. Sometimes 
the scientist members become nonscientists depending on the research area or 
methodology being discussed. (Scientist, social and behavioral IRB, private 
university) 
 
Our two nonscientists do have fair familiarity with some aspects of study design. 
So they’re a little more sophisticated in that than the community member who 
generally has none so the nonscientists might well make some comments 
speaking specifically to study design, from their point of view. I mean they won’t 
quibble about “is this dose of this drug better than this dose of that drug?” But 
they’ll talk about general aspects of design. The community people are more apt 
to say “well I don’t know about the science but I wouldn’t do this on a bet, it just 
sounds horrendous.” (Scientist, comprehensive IRB, public university) 
 
 These responses suggest the typical roles different members tend to assume when 
research methodology is a discussion point. The other side of this discussion relates to the 
overall “scientific merit” of a human subjects research protocol. As previously noted, 
some IRBs explicitly state that they usually do not purposely review for scientific merit. 
But most participants in this study agree that this review element is ever present in the 
discussion process if not overtly so: 
…we have to always look at the risk/benefit ratio so, there’s an implicit question 
‘is the risk to the subject worth the scientific benefit of the study?’ And I think 
there have been one or two instances during the past year where we really 
questioned that. So it’s an implicit question but not one that we typically address 
and discuss explicitly. Beyond that though, looking at the rigor of the study, the 
assumption is that the department provides oversight training and will sign off on 
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the merit of the study. If there’s a granting agency, whenever there’s a grant then 
there’s a place for the chair to sign off on all proposals. So there’s an assumption 
then that within all departments there’s an oversight. And in the instances where 
there has been poor scientific rigor, letters have gone back to the chair as well as 
to the PI. Or in the instance of junior faculty, not necessarily just to the chair or 
the department, but also to their mentor with the assumption that it’s their 
responsibility to kind of keep tabs rather than us as the IRB. (Scientist member, 
social and behavioral IRB, public university) 
 
In general, they try not to look at the basic science of it but every once in a while 
you come upon a protocol where the science is so bad that to let anyone enroll in 
it when you know that there can be no result worth publishing or worth thinking 
about, that would not make sense. So we say ‘well it’s not going to hurt anybody, 
let it go ahead’ but every once and a while you do come across a protocol where 
you actually look at the science of it and say ‘this is bogus and to waste anybody’s 
even five minutes at this is ridiculous’ much less to put drugs in people, or it is 
underpowered and there is no way you can learn anything from doing this horrible 
thing to three people, so why inflict it on three people. (Nonaffiliated member, 
biomedical IRB, private university) 
 
Informed consent 
A fourth component of IRB review is the informed consent process, which 
includes the actual consent form. Informed consent is one of the primary ethical 
requirements that underpin research with human subjects; it reflects the basic principle of 
respect for persons (Patton and Porter, 1993). Yet, many researchers forget that informed 
consent is an ongoing process and not just a piece of paper that research participants must 
sign to participate in a study. Truly informed consent assures that prospective research 
participants will understand the nature of the research and can knowledgeably and 
voluntarily decide whether or not to participate (Patton and Porter, 1993). Issues of 
coercion, deception, debriefing, compensation, and of course the risks and benefits to 
participants are key elements an IRB should consider during a review of the informed 
consent process. This is the only component of IRB review that is addressed in great 
detail by the federal guidelines, which specifically state that via the consent form, each 
participant must be provided with: 
1. A statement that the study involves research, an explanation of the purposes of the 
research and the expected duration of the subject's participation, a description of 
the procedures to be followed, and identification of any procedures which are 
experimental; 
2. A description of any reasonably foreseeable risks or discomforts to the subject; 
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3. A description of any benefits to the subject or to others which may reasonably be 
expected from the research; 
4. A disclosure of appropriate alternative procedures or courses of treatment, if any, 
that might be advantageous to the subject; 
5. A statement describing the extent, if any, to which confidentiality of records 
identifying the subject will be maintained; 
6. For research involving more than minimal risk, an explanation as to whether any 
compensation and an explanation as to whether any medical treatments are 
available if injury occurs and, if so, what they consist of, or where further 
information may be obtained; 
7. An explanation of whom to contact for answers to pertinent questions about the 
research and research subjects’ rights, and whom to contact in the event of a 
research-related injury to the subject; and 
8. A statement that participation is voluntary, refusal to participate will involve no 
penalty or loss of benefits to which the subject is otherwise entitled and the 
subject may discontinue participation at any time without penalty or loss of 
benefits to which the subject is otherwise entitled. (45 CFR 46.116) 
 
Thus it is not surprising that this element of the IRB review process shows the least 
variation among IRB members with respect to whether they agree or disagree on issues in 
this area of review.  
In the previous section I offered some explanations for differences that exist 
between male and female members, among social and behavioral, biomedical, and 
comprehensive IRBs, and between IRBs at public and private universities. To summarize 
here, the nature of the research protocol, or the associated level of risk, appears related to 
the amount of discussion over the consent process and elements of informed consent such 
as compensation, debriefing, and data confidentiality. For example, the issue of data 
confidentiality is often the greatest risk in social and behavioral science research. This is 
consistent with the finding that social and behavioral IRBs mention “data confidentiality” 
as a key element in the IRB review process more often than their peers who serve on 
biomedical IRBs where the risks are often physical or drug-related. 
7.2.2 Research Question 2: What is the relationship between members’ roles on the 
IRB and their level of expertise as they relate to their experiences and perceptions of 
the IRB process? 
 
Two themes—suggested by both the theoretical literature and the participant 
transcripts—are relevant to this research question: expertise and participation. Expertise 
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on the IRB is important because these interview responses suggest that nonscientist 
members (whether affiliated or not) tend to defer to scientist members (whom they 
perceive as “experts”) particularly on issues involving research design and scientific 
merit, and even potential risk. IRB members observe “there tends to be deferral to 
whoever is perceived to have expertise on the issue” (scientist member, biomedical IRB, 
private university).  
Expertise, as a concept, was defined in Chapter 3 as having a variety of 
characteristics. Often experts are defined as having specialized knowledge of some kind 
(Nowotny, 2003), a particular set of credentials or pedigree (Wachbroit, 1999), or the 
possession of certain characteristics that are distinctive from novices in the same field 
(Shanteau, 1992). Though IRB members loosely use the terms “expert” or “expertise” 
when talking about how research protocols are reviewed, expertise on the IRB cannot be 
conveniently compartmentalized into any of the definitions drawn from the literature. The 
challenge with defining expertise on the IRB is in some ways a strength for the IRB 
process and in other ways a source of contention for IRB adversaries. It is a strength 
because members from varying disciplinary backgrounds are required by law to meet and 
assess the risks and benefits of a research protocol. Arguably, such variation in expertise 
encourages the value of diversity of perspective. And, this diversity of perspectives and 
expertise is, in theory, more likely to result in a more comprehensive assessment of 
potential risks and benefits than if all IRB members come from the same disciplines or 
experience base. The drawback is that frequently in spite of the diversity of expertise, all 
of it is never entirely applicable to every protocol that comes through an IRB for review. 
In fact, critics of IRBs argue that not enough of it is relevant or useful for performing 
appropriate review. Even among IRB members, perceptions are mixed with regard to 
how expertise impacts the decision-making process: 
One of the dilemmas is that you don’t have your own area of expertise. Your own 
area of specialization doesn’t mean diddly squat in terms of the majority of the 
protocols that come through. That’s one of the things that I’ve found alarming in the 
past when things do go wrong and [people say] “well why didn’t the IRB do these 
literature reviews and why didn’t the IRB do this type of thing?” I’m sorry but 
knowledge is so specialized. (Scientist, biomedical IRB, private university) 
 
I personally am usually very cautious about going beyond that level if it’s a topic that 
I don’t know anything about [beyond the basic level of looking at the consent]. What 
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I will do is ask questions like “is this something that should concern it?” that either 
concern me or that are outside of my area of expertise. But there are amazingly a lot 
of things that are inside your area of expertise. Frame of reference is important for 
doing much more. (Scientist member, biomedical IRB, private university) 
 
Expertise also becomes highly relevant in the context of participation and group 
consensus. We have seen previously that nonscientist members, and nonaffiliated 
members in particular, tend not to participate in discussions of topics about which they 
feel unqualified or are lacking in expertise. But participation, or lack thereof, is affected 
by more than verbal contribution to the IRB discussion. Even if members actively 
participate—that is, they provide verbal input—in a technical discussion about risks and 
benefits or research design, ultimately even scientist members are likely to defer to 
whoever has the most relevant expertise on a particular issue especially if that issue 
spawns a debate at the IRB meeting: 
The challenge then is whether or not you’re going to defer to someone who 
presumably has more expertise or you’re not going to defer to them because you 
think their conflict of interest is too great. I don’t know how that gets worked out. I 
think it gets worked out through a process of trusting your best judgment and also 
then saying ‘you know we’ve got 20 more protocols to review’ and that may prompt 
someone then to either be overly conservative and say “well can we at least ask the 
investigator for more information before we give them any kind of approval”. Or it 
may prompt people to say “well you know let’s just trust this reviewers judgment this 
other person’s judgment on the committee and move on.” (Scientist member, 
biomedical IRB, private university) 
 
Most of the time the group agrees. We can get the majority opinion to shift to one 
particular point of view. There tends to be deferral to whoever is perceived to have 
expertise on the issue. I think that’s one of the big weaknesses of the IRB, if it’s not 
composed well. For example, on the subject of risks and benefits in my area, people 
tend to defer to me. If I don’t know it I’ll say I don’t know, we need to send this back 
to the investigator. But you wonder if always the expertise is of the highest quality 
because most of the time there is this deferral to whoever is perceived as having the 
expertise and maybe that perception is not always accurate. (Scientist member, 
biomedical IRB, private university) 
 
7.3 Summary 
 This chapter presented qualitative content analysis results for interviews with 37 
IRB members, compared across all of the IRBs. N6 qualitative analysis software was 
used to organize the data in a manageable way so that questions could be asked of the 
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data in order to inform the research questions driving this study. Using direct quotes I 
attempted to answer my research questions using the actual words of the participants 
themselves. In the next chapter, I will tie these findings together to draw conclusions 
about the relationship between member composition (specifically characteristics of 
expertise and participation) and the IRB decision-making process. I will then discuss my 
conclusions and recommendations in the context of possible contributions to theory and 
practice, as well as potential areas for future research. 
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8.0 CONCLUSIONS AND IMPLICATIONS 
 
8.1 Introduction 
The point of departure for this research was the observation that institutional 
review boards are increasingly being placed directly into the crossfire of researchers’ 
fight for academic freedom on the one hand and a push to expand public governance of 
science on the other. To increase our understanding of how IRB members make decisions 
about whether or not to approve human subjects research, I argued that systematic 
research was needed at the local level to inform our understanding of the actual decision-
making process and specifically how that process is affected by the characteristics of the 
IRB members. In this chapter I present my conclusions about the data analyzed in the 
previous chapters. Using these results, I also offer explanations for each research question 
and consider the implications of my findings for participatory democratic theory, small 
group decision-making, and human subjects research policy and practice. 
While the research described in this dissertation has application and direct 
usefulness to IRBs at universities and other research organizations, perhaps more 
importantly the findings also contribute to our understanding of decision-making at the 
intersection of science and society. The timing of this contribution is particularly 
important because, as discussed in Chapters 1 through 3, there has been very limited 
research on the “black box” of the IRB decision-making process and how it is affected by 
committee member characteristics. Given the current global push for democratizing 
science and technology and the 2001 NBAC recommendations for increasing the 
percentage of lay persons serving on IRBs, the results of this research are both timely and 
useful.  
 
8.2 Conclusions about each research question 
The value of the face-to-face group lies in its ability to nurture and integrate 
individual needs rather than reshaping the individual to meet the needs of the institution 
(Benello, 1971). This observation is particularly applicable to the IRB decision-making 
process, in which the needs of the institution are supposed to be secondary to the needs of 
individuals, specifically the potential research participants. In previous chapters, I 
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explored two dimensions of the IRB decision-making process, specifically (1) at the 
individual, pre-IRB meeting level and (2) at the convened group level of the actual IRB 
meeting. Now I will attempt to tie these two levels of participation together in a 
meaningful way that will inform our understanding of the IRB decision-making process. 
8.2.1 Research Question 1: How do IRB members decide whether to approve a 
human subjects research protocol—that is, about risk-benefit ratio, scientific merit, 
research design, and adequacy of informed consent? 
 
 The details surrounding the decision to approve a research protocol depend on 
whether the member is a scientist, nonscientist, or nonaffiliated member. While each of 
these members, for the most part, agrees on the list of protocol elements1 that IRBs 
should review, disparity exists with regard to the extent that different IRBs (social and 
behavioral, biomedical, and comprehensive), male and female members, and IRBs at 
public and private universities focus on each element. The difference that emerges most 
clearly is whether or not, or to what extent, IRBs should and do review research design 
and scientific merit. Regardless of gender, type of university (public or private), or type 
of IRB (biomedical, social and behavioral, or comprehensive), nonscientists and 
nonaffiliated members in this study tend to defer to the scientists on the committee on 
matters of scientific merit, and especially on matters of research design. Scientists, on the 
other hand, are more likely to review the research methodology but they, too, are willing 
to defer to other scientists whom they perceive as having more expertise in a particular 
area.  
 The research focus—social and behavioral, biomedical, or comprehensive—also 
impacts the ways in which IRB members determine whether to approve a protocol. 
Specifically, members on social and behavioral IRBs focus on particular aspects of 
“informed consent” (such as adequacy of informed consent and issues of data 
confidentiality) compared with their counterparts on biomedical and comprehensive 
IRBs, who tend to emphasize elements of risk and research design.  
 
                                                 




8.2.2 Research Question 2: What is the relationship between members’ roles on the 
IRB and their level of expertise as these characteristics relate to their experiences 
and perceptions of the IRB process? 
 
IRB members in this study perceive the IRB process as informal and casual. Yet, 
there were repeated references to the concept or importance of expertise by all members, 
regardless of their role on the committee. Several types of expertise are apparent in the 
IRB decision-making process. IRB chairs perform in a knowledge liaison type of role, 
filling in gaps in knowledge among IRB members and often connecting issues about 
research protocols that allow IRB members to move forward with a final decision. IRB 
administrators provide regulatory expertise and context for IRB decisions. This function 
is especially useful when information from a prior IRB decision bears relevance to a 
decision in process. Administrators offer institutional memory as it were. The scientist 
members affiliated with the university usually bring disciplinary expertise and 
methodological expertise to the IRB. However, unless there is intentional representation 
from each academic discipline (and even then, the breadth of expertise is questionable) 
adequate expertise for reviewing some protocols is lacking. Finally, IRB members 
perceive that lay expertise is brought into the process via the nonaffiliated member. 
However, this study suggests that nonaffiliated members are unsure about what their 
purpose is on the IRB other than to ensure that the consent form is understandable. Thus, 
there is no obvious mechanism by which lay expertise is certain to be considered. 
Furthermore, if small group decision-making characteristics such as the “common 
knowledge effect” exist in the IRB setting, lay expertise would need to be shared by the 
affiliated members in order to be fully considered during the IRB process. 
Although IRB members do not need to be experts in scientific methodology or 
statistics, they should understand the basic features of experimental design, and they 
should not hesitate to consult experts when aspects of research design seem to pose a 
significant problem (Penslar and Porter, 1993). In fact, both scientist and nonscientist 
IRB members in this study acknowledge that they consult with experts in other areas if 
they feel their own knowledge is lacking. It is probably impossible to have a nonaffiliated 
member who both represents the local community and is highly knowledgeable about 
research design, unless the local community is highly educated as a whole in similar 
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areas to the research in which they are likely to participate (and such research would 
probably violate the ethical principle of equitable subject selection). This dilemma poses 
a challenge to achieving full member participation during IRB discussion about 
methodological issues. 
Results from this research suggest that both nonscientist and nonaffiliated 
members do not participate in the same way as scientist members in the discussion about 
the “more technical” issues of human subjects research. That alone is not necessarily 
problematic. However, what is disturbing is the tendency that nonscientist members defer 
to the scientist members (whom they often perceive as “experts”) either because they feel 
unqualified to even ask questions about research design, or because they believe that their 
role is only to review the consent portions of the protocols. Members perceive this 
deference to expertise or perceived expertise not only during discussions about research 
design and scientific merit, but occasionally about potential risk. As one member 
explains: “There tends to be deferral to whoever is perceived to have expertise on the 
issue” (scientist member, biomedical IRB, private university). 
 
8.3 Conclusions about the research problem 
 Where then does this leave us with our understanding of how to resolve the policy 
problem that emerges from the regulation of human subjects research—that is, to ensure 
that human research participants are granted the three basic ethical rights of justice, 
beneficence, and respect for persons—while continuing to advance scientific knowledge? 
I began this research with one primary objective: to attempt to dissect the human subjects 
oversight system to enable a better understanding of the “black box” of IRB decision-
making. To achieve this objective I examined IRB members’ perceptions of the IRB 
process at seven research universities according to the principles of participatory 
democratic theory and research on small group decision-making. I argued that a 
participatory model was useful because of the expectation that better decisions will result 
if the IRB decision-making process incorporates a representative yet diverse set of 




8.3.1 Implications for theory 
 
To adequately compare the participatory features of IRB decision-making against 
principles of participatory democratic theory requires a much more elaborate and 
extensive research design than feasible for dissertation research. Thus, I have chosen to 
make some necessary concessions regarding participatory democratic theory by 
comparing the IRB decision-making process (as perceived by individual IRB members) 
with Fiorino’s (1990) criteria for assessing whether an institutional mechanism is 
democratic. Specifically, these criteria are: (1) is direct participation of amateurs in the 
decision-making process allowed, (2) how extensively does it enable the public to share 
in a collective decision-making process, (3) does the process provide a structure for face-
to-face discussion as a means to discuss, deliberate, search for shared values, and 
transform conflict into resolution, and (4) are citizen participants provided the 
opportunity to participate on equal footing with technical experts. How then does the IRB 
fare against these criteria? The process clearly allows for direct participation of amateurs 
in the decision-making process. However, the selection of those “amateurs” 
(nonscientists) is ambiguous at best. IRBs, at least in this study, do not adhere to written 
policies or consistent criteria for identifying the nonscientist members. In fact at the time 
of this study, they did not have a written policy for the selection of members. 
Furthermore, once on the committee, there is no mechanism to guarantee that the 
nonscientists or nonaffiliated members will participate in all (and in some cases, any) of 
the decision-making process. In that case, it is arguable whether they bring anything 
unique to the decision-making process in terms of incorporating public values into human 
subjects research.  
With regard to the second criterion for a democratic process, IRBs also fair 
poorly. Most IRBs do not go to great length to exceed the minimum requirement to 
include one nonscientist and one nonaffiliated member on their committees. Generally, 
their argument is that it is “difficult to find good members”. Affiliated IRB members in 
this study were quick to point out that nonaffiliated members ought to possess similar 
values for research and knowledge creation as the university-affiliated members do. That 
is, they should support the conduct of research and advancement of scientific knowledge, 
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two values not necessarily shared by all members of the general public. Furthermore, any 
attempt to mandate an increase in the number of nonscientists and particularly lay 
members is likely to generate opposition from the research community. 
Recommendations for such a requirement have already met with opposition as previously 
discussed. 
Perhaps the IRB scores best on Fiorino’s third and fourth criteria of a democratic 
institutional mechanism: does the process provide a structure for face-to-face discussion 
as a means to discuss, deliberate, search for shared values, and transform conflict into 
resolution; and, are citizen participants provided the opportunity to participate on equal 
footing with technical experts. Because of the federal regulations, IRBs must convene a 
face-to-face meeting to discuss and deliberate human research protocols. During my 
observations of each IRB meeting in progress, it was evident that some values are 
articulated and deliberated, and conflicting opinions about such values are discussed until 
the committees arrive at consensus. In cases where members oppose the final 
recommendation or vote, those differences are reflected in the letters sent to the research 
investigators. Although the IRBs participating in this study include only the minimal 
requirement for citizen representation on their committees, those nonaffiliated members 
appear to have equal opportunity to participate in the decision-making process. 
Interviews with these members reveal that they feel welcome to share their views during 
that process. Whether they choose to do so is a different matter, as noted in Chapter 6. 
With regard to participation and whether the IRB process follows the principles of 
participatory democratic theory, these data suggest that (according to Fiorino’s criteria) 
the IRB process is not a truly democratic process in the sense that those on the committee 
who “represent” the public are really not so representative, and probably cannot be 
representative particularly in such a limited participatory capacity when the requirement 
for including nonaffiliated members is so minimal. One might argue that this comparison 
is unfair because the IRB was not designed to be a truly democratic process; rather it was 
merely designed to allow for diversity in perspectives to be achieved through specific 
composition of the committee. In Chapter 3, I articulated why a participatory democratic 
process is best for IRB decision-making, specifically noting Kaufman’s argument that 
participatory democracy not only allows for protecting society at large, but it also 
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contributes to the development of human powers of thought, feeling, and action. 
Consequently, by assessing the IRB process against Fiorino’s set of normative 
democratic characteristics, opportunity exists to vastly improve the current human 
subjects oversight system, and perhaps even decision-making at the boundary of science 
and society, such that via the IRB goal to protect human research subjects, the playing 
field at the science-society intersection is leveled. Scientists should rest assured that 
realizing this objective does not freely grant nonscientists access to the realm and rigor of 
scientific research. Rather, it encourages breadth and depth of discussion about how 
scientific research involving humans ought to be conducted such that both protection of 
human participants and contribution of scientific research are maximized. 
8.3.2 Implications for policy and practice 
 
Fischer (2000, p. 45) presents us with a new question to ask about professional 
knowledge and citizen participation: rather than questioning the public’s ability to 
participate in technical decision-making, we must ask, “how can we interconnect and 
coordinate the different but inherently interdependent discourses of citizens and 
experts?” The results of this study suggest that the IRB is a useful and insightful arena 
for beginning to answer this question, particularly if recent recommendations to increase 
lay participation on IRBs are implemented. But even presently, due to the diversity of 
disciplines represented on an IRB, at one time or another during the decision-making 
process any IRB member is no more an expert than the nonaffiliated or lay member who 
sits next to him or her at the IRB meeting. 
The composition of the IRB has the potential to greatly impact the types of 
issues—that is, a range of values—that are discussed during IRB review of research 
design, scientific merit, risk-benefit and informed consent. But member roles are not well 
defined. A scientist member on one university IRB may characterize as a nonscientist on 
another university IRB, which could alter the ways in which that member’s contributions 
to the IRB process are perceived. Members even define themselves differently in some 
cases which could further impact the decision-making process, how members respond to 
each other, and the extent to which members participate or believe they ought to 
participate. Because different types of members approach the review process in various 
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ways, characteristics such as deference to expertise and the common knowledge effect 
can further impact the degree to which certain IRB issues are considered and ultimately 
factor into the decision. A good example is the conundrum that some IRBs experience 
with regard to whether or not to review scientific merit or research design. The extent to 
which a protocol is “tweaked” before it finally merits IRB approval hinges upon each of 
these dimensions and challenges of the IRB process. 
As earlier risk research has shown, experts and the public (usually assumed to be 
the nonexperts) do perceive risk differently. Take, for example, the decision to vaccinate 
a child or even to invite a child to participate in a vaccine research study. Ball et al. 
(1998) find that “although physicians may focus on the statistics regarding general 
vaccine effectiveness and known risks of vaccine-preventable diseases, parents making 
vaccination decisions may perceive risks in a broader religious, cultural, and personal 
context.” Arguably, IRBs composed of primarily physicians or members from a single 
race, religion or culture potentially could overlook such issues in the IRB decision-
making process unless someone who is sensitized to these differences points them out. 
Although most participants (whether scientist, nonscientist, or nonaffiliated members) in 
this research study believe that scientists are capable of bringing public values into the 
IRB decision-making process, many of them also provided caveats that support the 
requirement for member diversity on IRBs: 
The problem is that we all have our own blinders…that’s why the requirement for 
different members makes sense (Scientist member, social/behavioral IRB, public 
university). 
 
…when so involved in a review and bringing that professionalism and that 
academic perspective to a review, sometimes that perspective is not fully 
considered, which is why as a community member I can bring some of that to the 
committee. (Nonaffiliated member, social/behavioral IRB, private university) 
 
A more difficult question is how to determine how much diversity is sufficient to 
impose as a minimum membership requirement for IRBs. I have already stated that the 
current regulations are very vague and leave IRB member selection up to the universities, 
as long as the minimum number of members is satisfied. Several of the IRBs in this study 
admitted that their IRBs are neither racially nor culturally diverse and that this was a 
potential problem. Yet, they followed up this acknowledgement with the complaint that it 
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is difficult to find community members with the adequate “educational background so 
that they won’t be intimidated by the group that they’re working with” or members that 
are “not opposed to the research process”. To further complicate this issue, the federal 
guidelines explicitly state that, although IRBs should make every effort to maximize 
diversity among members, they should not select members on the basis gender.  
Based on the results of data analyses and discussion in the previous chapters, I 
conclude with the following recommendations to begin improving university IRB 
decision-making:  
 
Recommendation 1: IRBs should develop and implement clear and written guidelines 
for member selection and member role on the IRB.  
 
None of the universities participating in this study had written policies for 
member selection at the time the research was conducted. Interview responses confirm 
that these universities tend to rely on word of mouth, contacts through existing IRB 
members, or volunteers to identify and recruit potential new members. This is the case for 
recruiting both scientist and nonscientist members, as well as for recruiting nonaffiliated 
members. While many of the IRB administrators and chairs interviewed pointed out that 
efforts are made to include a diversity of disciplinary backgrounds, in many cases 
identifying IRB members comes down to finding “warm bodies” willing to serve on “yet 
another university committee”. Additionally, IRBs must consider the expertise they 
possess at any given time and be consistent about how such expertise is connected to 
appropriate roles on the committee. Some members in this study are perceived to serve in 
different roles depending on who classifies their role on the IRB. For example, at 
University D several members classify themselves as scientist members on their IRB; yet, 
their IRB administrator considers them to be nonscientists based on their academic 
disciplines. The way in which someone perceives their role can affect the ways in which 
they carry out that role or how they believe they are expected to perform within that role. 
Research discussed in Chapter 3 suggests that people respond to expertise in different 
ways, often deferring to those with perceived expertise. Phenomena such as the “common 
knowledge effect” can lead to certain information either factoring into or being omitted 
from a decision. Arguably, combining these two decision-making characteristics with 
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ambiguous roles on the IRB has great potential to influence the IRB process and ultimate 
outcomes. 
A rationally thought-out member selection policy would further serve to enhance 
IRB credibility among the research community. Currently, some research investigators 
allege that IRBs lack credibility and expertise to judge protocols that are often outside 
their domain, causing delays in and unnecessary burden upon the research process. 
Contrary to what research investigators allege, IRBs (at least in this study) are also 
concerned with facilitating research and not just protecting human subjects.  
Understandably, it can be challenging to identify the “right” person to serve in the 
nonaffiliated capacity. IRB members complain that it is particularly difficult to identify 
nonaffiliated members who not only support the goals and objectives of scientific 
research, but also reflect local community values as much as possible and are willing to 
actively participate in a decision-making process that offers little to no compensation for 
their time or contribution. But, results from this study suggest that universities are not 
trying hard enough to find these potential members. In fact, it appears that some 
universities are willing to overlook the fact that their nonaffiliated member may not be so 
“nonaffiliated” or is hardly representative of the surrounding community. For example, at 
University E, the nonaffiliated member is actually a graduate of one of the university’s 
academic programs. And, at University D, the IRB administrator suggested that she will 
try to recruit an outgoing affiliated member into the “community member” role. Such 
interpretation of the federal regulations on IRB composition does little to add to diversity 
in perspectives among IRB members. Universities must discuss, develop and implement 
policies for selecting IRB members, particularly with regard to the nonaffiliated members 
and members who have prior or current experience as actual research participants. 
Greater attention to the member selection process could only improve upon the current 
“policy” which seems to rely mostly on serendipity or “who you know”. 
 
Recommendation 1.1: Mandatory service on the IRB should be encouraged for 




Recommendation 1.2: Mock IRBs should be implemented at the student level, with the 
requirement that graduate students (at a minimum) and even undergraduate students 
participate. 
 
 These two recommendations are related to Recommendation 1 in that they 
address the structure and composition of the IRB. IRB members interviewed in this study 
articulated that they had a different appreciation for, or at least an understanding of, the 
IRB process. At least one participant noted that the reason she got involved with her IRB 
was because as a research investigator she was so frustrated with the process. 
Recommendation 1.1 should also be extended to student researchers. In this study, only 
University E included a student member on the IRB. However, that member’s nomination 
to the committee was because of circumstance rather than student status. The objective of 
Recommendation 1.1 is not necessarily to “convert” researchers into IRB cheerleaders. 
Rather, the diversity in perspectives and expertise potentially represented on the IRB 
sensitizes members to and deepens their appreciation of methodological and 
philosophical differences among different disciplines. For example, the inclusion of 
students as official IRB members invites a perspective that is particularly beneficial for 
research involving students as research participants. 
 Similarly, students (i.e., would-be or will-be researchers) can benefit from early 
exposure to the peer review and ethical review components of the IRB process, either by 
direct participant as an IRB member or via a mock IRB process. Generally they are not as 
yet disenchanted with the IRB process or skeptical of its purpose, which may encourage 
greater freedom of discussion at IRB meetings regardless of areas of expertise or 
experience—two factors that seem to inhibit more seasoned scientists and nonscientists 
alike. Additionally, because student research tends to be “weaker” in terms of its research 
design, the process of openly discussing the relationship between research design and the 
other IRB review elements is likely to lead to more careful consideration of and 
improvements in the research design. 
 
Recommendation 2: IRBs must resolve and be prepared to defend their position on 





One of the criticisms many scientists level at IRBs is that they have no business 
critiquing scientific research for which they allegedly possess no qualifications. This is a 
serious challenge for IRBs, particularly in light of the federal requirement that IRBs 
should review research design and scientific merit. As with member selection, the IRBs 
in this study do not appear to have written policies that specifically address IRB review 
of research design or scientific merit, other than by reference to the 45 CFR 46 IRB 
review elements in their institute IRB guidelines. Two participating universities in this 
study seem to have found an approach that blends the regulations with the realities of 
reviewing research outside the domain of the IRB expertise. IRBs at both private 
University A and public University E have taken the approach of offering “friendly 
suggestions” or “friendly gestures” to researchers in instances where members feel that 
the proposed research design is lacking or may not achieve the research objectives. This 
process—“free” but not required research design advice—might be most invaluable for 
junior researchers, and certainly for student researchers. But, it must be pointed out that 
the IRBs interviewed at both of these universities review social and behavioral research 
protocols in which the choice of research methodologies and contribution to knowledge 
often is not as “cut and dry” as those of biomedical research protocols. Certainly the 
implications of such “friendly” advice may be drastically different for human subjects 
research in which potential physical risk is higher. 
 
Recommendation 3: The federal policy on human subjects research must be revised to 
specifically and adequately address the differences among domains of human subjects 
research. 
 
 This recommendation echoes that which many social science researchers have 
already demanded. One of the most notable differences to emerge from this research 
study is the difference between the elements of IRB review emphasized by members on 
social and behavioral committees compared with their counterparts on biomedical and 
comprehensive IRBs. Undoubtedly differences do exist with regard to both risk and 
benefit. This is implicit in the very nature and purpose of social and behavioral research 
compared with biomedical research. And in fact, efforts have been made and continue to 
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examine these differences in greater detail than possible here (see National Research 
Council, 2003).  
 Similarly, the issue of student research warrants greater discussion in the context 
of appropriate IRB review. Unless departments are subjecting student research projects to 
stringent review at the departmental level, most student research probably will benefit 
from IRB review of elements of scientific merit and research design, as well as 
assessment of the risk-benefit ratio and informed consent process. While some IRBs are 
already reviewing student research, many others do not and rely solely on students’ 
advisors who often are not as intimately aware of the details of the student’s methodology 
as one might expect.  
These study results also suggest that IRBs often decrease the importance of 
reviewing research design or scientific merit for student research. That decision is 
justified via the argument that such review would prevent the research from ever 
happening in the first place, and thus impinge upon the inherent benefit to the student of 
conducting research at all. This argument is a disservice to research and to students. 
While the burden on the IRB may increase by reviewing all student research, if student 
researchers are not subject to the same criteria as more experienced researchers, they only 
are they denied a valuable learning experience but they also enter the research world 
inappropriately prepared to conduct “real research”. Arguably, the IRB review process 
can (and often does) add value to a research protocol particularly in the case of student 
research where the research design has much room for improvement. In the same way 
that experiential learning outside of the classroom complements scholastic learning, skills 




Every study has limitations; some imposed upon it (as discussed in Section 1.7) 
and some that result from inherent weaknesses within the methodology of choice. In this 
study, open-ended questioning techniques were used as the primary method for 
investigating the complex issues that exist in decision-making at the boundary of science 
and society. Compared with quantitative techniques such as survey methods, qualitative 
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methodologies are used more appropriately with smaller numbers of participants to elicit 
deeper and more complex understandings. This study focused on an in-depth examination 
of the perceptions IRB members have about their IRB experience and their perception of 
the IRB process. For this reason it was limited to small groups of IRB members at seven 
strategically selected IRBs.  
 This is a qualitative study of the voices of IRB members in which I examined 
members’ understanding of their IRB experiences, the meanings they attached to these 
experiences, and the implications these experiences have on the oversight of human 
subjects research and governance of science. A qualitative approach was chosen because 
it permits deeper understanding of the phenomena explored in this study, knowledge not 
gained by previous quantitative studies of IRBs. The extent to which the results of a study 
can be generalized to another setting or group of people is an important consideration, 
and even a primary objective, in quantitative research (Benz and Newman, 1998). But 
such generalization is not easily determined for qualitative studies. Benz and Newman go 
so far as to argue that if the purpose of a research study is to generalize, then one should 
employ quantitative methodology. As with most case study designs, the purpose of this 
study was not necessarily to generalize but rather to investigate various aspects of the 
IRB decision-making process through the eyes of those who actually participate in this 
process. To this end, IRB member experiences are quoted in context to substantiate the 
research findings about the relationship between IRB member composition and members’ 
perceptions about the IRB decision-making process. 
 Rather than assessing the generalizability to other research settings or decision-
making processes it makes more sense to consider the results in the context of the 
following questions: Can this research be applied to other samples? Do the findings of the 
research hold up in other settings or situations? What is the likelihood that a given 
outcome or event will happen again if given the same circumstances? (Benz and 
Newman, 1998) Because similarities exist between the different types of members at 
each of the participating IRBs, the “thick description” (Geertz, 1973; Denzin, 1989) of 
these characteristics enables generalization to some extent, particularly to other research 
universities that conduct human subjects research. With regard to the second concept of 
generalizability, it is possible to show that the behavior observed in this study, with 
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regard to participation, perhaps is not dependent upon context. Previous studies of lay 
participation in technical decision-making also demonstrate deference to experts in such 
settings. 
Patton (1990) argues “the validity, meaningfulness, and insights generated from 
qualitative inquiry have more to do with the information-richness of the cases selected 
and the observational/analytical capabilities of the researcher than with sample size.” If 
the number of subjects is too small, it is not possible to make statistical generalizations or 
to test hypotheses of differences among groups but if the purpose of a study (such as this 
one) is to understand the world as experienced by one specific person, this one subject is 
sufficient (Kvale, 1996). Every reasonable effort was made to include a diverse set of 
IRB participants to capture the experiences of each member type. Because the proportion 
of nonaffiliated members serving on IRBs tends to be small compared with affiliated and 
particularly scientist members, fewer nonaffiliated members are represented in this 
sample. However, three to five interview transcripts often provides the situational 
diversity necessary for identifying thematic patterns (Pollio et al., 1997), which was 
achieved for each type of IRB member in this research study. 
 
8.5 Further research 
 One of the reasons for my interest in IRB decision-making is because there are so 
many unanswered questions about this process and yet so many criticisms of it. Analysis 
of the data obtained for this study only emphasizes how much research remains to be 
done in order to more fully characterize the IRB decision-making process and its 
implications for governance of science. The most obvious area in which this research can 
and should be extended is to other human subjects research settings such as universities 
with smaller research budgets, hospitals, private research organizations, and even private 
IRBs. Before it is possible to implement any of the policy recommendations presented 
above, additional research is needed in these areas to determine whether the differences 
observed here are endemic only to research universities. Additional qualitative research 
studies would help to further characterize the ways in which members assess risk in a 
human research protocol. Armed with that knowledge, larger scale, quantitative studies 
should be done to enhance generalizability of anticipated findings. Thus, the next phase 
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of research is to conduct more extensive studies on the actual IRB group-decision making 
process to investigate whether member perceptions of the IRB process corroborate with 
the actual decision-making process. Such research should include more extensive and 
longer-term observations of group deliberations at convened IRB meetings. 
 Another area that merits additional examination is comparative research to 
identify and understand differences between the U.S. human subjects research system and 
similar systems in other countries. U.S. researchers argue that our policies are too strict or 
are not appropriately applied to social science research. If the larger scale studies 
suggested above find these allegations to be true, it is possible that we might learn from 
other countries where researchers may share different opinions about human subjects 
research oversight. Coincidentally, some countries require a greater proportion of 
research ethics committee members to be from the local community. In contrast with the 
U.S., scientists do not dominate those committees. The U.S. might also consider whether 
certain distinctions about research might improve our human subjects oversight system. 
For example, in France, biomedical research is divided into two areas: research of direct 
benefit to the individual, and research of no direct benefit to the individual such that 
specific rules apply depending on whether or not a direct benefit is anticipated for the 
person consenting to the research (McDonald, 2000). Similar distinctions might also be 
considered for social and behavioral science research, in which the potential risks to 
participants are often minimal or nonexistent compared with those of biomedical 
research. 
Finally, research should be conducted to determine whether IRB review adds 
value to the research process. In other words, does the IRB process make research better 
not only insofar as human subjects are protected but also with regard to the potential 
contributions such research can make to society and scientific knowledge in general? I 
have suggested in my conclusions that IRB review can be a value-added process, 
particularly for student research but perhaps even in research conducted by junior faculty. 
This suggestion is likely to invite strong criticism from the research community 
(particularly by social and behavioral scientists), which is precisely why research on the 
value-added component of IRB review is warranted. 
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APPENDIX B: INVITATION TO PARTICIPATE IN RESEARCH STUDY 
 
Dear <insert IRB administrator’s name>, 
 
I am a PhD candidate in Science & Technology Policy at the Georgia Institute of 
Technology. My dissertation research examines the decision-making processes in the 
human subjects review system. Recently, I received dissertation research funding from 
the National Science Foundation (Award No. SES-0240394) to collect data for this 
research. The project summary is included below to provide more information about the 
study, which has received IRB approval from Georgia Tech. 
 
Today, I am writing to invite the participation of one of <insert university name> IRBs. 
Your participation would consist of short interviews with about 5-6 committee members 
(including one scientist, one nonscientist, one nonaffiliated member, the chair, and the 
IRB administrator). My NSF grant provides travel funds such that I would conduct the 
interviews at <insert university name. 
 
Upon completion of my research, I would be happy to share the results with <insert 
university name>. I look forward to hearing from you and sincerely hope that I will have 
the opportunity to meet some of the members of your IRBs. If it is helpful to speak with 
my advisor about the study, you can reach him at 404-894-8282. His name is Dr. Richard 
Barke (Professor in Public Policy and Associate Dean of the Ivan Allen College of 
Liberal Arts at Georgia Tech). My number is 770-491-0063 if you would like to talk with 
me. 
 




Decision-making in the Human Subjects Review System 
 
Eliesh O'Neil Lane, PhD Candidate 
Georgia Institute of Technology 
 
Research Summary 
Human subjects issues rest at the intersection of research in areas of engineering, science, 
technology and society. With this research come questions about risks and benefits to 
research participants and society. A group of individuals, chosen at the local institutional 
level, known as the institutional review board (IRB) decide whether to approve research 
protocols with human subjects. Current IRB regulations provide general guidance on 
board member composition. By law, IRBs include one scientist, one nonscientist, and one 
nonaffiliated member. 
 
Recent research studies have examined such IRB issues as workloads and efficiency, 
primarily focusing at the administrative level (e.g., on the chair and/or the institutional 
review board administrator) or on quantifying the number of different types of members 
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(see Bell et al., 1998). However, as the human subjects protection system comes under 
intense legislative and media scrutiny and confronts significant revision, much is still 
unknown about their operation. Systematic theory-driven empirical research is lacking on 
the effects of varying compositions of IRB membership and on how IRB behavior varies 
from institute to institute. 
 
In this study, I will conduct personal interviews with IRB members from a sample of 
research universities to explore the relationship of IRB composition with decision 
processes about ethical and value issues of human subjects research. This research will 
contribute to larger questions in the scholarly body of knowledge regarding processes and 
social contexts of scientific research. 
 
********************************************************* 
Eliesh O'Neil Lane, MS 
PhD Candidate, Science & Technology Policy 
Georgia Institute of Technology 




APPENDIX C: IRB MEMBER INTERVIEW PROTOCOL 
 
*Q1 How did you come to be a member of the Institutional Review Board?  
 
*Q2 What is your current position at the university?  
  
*Q3 How long have you worked here? 
 
*Q4 Have you ever served (or do you serve) on an IRB at another organization? In what 
role? 
 
*Q5 Do you currently serve (or have you ever served) on any other type of research 
ethics committee (e.g., IACUC, Biosafety)? 
 
*Q6 How were you selected to serve on this IRB? 
 
*Q7 Why do you think you were chosen to serve on the board? 
 
*Q8 Tell me about your experience as an IRB member. 
 
*Q9 What is your position/role on the IRB? (Administrator, Chair, scientist,  
 
*Q10 Did you have any training in preparation for your role on the IRB? 
 
*Q11 Describe the training you receive(d) in preparation for your role on the IRB. 
 
*Q12 What type of research does your IRB typically review (e.g., biomedical, 
social/behavioral, etc.)? 
 
*Q13 Has this always been the case? 
  
* Q14 Who assigns protocols to you for review? (N/A for administrators) 
  
*Q15 Do you know how they are assigned? (Probe: On what basis - randomly, based on 
your area of expertise, etc.) 
 
*Q16 How is your typical IRB meeting organized?   
 
*Q17 How formal are the meetings? 
  
*Q18 How are the meetings structured? 
 
*Q19 What is the role of the Chair? 
 




*Q21 Tell me about the elements of a research protocol that the IRB is responsible for 
reviewing. 
 
*Q22 About how many hours do you spend preparing for a typical IRB meeting? 
  
*Q23 Describe what you do to prepare for the meeting? 
 
*Q24 Do you talk with other members about the protocols up for review prior to the 
meeting? 
 
*Q25 Does your IRB use a web-based system to review and manage protocols? Do you 
use this system? How? 
 
*Q26 Do you prepare/submit reviews ahead of time? 
 
*Q27 Before the actual meeting, what aspects of the proposals do you usually focus on 
during your review?  
  
*Q28 During the actual IRB meeting, how do you usually bring up issues or problems 
with a protocol? 
 
*Q29 (N/A for "biomedical only" or "social/behavioral only" boards) Which elements of 
a protocol do you usually focus on for a biomedical study? 
 
*Q30 N/A for "biomedical only" or "social/behavioral only" boards) Which elements of a 
protocol do you usually focus on for a social or behavioral science study? 
 
*Q31 (N/A for "biomedical only" or "social/behavioral only" boards) Do you review 
biomedical protocols and social/behavior science protocols differently? 
 
*Q32 Now I'd like you to think about the different types of members who serve on an 
IRB. How do you define each of the member types on your IRB? In other words, what 
education or experiential background do "scientist" members on your IRB possess? 
 
*Q33 Are there qualities or characteristics "scientist" members share? 
 
*Q34 What educational or experiential background should an IRB member possess to be 
classified as a "scientist" on the board? 
 
*Q35 What qualities or characteristics should scientist members possess? 
 
*Q36 What about the "nonscientist" members? Education or experiential background? 
 




*Q38 What educational or experiential background should an IRB member possess to be 
classified as a "nonscientist" on the board? 
 
*Q39 What qualities or characteristics should nonscientist members possess? 
 
*Q40 And the "nonaffiliated" members? Education or experiential background? 
 
*Q41 Shared qualities or characteristics? 
 
*Q42 What educational or experiential background should an IRB member possess to be 
classified as a "nonaffiliated member" on the board? 
 
*Q43 What qualities or characteristics should nonaffiliated members possess? 
 
*Q44 (If applicable) What role does your IRB's student member serve? Who does s/he 
represent? 
 
*Q45 Now think about the Chair of your IRB, tell me about his or her (your, if Chair is 
answering) role on the IRB. 
 
*Q46 Would you characterize the Chair as a scientist, nonscientist, or nonaffiliated 
member? 
 
*Q47 What is their role in leading the discussion? 
 
*Q48 Do others sometimes tend to take the lead? 
 
*Q49 Which members typically take the lead in bringing up or discussing issues? 
 
*Q50 What issues do they typically focus on? 
 
*Q51 How do other members typically respond to this person? 
 
*Q52 Thinking about the scientists on your IRB, how do they usually address questions 
or issues about a proposed research protocol? How do they bring up problems with a 
protocol? (Probes: via email or a web-based system prior to the meeting, during 
discussion at the meeting, or in another way) 
 
*Q53 What aspects of the proposals do they typically focus on? (Probes: scientific rigor, 
research potential, risk potential, etc.) 
 
*Q54 (N/A for "biomedical only" or "social/behavioral only" boards) Do you think there 
is a difference between how scientist members review biomedical protocols and 




*Q55 Now let me ask you about the nonscientists on the Board:  do they typically bring 
up questions or issues about a proposed research protocol? How? What aspects of the 
protocol do they usually focus on? 
 
*Q56 (N/A for "biomedical only" or "social/behavioral only" boards) Is there a difference 
between how nonscientist members review biomedical protocols and social/behavior 
science protocols?   
 
*Q57 Tell me about the role of nonscientist members when research methodology is 
being discussed. 
 
*Q58 What about the nonaffiliated members? Compared to other members, how do they 
approach the discussion about a protocol? 
 
*Q59 (N/A for "biomedical only" or "social/behavioral only" boards) Is there a difference 
between how nonaffiliated members review biomedical protocols and social/behavior 
science protocols? 
 
*Q60 How do nonaffiliated members generally participate when research methodology is 
being discussed? 
 
*Q61 What happens when members disagree on certain aspects of a proposal? (e.g., the 
research objectives, the potential for risk, whether/how much compensation is coercive, 
etc.) In other words, how are disagreements are handled for (each of the major types of 
issues)? 
 
*Q62 Are there cases in which conflicts of interest (with respect to a protocol focus) 
emerge among the IRB members in the decision-making process? How are these usually 
handled? 
 
*Q63 Do you ever (or have you ever) feel like you need to convince the IRB that a 
protocol should be approved? Or disapproved? For what reasons? (e.g., a colleague's 
proposal, your department head's proposal, the proposal of a student you supervise) 
 
*Q64 When protocols are approved pending modifications, tabled/deferred, or 
disapproved, how do PIs generally receive IRB feedback?   
 
*Q65 Does the IRB administrator send an email or a letter?   
 
*Q66 How much detail about the IRBs concerns or suggestions is typically given? 
 
*Q67 How does the IRB work with PIs to incorporate this feedback? 
 
*Q68 Has your IRB ever received complaints regarding its decisions? 
 




*Q70 From whom (e.g., PIs, other research administrators, OHRP)?   
 
*Q71 Are such complaints formal (e.g., letters, emails) or "informal" (e.g., phone call, 
hallway discussions)? 
 
*Q72 What is the process by which PIs can appeal the IRBs decision? How do they view 
this process? 
 
*Q73 How does your IRB generally respond to such complaints or appeals? 
 
*Q74 Has your IRB ever reversed a decision to disapprove a protocol based on a PIs 
appeal? 
 
*Q75 Under what circumstances (generally)? 
 
*Q76 Now I'd like you to reflect on the meaning of your role on the IRB. Given what you 
said about how you came to be an IRB member and what it's like for you to fulfill this 
position, what does it mean to you to be a (scientist, nonscientist...) member on the IRB? 
 
*Q77 What do you believe is the purpose of your university's IRB? 
 
*Q78 Given that, what do you feel is the most important function of the IRB? 
 
*Q79 Do you think all of the IRB members here perceive the purpose of the IRB the 
same way? 
 
*Q80 What about the researchers whose proposals you review? Would they agree with 
your perception of the role of the IRB? 
 
*Q81 What weight do you feel your opinion carries on your IRB? 
 
*Q82 Do you feel that your IRB training adequately prepared you for this job? 
 
*Q83 (If applicable) How would you compare your experience on this IRB with other 
IRBs (or research ethics committees) on which you have served or currently serve? 
 
*Q84 Reflecting on the different types of IRB members: What do you feel is the rationale 
for requiring IRBs to include at least one scientist, one nonscientist, and one nonaffiliated 
member? 
  
*Q85 What purpose do you think scientists on the IRB should serve? 
 
*Q86 What about nonscientists? 
 




*Q88 Who or what do you think scientist members represent on the IRB? 
What do they represent? Or who? 
 
*Q89 What about nonscientists? 
 
*Q90 What about nonaffiliated members?  
 
*Q91 Do you think scientists are capable of bringing public values into the IRB decision-
making process? 
 
*Q92 If you could, would you change the composition of IRB member types on your 
IRB?  
 
*Q93 Do you think the breakdown of scientists and nonscientists is appropriate? If not, 
what would you change? 
 
*Q94 What, in your opinion, would necessitate a change in the number of scientist or 
nonscientist members on the board? 
 
*Q95 Do you think the number of nonaffiliated members is appropriate? If not, what 
would you change? 
 
*Q96 What, in your opinion, would necessitate a change in the number of nonaffiliated 
members on the board? 
 
*Q97 (Only for "biomedical only" or "social/behavioral only" boards) Given the research 
focus of your IRB, do you think the board makes decisions differently than if the research 
focus included social/behavioral science protocols (or biomedical protocols)? 
 
*Q98 If you could, is there anything you would change about how decisions are made on 
your IRB? 
 
*Q99 If you could, is there anything you would change about how your IRB responds to 
appeals or complaints by researchers? 
 
*Q100 The Institute of Medicine recently recommended that IRBs should only be 
responsible for reviewing the ethics of human subjects research and that scientific and 
financial conflict-of-interest issues be left to other oversight committees for review. What 
are your thoughts on this recommendation? 
 
*Q101 Do you think the IRB process does its job adequately? 
  





*Q103 I have reached the end of my questions. Is there anything you would like to add 
about your experience as an IRB member or what it means to you to be an IRB member? 
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*QS1 When was “your university’s” IRB created?  
 
*QS2 How many IRBs are there and what are their research focus areas? 
 
*QS3 How many members serve on this/these IRB(s)? 
 
*QS4 What is the organizational structure in which the IRB is situated? Is your IRB 
within the Office of Sponsored Programs, directly under an academic officer, or in 
another department? To whom does the IRB report? 
 
*QS5 Where do the resources (e.g., budget) for the IRB come from?    
 
*QS6 How frequently does your IRB meet?  
 
*QS7 How long do the meetings usually last? 
 
*QS8 Approximately how many protocols does your IRB review each month or year? 
 
*QS9 About how many of these are reviewed by the full board? 
 
*QS10 Do you assign expedited protocols to the board? How? 
 
*QS11 Does your IRB use an electronic communications system (e.g., IRBWISE)? Do 
members utilize its capabilities for reviewing and posting their comments on protocols? 
 
*QS12 Please describe the demographic characteristics of your IRB. How many women 
and men? What is the ethnic breakdown? 
 
*QS13 What role (e.g., Latino nonscientist, male nonaffiliated member, etc.) does each 
fulfill? 
 
*QS14 Does your IRB have a policy on how members are selected to the board? 
 
*QS15 How do you identify or recruit nonaffiliated members? 
 
*QS16 How is the IRB chair selected? 
 
*QS17 Are there any student members on your IRB? How many? What role do student 
members serve? 
 
*QS18 Do any of your members receive compensation for their service on the IRB? 
 





APPENDIX E: FINAL CODEBOOK FOR INTERVIEW PROTOCOLS 
 
Code Definition/explanation Synonyms/related themes 



















Presence (or lack thereof) of 
mechanisms that encourage 
members to participate in the 
decision-making process both 
independently before the 
convened IRB meeting and as a 
group during the convened IRB 
meeting 
Communicate with other 
members via email or phone 
 
Group training and workshop 
opportunities  
 
Assignment of reviews to 
members 
 
Opportunity to directly 
participate 
 
Influence over decision outcome 
(weight opinion carries during 
group discussion) 
 
Number of nonaffiliated or lay 
members on the committee 
 
Presence of nonaffiliated or lay 
members during vote 
 












Refers to the group discussion 
process, specifically 
characteristics of the convened 
IRB meeting such as how formal 
or structured the meetings are, 
how disagreement over specific 
issues are resolved (e.g., level of 
risk, research design, 
compensation) 
 
Formality or structure of 
meetings  
 
Consensus versus majority vote 
 
Work out differences of opinion 
through discussion 
 
Give and take on certain issues 
 
Incorporate differences of 
opinion in condition letter to 
research investigator 
 
Deference to authority or experts 
 
Presence of dominant 
personalities 










The purview of the IRB; what 




Protect the researchers 
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members believe is the purpose 
or goal of the IRB 
 















Benefit of the research to society 
and/or knowledge in general 
Scientific value 
 




Contribution to knowledge 
generation 
 
Contribution to science (or 
medicine) 
 












IRB must consider potential risks 
that are posed by design features 
employed to assure valid results 
as well as by the particular 
interventions that may be 
performed in the course of the 
research. Subjects participating in 
a study whose research design 
involves random assignment to 
treatment groups face the chance 
that they may not receive the 
treatment that turns out to be 
more efficacious. Subjects 
participating in a double-masked 
study take the risk that the 
information necessary for 
individual treatment might not be 
available to the proper persons 
when needed. In behavioral, 
social, and some biomedical 
research, the methods for 
gathering information may pose 
the added risk of invasion of 
privacy and possible violations 
of confidentiality. Many risks of 
research are the risks inherent in 
the methodologies of gathering 
and analyzing data, although the 
more obvious risks may be those 
posed by particular interventions 
and procedures performed during 




Research methods or 
methodology 
 
Recruitment of participants 
 
Subject selection, sampling issues 
– who research is limited to, 
generalizability of the results to 
other populations 
 
Random assignment to study 
groups 
 
Does the research design 
adequately answer or have the 
potential to answer the research 
questions? 
 
Internal consistency between the 
research protocol/IRB application 
and the research design; 














Coercion - Potential coercion to 
































Informed consent is one of the 
primary ethical requirements 
underpinning research with 
human subjects; it reflects the 
basic principle of respect for 
persons. Informed consent is an 
ongoing process, not a piece of 
paper or a discrete moment in 
time. Informed consent assures 
that prospective human subjects 
will understand the nature of the 
research and can knowledgeably 
and voluntarily decide whether 
or not to participate. This 
assurance protects all parties: 
both the subject, whose 
autonomy is respected, and the 
investigator, who otherwise faces 
legal hazards. 
 
The terms and phrases listed in 
the next column indicate the 
various elements of informed 
consent that emerge during 
human subjects research. 
research design involves 
incomplete disclosure or 
deception, and if so, is debriefing 
included in the research process 
 
Debriefing (if deception was 
used) 
 
Full disclosure of risks, benefits, 
and required elements of 
participation (i.e., what must the 
participant do to participate in the 
study) 
 
Anonymity versus confidentiality 
 
Data confidentiality - 
Confidentiality is discussed; how 
will confidentiality be assured 
(specific steps that will be taken) 
 
Consent as a process throughout 
the study and not just a form for 
participants to sign at the 
beginning of the study. 
 
Who will consent the potential 
participants (research 
investigator, graduate assistants, 
etc.)? Do they have human 
subjects training? If vulnerable 
populations are involved, do the 
people consenting them have 
extra training to work with these 
populations? 
 
Reading level of consent form 
(8th grade level) 
 
Conflict of interest - Disclosure 
of conflict of interest that 
research investigator or university 
may have with any potential 
outcomes of the study (e.g., 
financial benefit) 
 
Research venue – where will 
research be performed? 
 
Vulnerable populations – are 
additional provisions in place to 
protect participants such as 


















The benefits of research fall into 
two major categories: benefits to 
subjects and benefits to society. 
 
Direct payments or other forms of 
compensation offered to potential 
subjects as an incentive or reward 
for participation should not be 
considered a "benefit" to be 
gained from research. 
Advantages or gains to 
participants 
 
Contribution to general 
knowledge in a particular domain 
 
Opportunity for further 
understanding, prevention, or 
alleviation of a serious problem 
affecting the health or welfare of 
study population 
 
Research experience of 
investigator (esp. if s/he is a 
student researcher) 
 





A risk is minimal where the 
probability and magnitude of 
harm or discomfort anticipated in 
the proposed research are not 
greater, in and of themselves, 
than those ordinarily encountered 
in daily life or during the 
performance of routine physical 





Low level of risk 
 
No more risk that one might 




















The probability of harm or injury 
(physical, psychological, social, 
or economic) occurring as a result 
of participation in a research 
study. Both the probability and 
magnitude of possible harm may 
vary from minimal to significant. 
Federal regulations define only 
"minimal risk." 
 
In the process of determining 
what constitutes a risk, only those 
risks that may result from the 
research, as distinguished from 
those associated with therapies 
subjects would undergo even if 
not participating in research, 
should be considered. 
 
Physical Harms (injury or illness) 
 
Psychological Harm (stress, 
embarrassment, emotional) 
 
Social and Economic Harms (loss 
of a job as a result participating in 
the study) 
 
Legal Harms (lawsuits resulting 
from participating in a study) 
 
Negative outcomes for 
participants 
 
Negative press for university 
 
Would I want my parent, child, 
friend, etc. to participate? 
 
Would I be comfortable 
participating in this study? 
 
Is experience of research 
investigator adequate to conduct 
the study safely? 










Assessment of risk-benefit ratio 
and anticipated benefits involves 
a series of steps. The IRB must: 
(1) identify the risks associated 
with the research, as 
distinguished from the risks of 
therapies the subjects would 
receive even if not participating 
in research; (2) determine that the 
risks will be minimized to the 
extent possible; (3) identify the 
probable benefits to be derived 
from the research; (4) determine 
that the risks are reasonable in 
relation to be benefits to subjects, 
if any, and the importance of the 
knowledge to be gained; (5) 
assure that potential subjects will 
be provided with an accurate and 
fair description of the risks or 
discomforts and the anticipated 
benefits 
 
Evaluation of the risk/benefit 
ratio is the major ethical 
judgment that IRBs must make in 
reviewing research proposals. 
The risk/benefit assessment is not 
a technical one valid under all 
circumstances; rather, it is a 
judgment that often depends upon 
prevailing community standards 
and subjective determinations of 
risk and benefit. 
 





Potential value to participant, to 
society, to knowledge 
 













Some IRBs feel that they are not 
or should not be responsible for 
assessing the quality of a 
protocol’s research design.  
 
Member must explicitly state that 
their IRB is not responsible for or 
should not be reviewing the 
research design of a research 
protocol 
 




NOT our job to review research 
design 
 
NOT peer review (of design or 
methods) 
 












Some IRBs feel that they are not 
or should not be responsible for 
assessing the scientific merit of a 
study. Some members also 
believe that certain research (e.g., 
most student research) should not 
be subject to this criterion 
because there is inherent value to 
 
 
NOT scientific review 
 
NOT scientific value 
 
NOT our job to review scientific 
merit or value 
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NOT scientific merit society by virtue of the student’s 
experience conducting the 
research study.  
 
Member must explicitly state that 
their IRB is not responsible for or 
should not be reviewing the 
scientific merit of a research 
protocol 
 
NOT peer review (of merit or 
value) 
 















Characteristics or qualities 
inherent to each member or that 














Years of IRB experience 
 
Service on another IRB 
 
Role on committee (e.g., devil’s 










Domain of expertise 






Lack of expertise 
 
Development of expertise over 





APPENDIX F: FINAL CODEBOOK FOR IRB MEETING OBSERVATION TRANSCRIPTS 
 
Code Definition/explanation Synonyms/related themes 















Presence (or lack thereof) of 
mechanisms that encourage 
members to participate in the 
decision-making process both 
independently before the 
convened IRB meeting and as a 
group during the convened IRB 
meeting 
Assignment of reviews to 
members 
 
Opportunity to directly 
participate 
 
Influence over decision outcome 
(weight opinion carries during 
group discussion) 
 
Number of nonaffiliated or lay 
members present at meeting 
 
Presence of nonaffiliated or lay 
members during vote 
 
Resources for participation 


















Refers to the group discussion 
process, specifically 
characteristics of the convened 
IRB meeting such as how formal 
or structured the meetings are, 
how disagreement over specific 
issues are resolved (e.g., level of 
risk, research design, 
compensation) 
 
Also includes leadership roles of 
various members, history of 
group, cohesiveness of group, 
composition of group 
 
Formality or structure of 
meetings  
 
Consensus versus majority vote 
 
Work out differences of opinion 
through discussion 
 
Give and take on certain issues 
 
Incorporate differences of 
opinion in condition letter to 
research investigator 
 
Deference to authority or experts 
 
Presence of dominant 
personalities 
 
Leadership style of IRB chair 
(autocratic versus democratic) 
 
Role of  IRB administrator (group 
history, regulatory knowledge) 
 
Agreement on purpose of IRB 
 
Favorable opinion of IRB chair 
 




Respect for different opinions and 
perspectives 










The purview of the IRB; what 
members believe is the purpose 
or goal of the IRB 




Protect the researchers 
 


















Benefit of the research to society 
and/or knowledge in general 
Scientific value 
 




Contribution to knowledge 
generation 
 
Contribution to science (or 
medicine) 
 












IRB must consider potential risks 
that are posed by design features 
employed to assure valid results 
as well as by the particular 
interventions that may be 
performed in the course of the 
research. Subjects participating in 
a study whose research design 
involves random assignment to 
treatment groups face the chance 
that they may not receive the 
treatment that turns out to be 
more efficacious. Subjects 
participating in a double-masked 
study take the risk that the 
information necessary for 
individual treatment might not be 
available to the proper persons 
when needed. In behavioral, 
social, and some biomedical 
research, the methods for 
gathering information may pose 
the added risk of invasion of 
privacy and possible violations 
of confidentiality. Many risks of 
research are the risks inherent in 
the methodologies of gathering 
and analyzing data, although the 




Research methods or 
methodology 
 
Recruitment of participants 
 
Subject selection, sampling issues 
– who research is limited to, 
generalizability of the results to 
other populations 
 
Random assignment to study 
groups 
 
Does the research design 
adequately answer or have the 
potential to answer the research 
questions? 
 
Internal consistency between the 
research protocol/IRB application 
and the research design; 




posed by particular interventions 
and procedures performed during 






































Informed consent is one of the 
primary ethical requirements 
underpinning research with 
human subjects; it reflects the 
basic principle of respect for 
persons. Informed consent is an 
ongoing process, not a piece of 
paper or a discrete moment in 
time. Informed consent assures 
that prospective human subjects 
will understand the nature of the 
research and can knowledgeably 
and voluntarily decide whether 
or not to participate. This 
assurance protects all parties: 
both the subject, whose 
autonomy is respected, and the 
investigator, who otherwise faces 
legal hazards. 
 
The terms and phrases listed in 
the next column indicate the 
various elements of informed 
consent that emerge during 
human subjects research. 
Coercion - Potential coercion to 




Deception - Consider when the 
research design involves 
incomplete disclosure or 
deception, and if so, is debriefing 
included in the research process 
 
Debriefing (if deception was 
used) 
 
Full disclosure of risks, benefits, 
and required elements of 
participation (i.e., what must the 
participant do to participate in the 
study) 
 
Anonymity versus confidentiality 
 
Data confidentiality - 
Confidentiality is discussed; how 
will confidentiality be assured 
(specific steps that will be taken) 
 
Consent as a process throughout 
the study and not just a form for 
participants to sign at the 
beginning of the study. 
 
Who will consent the potential 
participants (research 
investigator, graduate assistants, 
etc.)? Do they have human 
subjects training? If vulnerable 
populations are involved, do the 
people consenting them have 
extra training to work with these 
populations? 
 
Reading level of consent form 
(8th grade level) 
 
Conflict of interest - Disclosure 
of conflict of interest that 
research investigator or university 
may have with any potential 
outcomes of the study (e.g., 
financial benefit) 
 
Research venue – where will 
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research be performed? 
 
Vulnerable populations – are 
additional provisions in place to 
protect participants such as 











A valued or desired outcome; an 
advantage. 
 
The benefits of research fall into 
two major categories: benefits to 
subjects and benefits to society. 
 
Direct payments or other forms of 
compensation offered to potential 
subjects as an incentive or reward 
for participation should not be 
considered a “benefit” to be 
gained from research. 
Anticipated benefit 
 
Advantages or gains to 
participants 
 
Contribution to general 
knowledge in a particular domain 
 
Opportunity for further 
understanding, prevention, or 
alleviation of a serious problem 
affecting the health or welfare of 
study population 
 
Research experience of 
investigator (esp. if s/he is a 
student researcher) 
 





A risk is minimal where the 
probability and magnitude of 
harm or discomfort anticipated in 
the proposed research are not 
greater, in and of themselves, 
than those ordinarily encountered 
in daily life or during the 
performance of routine physical 





Low level of risk 
 
No more risk that one might 














The probability of harm or injury 
(physical, psychological, social, 
or economic) occurring as a result 
of participation in a research 
study. Both the probability and 
magnitude of possible harm may 
vary from minimal to significant. 
Federal regulations define only 
“minimal risk.” 
 
In the process of determining 
what constitutes a risk, only those 
risks that may result from the 
research, as distinguished from 
those associated with therapies 
subjects would undergo even if 
not participating in research, 
should be considered. 
 
Physical Harms (injury or illness) 
 
Psychological Harm (stress, 
embarrassment, emotional) 
 
Social and Economic Harms (loss 
of a job as a result participating in 
the study) 
 
Legal Harms (lawsuits resulting 
from participating in a study) 
 
Negative outcomes for 
participants 
 
Negative press for university 
 
Would I want my parent, child, 




Would I be comfortable 
participating in this study? 
 
Is experience of research 
investigator adequate to conduct 











Assessment of risk-benefit ratio 
The IRB’s assessment of risks 
and anticipated benefits involves 
a series of steps. The IRB must: 
(1) identify the risks associated 
with the research, as 
distinguished from the risks of 
therapies the subjects would 
receive even if not participating 
in research; (2) determine that the 
risks will be minimized to the 
extent possible; (3) identify the 
probable benefits to be derived 
from the research; (4) determine 
that the risks are reasonable in 
relation to be benefits to subjects, 
if any, and the importance of the 
knowledge to be gained; (5) 
assure that potential subjects will 
be provided with an accurate and 
fair description of the risks or 
discomforts and the anticipated 
benefits 
 
Evaluation of the risk/benefit 
ratio is the major ethical 
judgment that IRBs must make in 
reviewing research proposals. 
The risk/benefit assessment is not 
a technical one valid under all 
circumstances; rather, it is a 
judgment that often depends upon 
prevailing community standards 
and subjective determinations of 














Potential value to participant, to 
society, to knowledge 
 












Some IRBs feel that they are not 
or should not be responsible for 
assessing the quality of a 
protocol’s research design.  
 
Member must explicitly state that 
their IRB is not responsible for or 
should not be reviewing the 
research design of a research 
protocol 
 




NOT our job to review research 
design 
 
NOT peer review (of design or 
methods) 
 












NOT scientific merit 
Some IRBs feel that they are not 
or should not be responsible for 
assessing the scientific merit of a 
study. Some members also 
believe that certain research (e.g., 
most student research) should not 
be subject to this criterion 
because there is inherent value to 
society by virtue of the student’s 
experience conducting the 
research study.  
 
Member must explicitly state that 
their IRB is not responsible for or 
should not be reviewing the 





NOT scientific review 
 
NOT scientific value 
 
NOT our job to review scientific 
merit or value 
 
NOT peer review (of merit or 
value) 
 















Characteristics or qualities 
inherent to each member or that 














Years of IRB experience 
 
Service on another IRB 
 
Role on committee (e.g., devil’s 










Domain of expertise 






Lack of expertise 
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